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Abstract
 
 
Introduction: Myofascial release (MFR) is a form of manual therapy that involves the 
application of a low load, long duration stretch to the myofascial complex, intended to restore 
optimal length, decrease pain, and improve function. MFR is being used to treat patients with 
a wide variety of conditions, but there is a scarcity of evidence to support its efficacy. Studies 
are emerging in this field with varying results and conclusions. Analysis of the recent research 
trials and reviews will be a better way to appraise the quality and reliability of such works. 
  
Objective: This work attempts to analyse and summarise the evidence from three randomised 
controlled trials (RCTs) and one systematic review of the effectiveness of MFR on various 
neuromuscular conditions and pain. 
 
Methodology: Effectiveness of MFR on tension type headache, lateral epicondylitis and 
chronic low back pain were the RCTs identified for the analysis. The systematic review 
selected analysed the published RCTs on MFR till 2014. The methodological qualities of the 
studies were assessed using the PEDro, Centre for Evidence-Based Medicine's (CEBM) Level 
of Evidence Scale, Risk of Bias (RoB) Analysis Tool and AMSTAR 2. 
  
Results: The RCTs analysed in this study were of moderate to high methodological quality 
(PEDro scale), with higher level of evidence (CEBM scale) and less bias (RoB). The 
effectiveness of MFR on tension type headache (TTH) was the first among the studies with a 
moderate methodological quality (6/10 in PEDro), with a 2b level of evidence on the CEBM 
scale. The study proved that direct technique or indirect technique MFR was more effective 
 than the control intervention for TTH. The second RCT studied MFR for lateral epicondylitis 
(LE). The study was of a moderately high quality on the PEDro scale (7/10) with a 1b- level in 
CEBM.  The MFR was found more effective than a control intervention for LE in computer 
professionals. The RCT on chronic low back pain (CLBP) also scored 7/10 in the PEDro scale 
and 1b in the CEBM scale.  This study confirmed that MFR is a useful adjunct to specific back 
exercises and more helpful than a control intervention for CLBP. All three RCTs stated the 
usage of self-report measures and underpowered sample size as the major limitations along 
with a performance bias reported in the TTH trial.  
The systematic review demonstrated moderate methodological quality as per the 
AMSTAR 2 tool which analysed 19 RCTs for a result. The literature regarding the 
effectiveness of MFR was mixed in both quality and results. Omission of a risk of bias analysis 
was the major limitation of this review. The authors quoted that “MFR may be useful as either 
a unique therapy or as an adjunct therapy to other established therapies for a variety of 
conditions”.  
 
Conclusion: Critical appraisal is an important element of evidence-based medicine to carefully 
and systematically examine research to judge its trustworthiness, its value and relevance in a 
particular context. This review concludes that the three RCTs and the systematic review 
analysed were completed with moderate to good quality as per various quality measures, but 
with reported methodological flaws and interpretation biases. These studies with the critical 
appraisal can act as ‘pavements’ on which high quality future MFR trials and evidence can be 
built on.    
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Chapter 1 
Introduction 
 
1.1. Introduction 
Musculoskeletal pain and dysfunction are amongst the leading reasons for visits to 
physicians and manual therapists and are the most common cause of long-term chronic pain, 
affecting people worldwide in the range of hundreds of millions (Woolf & Pfleger, 2003). 
Without proper treatments, chronic pain can have a strong disruptive impact on an individual’s 
physical, psychological and social well-being.  At the societal level, pain creates a tremendous 
economic and workplace burden. As the prevalence of musculoskeletal pain is projected to rise 
with a sedentary but longer living worldwide population (Woolf & Pfleger, 2003), it calls for 
greater effort in the development and evaluation of new ways of managing these patients. 
Recent studies have demonstrated the role of fascia in various musculoskeletal dysfunctions as 
the fascial tissues connect the skeletal muscles forming a body wide web with some pattern 
called as ‘myofascial meridians’ (Luomala & Pihlman, 2016). As fascia is able to modify its 
tensional state, strain transmission along the meridians might occur in response to changes of 
muscle activity (Wilke et al., 2016). 
Fascia is a ubiquitous tissue permeating the entire body. It surrounds, supports, 
suspends, protects, connects and divides muscular, skeletal and visceral components of the 
organism (Kumka & Bonar, 2012). It not only lubricates the fibres but gives nourishment to all 
parts of the body (Still, 1910). The fascial system is considered as a “tensegrity” or tensional 
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integrity structure to manage the balance between tension and compression around the organs, 
joints and muscles (Chen et al., 2016).  Its continuity aids in force transmission both longitu-
dinally and epimuscularly (Maas & Sandercock, 2010; Yucesoy, 2010). Through ‘mechano-
transduction’, these forces may be transmitted at a cellular level, altering gene expression of 
fibroblasts and thereby changing the extracellular matrix composition (Langevin et al., 2010; 
Chaitow, 2016). 
Repetitive mechanical straining of fibroblasts can also result in secretion of 
inflammatory mediators (Dodd et al., 2006). All of these changes could affect the normal 
functions of force transmission or sliding in the musculoskeletal system. This dysfunction 
could lead to pain or proprioceptive issues, considering that fascia has been shown to be 
innervated. Thus, treatment of disorders affecting the musculoskeletal system may need to be 
focused on this fascial network (Kwong& Findley, 2014). Recently, treatments of fascial 
tissues have become increasingly popular in musculoskeletal disorders (Wilke et al., 2016). 
This tensional network of fibrous tissues includes dense sheets such as muscle 
envelopes, aponeuroses, as well as specific local adaptations, such as ligaments or tendons 
(Schleip et al., 2013). The importance of the fascia to normal function has been recognized by 
‘hands-on’ practitioners for more than a century (Still, 1910; Findley & Shalwala, 2013) but it 
is only recently that it has emerged as a significant contributor to mainstream orthopaedic 
knowledge (Schleip et al., 2012).  
There are multiple theories as to how myofascial tissue is altered after trauma or 
overuse, extending from cellular (viscoelasticity, piezoelectricity, tensegrity etc.) to global 
level (force transmission, sliding, fluid dynamics, hysteresis, innervation, sensitisation etc.), 
which are explained later in this thesis. Chronic tension in fascia, impaired fascial healing 
response, damage to proprioception, alteration of collagen fibre composition, transformation 
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of fibroblasts into myofibroblasts, or changes in ground substance were the most attributable 
pathological processes mentioned in literatures (Liptan, 2010; Stecco et al., 2010). 
After an injury, inflammation may occur, which could have a role in altering fascia. 
The biochemical milieu of myofascial trigger points- hyperirritable spots in the fascia 
surrounding skeletal muscle- has been shown to contain many substances both locally and 
remotely, including substance P, calcitonin, gene-related peptide, bradykinin, 5-
hydroxytryptamine, norepinephrine, tumor necrosis factor alpha, and interleukin 1-beta 
(Kwong & Findley, 2014). These inflammatory substances may result in activation of 
fibroblasts into myofibroblasts when combined with a tensioned environment (Tomasek et al., 
2002). This, in turn, may lead to alterations in gene expression (Arnsdorf et al., 2010) causing 
changes in the extracellular matrix including altered ‘hyaluronic acid’ production. This may 
result in restriction in fascia, leading to altered lines of force with muscle contraction (Stecco 
et al., 2013; Meltzer et al., 2010). These processes may contribute to the decreased movement 
between fascial layers (Langevin et al., 2011). Over time, these biomechanical changes from 
restricted fascia could lead to decreased strength, coordination, (Ercole et al., 2010; Stecco et 
al., 2013) pain or proprioceptive issues; considering that fascia has been shown to be innervated 
(Tesarz et al., 2011). Thus, treatment of disorders affecting the musculoskeletal system may 
need to be focused on this fascial network.  
Studying fascia objectively at the basic science and clinical levels will provide 
important information that may change clinical practice. Once the structure and functions of 
fascia in the musculoskeletal system are further elucidated, the pathophysiology of many 
disorders and their consequences may be better explained. Many neuromuscular and 
musculoskeletal disorders can be additionally served by research with a fascial perspective in 
order to optimize treatment strategies (Kwong & Findley, 2014). 
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1.2. Fascia Explained 
Once dismissed as a packing tissue of little consequence, the fascia is now recognized 
as a continuous interconnected network that permeates and envelops almost every part of the 
body and is now taking its rightful place at the ‘top table’ of anatomical and physiological 
research (Scarr, 2016).Fascia is an uninterrupted viscoelastic tissue which forms a functional 
three-dimensional collagen matrix (Kumka & Bonar, 2012; LeMoon, 2008)“continuous 
throughout the entire organ” (Purslow & Delage, 2012) with many diverse and important 
functional roles (Schleip et al., 2012a; Tozzi, 2015a).  “Fascia is the place to look for the cause 
of disease and the place to consult and begin the action of remedies in all diseases” (Still, 1899).  
The term ‘fascia’ refers to dense planar tissue sheets such as the ‘deep’ or ‘investing’ 
fascia (fascia profunda), septa, aponeuroses, joint and organ capsules, the epimysium that 
surrounds muscles, the softer ‘superficial’ fascia beneath the skin, the intra-muscular 
endomysium that surrounds individual muscle fibres and perimysium that surrounds bundles 
of these fibres. It also includes the dura mater, periosteum, neurovascular sheaths, abdominal 
mesentery etc. and is continuous with ‘non- fascial’ densifications in the form of ligaments, 
tendons (Benjamin, 2009; Schleip et al., 2012b), periosteum and bone (Aaron, 2012). Because 
fascia has a sheet-like structure attaching to muscles and bones at multiple sites, it is exposed 
to different states of multi- or biaxial strain. 
Fascia surrounds, supports, suspends, protects, connects and divides muscular, skeletal 
and visceral components of the organism (Kumka & Bonar, 2012; Schleip, 2003). It is formed 
of numerous layers of collagen fibre bundles (Stecco et al., 2007a) and is extremely strong 
(Findley et al., 2012) but plastic (Schleip, 2003). It has been reported that fascia displays 
piezoelectric effects (Façade &Yasuda, 1964), alters in stiffness following changes in water 
content (Chaitow, 2009), is richly innervated with nerve endings (Benjamin, 2009; Stecco et 
al., 2007a) and contains many mechanoreceptors (Yahia et al., 1992). 
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Fascia seems to be integrally involved in the biomechanics of the musculoskeletal 
system (Gerlach & Lierse, 1990), may be involved in force transmission (Benjamin, 2009), 
may contract like smooth muscle (Schleip et al., 2005), and can become inflamed and 
potentially cause pain (Bednar et al., 1995). 
The fascia plays different physiological and functional roles related to joint stability, 
general movement coordination, proprioception, nociception (Tozzi, 2012) and is associated 
with wound healing, tissue repair and many connective tissue pathologies (Gabbiani, 2003). 
Fascia is a continuous structure that attaches, stabilizes, encloses and separates almost all 
internal organs including muscles and bones. The fascia embodies the element of structural 
interconnectedness around, within and between body elements starting from the cellular level, 
with simultaneous sliding and gliding motions (Tozzi, 2015a). Since it appears everywhere in 
the body with its characteristics structure and functions, it has been referred to as both an ‘organ 
of form’ (Varela and Frenk, 1987) and as an ‘organ of innerness’ (“due to its phenomenological 
dimension of ‘in between’ the ‘outer’ and the ‘inner’ boundaries of the body”) (Tozzi, 2015a). 
Instead of consisting of different superimposed layers, gliding on each other, it has been 
proposed as a single architecture with various levels of form and complexity (Guimbertau, 
2012). It has been defined as an ‘ectoskeleton’ (Wood Jones, 1944), in relation to its continuity 
and function of muscle attachment, enveloping, force transmission and body-wide 
proprioception.  
Even at a cellular level, fascia displays an interconnected arrangement with soft tissue 
fibroblasts within the Extra-cellular matrix (ECM) forming an extensive reticular network, via 
their cytoplasmic expansions, that permeates the whole body (Langevin et al., 2004). 
Fibroblasts may actually form ‘adherens’ and ‘gap junctions’ at the intercellular levels of 
contact, allowing also for a more concerted response to mechanical loading (Ko et al., 2000). 
Furthermore, each fibroblast’s cytoskeleton is structurally connected to the external 
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environment, either directly with contiguous cells or through the ECM constituents (Fletcher 
& Mullins, 2010). The entirety of this system may indeed represent a body-wide signalling 
network (Langevin, 2006) that depends on the relationship between cells and the surrounding 
matrix. Mechanical tension signals from the ECM are transferred through transmembrane 
mechanoreceptors to the cytoskeleton and cell nuclei, while being transduced into chemical 
information -via mechanotransduction- so impacting on various aspects of cell behaviour and 
metabolism via the modulation of gene expression (Wang et al., 2009; Tozzi, 2015a).  
The myofascia is a fibrous specialization of fascial/ ECM tissues that enclose and inter-
penetrate muscles as a complex hierarchy of tubes containing smaller tubes within them; and 
is continuous with higher-level fascial tubes that surround groups of muscles, the limbs and 
entire body (Scarr, 2016). Bundles of collagen fibres within the perimysium and epimysium 
are typically aligned in two distinct directions that together form crossed-helical patterns, and 
this arrangement also appears within the deep investing fascia surrounding groups of muscles 
and the body wall (Tozzi, 2015b). These particular fibre orientations are a reflection of the 
most efficient distribution of mechanical stresses; and the same basic principles are likely to 
apply to the walls of all these tubular sheaths (Tozzi, 2015b). 
1.2.1. Fascial Classification System 
In an effort to organize nomenclature for fascia provided by the ‘Federative 
International Committee on Anatomical Terminology’ (FICAT), Kumka, & Bonar (2012) 
developed a functional classification system which includes four categories of fascia: i) linking, 
ii) fascicular, iii) compression and iv) separating fasciae. 
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1.2.1. a. Linking Fascia 
The linking category is predominantly dense, regular, parallel ordered and 
unidirectional connective tissue proper with a significant amount of collagen type I (Gordon & 
Hahn, 2010). This includes fasciae of muscles, fasciae of regions (head & neck, trunk, limbs), 
aponeuroses, tendinous arches and neurovascular sheaths (FICAT, 2008). 
This category is subdivided into dynamic and passive divisions (Kumka, & Bonar, 
2012). The dynamic division includes major fascial groups more significantly related to 
movement and joint stability, and characterized by higher concentrations of contractile and 
proprioceptive fibres. The dynamic division is composed of fasciae of muscles (investing layer, 
fascia of individual muscle) and fasciae of the trunk (FICAT, 2008). 
 The passive division is acted on by other extramuscular tissues to maintain continuity 
throughout the body or form tunnels and sheaths (van der Wal, 2009). The passive division 
incorporates fasciae of muscles (muscle sheaths), fasciae of the head and neck, fasciae of limbs, 
aponeuroses, tendinous arches, and retinaculae (Kumka, & Bonar, 2012).  The 
passive linking fasciae can only transmit force when they are stretched and loaded, 
while dynamic fasciae can theoretically contract more autonomously like smooth muscle, 
thereby affecting tension in the musculoskeletal system, but not significant enough to be the 
primary mover of limbs (Schleip et al., 2005). 
1.2.1. b. Fascicular Fascia 
Fascicular fascia forms adaptable tunnels which bundle vessels as well as fascicles 
within muscle, tendon, bone and nerves. Fascicular fascia plays an important role in 
organization, transport, strength and locomotion (Purslow & Delage, 2012). This category is 
organized as a mixture of both loose and dense regular multidirectional connective tissues 
(FICAT, 2008). Types I and III collagen are the major components of these tissues with lesser 
 
9 
amounts of Types V, VI, XII, and XIV (Gordon & Hahn, 2010; Purslow & Delage, 2012). 
Fascicular fascia of the muscle comprises three distinct layers: epimysium, perimysium and 
endomysium (Purslow & Delage, 2012). 
The fascicular fascia of the muscle converges into a dense, regular connective tissue 
link at the myotendinous junction to become fascicular fascia of the tendon, comprising 
endotendon, peritendon and epitendon (van der Wal, 2009). At this junction, fascicular fascia 
is richly innervated by Golgi tendon organs which are stimulated by muscle contraction (Ross 
& Pawlina, 2011). Tension in the tendon results in a reflex decrease in tonus in contiguous 
striated muscle fibres (Langevin & Sherman, 2007). 
Fascicular fasciae allow forces to be transferred from within muscle to synergistic 
muscles, and also, via the extramuscular pathway, through the linking fascia, to antagonistic 
muscles (Huijing, 2009). The fascicular fascia forms the connective tissue envelope for nerve 
fascicles and whole peripheral nerves: perineurium and epineurium, respectively (Ross & 
Pawlina, 2011). The perineurium serves as a metabolically active diffusion barrier that 
contributes to the formation of a blood-nerve barrier (Passerieux et al., 2006).   
1.2.1. c. Compression Fascia 
Compression fascia is a mixture of dense regular woven and multidirectional parallel 
ordered connective tissue layers that ensheath the whole limbs to create a stocking effect 
(FICAT, 2008). This fascial category plays an important role in locomotion and venous return 
due to its influence on compartmental pressure, muscle contraction and force distribution 
(Stecco et al., 2009).  The spatial orientation of the collagen fibres changes from layer to layer 
within the compression fascia. The presence of loose connective tissue interposed between 
adjacent layers permits local sliding, allowing the single layers to respond more effectively 
(Stecco et al., 2009).   
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1.2.1. d. Separating Fascia 
Separating fascia is generally loose connective tissue and dense irregular fusocellular 
connective tissue (FICAT, 2008). The reticular Type III collagen fibres and elastic fibres are 
the major components of the ECM of separating fascia, with small amounts of collagen Types 
V and VII. While the reticular fibres provide a supporting framework for the cellular 
constituents, the elastic fibres form a three dimensional network to allow separating fascia to 
respond to stretch and distention (Ross & Pawlina, 2011). Separating fascia divides the body 
in visible sheets and layers of varying fibres allowing it to take up forces and friction in all 
directions. While its major function is to allow more efficient sliding of tissues over one 
another, it may still form adhesions from faulty movement patterns or injury (Hedley, 2010).  
FICAT’s terms for separating fascia include: parietal fascia, visceral fascia, 
extraserosal fascia and investing/subcutaneous fascia. This category also includes synovial 
sheaths and fasciae of limbs (FICAT, 2008). Parietal fascia lies outside the parietal layer of 
serosa such as pericardium, pleura and peritoneum and lines the wall of a body cavity. Visceral 
fascia lies immediately outside the visceral layer of the serosa and surrounds the 
viscera. Extraserosal fascia lies within the space between the visceral and parietal fasciae 
(FICAT 2008).  
This fascia class is a complex connective tissue matrix, enveloping everything from 
body cavities to individual organs. It separates, supports, and compartmentalizes organs and 
regions in order to maintain proper structural and functional relationships throughout the body. 
This group of fascia has a unique appearance and texture upon observation, ranging from 
transparent woven sheets to a fuzzy cotton-like consistency (Hedley, 2010). 
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1.2.2. Histology 
Fascia has specific cells, ground substance and fibre types that make it a form of 
connective tissue proper (Kumka, & Bonar, 2012). Collagen, a triple helix glycoprotein, is the 
key structural fibre that gives connective tissue its ability to resist tension. There are twenty 
five distinct collagen types recognized in the Ross histology textbook and atlas, and twenty 
eight collagen types recognized in the latest review by Gordon (Ross & Pawlina, 2011; Gordon 
& Hahn, 2010). Although, type I collagen is the main type accounting for 90% of the human 
body’s collagen, fascia contains an array of collagen type combinations including, but not 
limited to, types I, III, IV, V, VI, XI, XII, XIV and XXI (Gordon & Hahn, 2010). Collagen 
provides resistance to tension and stretch, which commonly occur in fascial tissues, such as 
ligaments, tendons, sheaths, muscular fascia and deeper fascial sub-layers (Ross & Pawlina, 
2011).  
Collagen type III, also known as reticular fibre, is involved in forming the scaffolding 
for the cells of the loose connective tissues related to the endoneurium, vascular walls and 
smooth muscle (LeMoon, 2008). A collagen fibril needs the support of not only fibrillar 
collagen types, but also a mix of non-fibrillar forms known as fibril-associated collagens with 
interrupted triple helices (FACITs). The functions of FACITs include: i) anchoring to the 
basement membrane, ii) regulating the diameter of fibrils, iii) forming lattice networks and iv) 
acting as transmembrane structures (Gordon & Hahn, 2010). These fibrils are important to the 
integrity and function of fascia within the ECM. Elastic fibres within the ground substance give 
fascia its characteristic stretch (Kumka, & Bonar, 2012).  
A combination of multiple types of collagen within the extracellular matrix forms a 
unique structure, like a blueprint that reflects the function and compliance of fascia in various 
regions. Without a characteristic fibre arrangement and composition for each fascial region, it 
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is likely that fascia would not withstand stresses or have the same function (Kumka, & Bonar, 
2012). 
The cells within fascia include fibrocytes (fibroblasts, myofibroblasts), adipocytes and 
various migrating white blood cells (Chirasatitsin & Engler, 2010). Fibroblasts are highly 
adaptable to their environment and show a capacity to remodel in response to the direction of 
various mechanical stimuli, producing biochemical responses (Stecco et al., 2009; Meltzer et 
al., 2010). If function changes, as with increased mechanical stress, or prolonged 
immobilization, deoxyribonucleic acid (DNA) transcription of pro-collagen in the fibroblasts 
will change types (e.g., collagen type I into collagen type III), or undifferentiated cell types 
may adapt towards a more functionally appropriate lineage (e.g., chondrocyte) (Kumka, & 
Bonar, 2012).  
 It was established that the tissue structure and the molecular composition of ECM are 
directly correlated with the local mechanical forces. Under significant states of 
compression, tissue once populated with fibroblasts becomes invested predominately with 
chondrocytes and forms specialized connective tissue, cartilage, with further solid mineral 
deposition (Milz et al., 2005). These adaptations have been demonstrated in the supraspinatus 
tendon, transverse acetabular ligament, transverse ligament of atlas, as well as various other 
ligaments and tendons throughout the body (Milz et al., 2005).  
Myofibroblasts within fascia demonstrate contractile properties and contain actin-
myosin filaments typically seen in smooth muscle.  An estimation of tension created by 
contraction of myofibroblasts when extrapolated to a large fascial sheet (i.e., thoracolumbar 
fascia) may produce tension within the musculoskeletal system between 30–40N (Schleip et 
al., 2009).  
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Increased concentration of myofibroblasts in pathological fascia has been observed, 
suspected to create tissue contractures in clinical conditions like palmar fascial fibromatosis 
(Dupuytren’s disease), plantar fascial fibromatosis (Ledderhose’s disease) and adhesive 
capsulitis (frozen shoulder) (Hedley,2010). Fascia is also susceptible to the actions of typical 
cells of inflammation influencing communication, growth and function (Ross & Pawlina, 
2011).  
 Based on certain common characteristics, including the fibre arrangement, connective 
tissue proper is classified by the Terminologia Histologica as loose connective tissue and dense 
connective tissue. The dense connective tissue is sub-categorized as: i) unidirectional parallel 
ordered dense connective tissue, ii) multidirectional parallel ordered dense connective tissue, 
iii) woven connective tissue and iv) irregular fusocellular connective tissue (Kumka, & Bonar, 
2012). 
1.2.3. The Helical Tube 
The myofascia, as a fibrous specialization of fascial/ECM tissues that surround and 
interpenetrate muscles is then a complex hierarchy of helically-reinforced tubes contained 
within larger tubes and continuous with higher-level fascial tubes that surround groups of 
muscles, the limbs and entire body. Bundles of collagen fibres within the perimysium and 
epimysium form crossed-helical configurations that balance longitudinal and circumferential 
stresses and coordinate changes in muscle shape during contraction and extension and should 
thus be considered as an essential part of muscle function (Scarr, 2016). Tendon has a 
hierarchical structure that links tendon, fascicle, fibre and fibrils. In particular, tendon fibres 
are made up of fibrils that have distinctive wavy forms called crimps (Shim et al., 2012). 
The ‘walls’ of the perimysium and epimysium are distinct in that they frequently 
contain two crossed-ply sets of collagen cables aligned at about 55-600 (relative to the long 
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axis in resting fusiform muscles). All these angles increase with muscle contraction and when 
the muscle is stretched the angles decrease (Chaudhry et al., 2012).  
The cross helical model of fascial fibre arrangement are indeed contributing to the 
coordination of changes in muscle shape. They would also enable such tubes to bend smoothly 
without kinking and resist torsional deformations, thus further demonstrating the value of this 
particular arrangement to muscle mechanics (Scarr, 2016). Biological helixes consist of 
multiple discrete components (fibres) arranged into these particular geometric configurations 
since they are the most efficient packing arrangement within a dynamic environment (Pickett 
et al., 2000).  
Myofibroblasts generate significant tensional forces due to the presence of smooth 
muscle-like actin filaments within their cytoskeletons and transfer this into the surrounding 
ECM through transmembrane proteins, and they play an important role in tissue contracture 
during wound healing and other fascial pathologies (Tomasek et al., 2002). This contractile 
ability thus enables myofibroblasts to contribute to the intrinsic tension/passive stiffness of 
muscle and other tissues (Schleip et al., 2006), and perhaps even assist in organizing or fine-
tuning the crossed-helical lattice as the most efficient distribution of tension. 
1.2.4. Fascial Remodelling 
Fascia, when regularly put under increasing yet physiological strain, the inherent 
fibroblasts adjust their matrix remodelling activity such that the tissue architecture better meets 
demand. Fascial tissues also react to their dominant loading patterns. With the help of the 
fibroblasts, they slowly but constantly react to everyday strain as well as to specific training, 
steadily remodelling the arrangement of their collagenous fibre network (Kjaer et al., 2009). 
Research has confirmed the previously optimistic assumption that proper exercise 
loading -if applied regularly- can induce a more youthful collagen architecture, which shows a 
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more wavy fibre arrangement (Jarniven et al., 2002) and which also expresses a significant 
increased elastic storage capacity (Schleip & Müller, 2013) 
1.2.5. Myofascial Meridians 
Muscles of the human body do not function as independent units. Instead, they are 
regarded as part of a tensegrity-like body-wide network, with fascial structures acting as linking 
components (Wilke et al., 2016). Myofascial Meridians are based on gross anatomy and the 
ability of the myofascial system to pull, transmit strain, rebound, facilitate movement and 
provide stability to the human body (Tozzi, 2015a). Myers (2009, 2014) defined eleven 
myofascial meridians connecting distant parts of the body by means of muscles and fascial 
tissues. The central rule for the selection of a meridian’s components is a direct linear 
connection between two muscles. The theory of the myofascial meridians helps manual and 
movement practitioners explore how one structure affects other distance structures in the body. 
Because fascia can transmit tension (Norton-Old et al., 2013)and in view of its proprioceptive 
and nociceptive functions, existence of myofascial meridians could be responsible for disorders 
and pain radiating to remote anatomic structures (Myers, 2009).  
  The myofascial meridians have been referenced in several studies (Hyong & Kang, 
2013; Weisman et al., 2014; Grieve et al., 2015). Despite the references, the theory of the 
myofascial meridians is based on anecdotal evidence rather than evidence based research.  
Wilke et al. (2016), first showed that there was good evidence for the existence of three 
myofascial chains proposed by Myers (2009, 2014) through a systematic review, a search for 
peer-reviewed anatomic dissection studies published from 1900-2014. The review was adhered 
to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 
guidelines. The methodological quality of the enclosed studies was evaluated by using QUACS 
scale (QUality Appraisal for Cadaveric Studies) by two independent evaluators. Of these 
studies, evidence of each meridian and its transitions were classified as strong, moderate, 
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limited, conflicting or not existent (Wilke et al., 2016). A transition was considered a 
myofasical link between two muscles. For example, the gastrocnemius and hamstring are 
considered to be a transition of the superficial back line. The results yielded strong evidence 
for myofascial transitions in three of the six examined myofascial meridians: Superficial back 
line, back functional line and front functional line. In the superficial back line, three myofascial 
transitions (plantar fascia-gastrocnemius, gastrocnemius-hamstrings and hamstrings-lumbar 
fascia/erector spine) were verified in fifteen studies. In the back functional line, three 
myofascial transitions (latissimus-lumbar fascia, lumbar fascia-gluteus maximus and gluteus 
maximus-vastus lateralis) were verified in eight studies. Finally, the front functional line 
verified strong evidence for two myofascial transitions (pectoralis major-rectus abdominis and 
rectus abdominis-adductor longus) in six studies. There was moderate evidence for the 
meridians and transitions of the spiral line (five of nine verified transitions, based on twenty 
one studies) and the lateral line (two of five verified transitions, based on ten studies). There 
was no evidence for the meridians and transitions of the superficial front line, based on seven 
studies) (Wilke et al., 2016).    
The practical relevance of the findings by Wilke et al. (2016) regarding the existence 
of myofascial meridians can help explain how lines of pull and compensations in one structure 
of the body can impact other distance structures. As a result, more appropriate diagnostic, 
therapeutic and exercise strategies can be developed by manual and movement practitioners 
for their patients and clients. 
The research by Wilke et al. (2016) is the first systematic review to provide solid 
evidence for the existence of the ‘anatomy trains’ or myofascial meridians, especially for the 
superficial back line and front and back functional lines. Most of the reviewed studies did not 
specifically search for the finding of facial connectivity but mentioning them as a subordinate 
finding. Future studies can address and rectify these limitations. Future studies should include 
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randomised controlled in-vitro studies since most of the experimental researches were carried 
out using cadavers (Norton-Old, 2013; Barker et al., 2004). It will also be valuable to conduct 
further research on the spiral, lateral and superficial front lines to determine if there is stronger 
evidence to support their existence and begin to explore evidence for the deep front line and 
arm lines. Overall the finding from this systematic review can be considered as a starting point 
for further high-quality studies in search of the existence of strain transmissions across tissues 
connected by myofascial meridians.  
Therapists may use the myofascial chains as a conclusive orientation, but they should 
be aware that the functional implications remain to be studied (Wilke et al., 2016). Currently 
an increasing number of clinicians and anatomists show continued interest in the subject of 
myofascia, hence the possibility of further researches focused on the existence of myofascial 
links remains very high (van der Wal, 2009). The existence of myofascial meridians might help 
to explain the phenomenon of referred pain, which often occurs in nonspecific disorders. For 
example, myofascial trigger points of the calf have been shown to elicit pain that radiates to 
the sole of the foot and the dorsal thigh (Travell & Simons, 1992). 
Direct morphologic continuity between adjacent muscles provides the empirical 
background to extend diagnostic and therapeutic focus beyond a single anatomic structure 
(Wilke et al., 2016). Treatment according to myofascial meridians could be effective in 
reducing low back pain. Several studies have shown that patients with low back pain display 
reduced hamstring flexibility (Feldman, 2001; Hultman et al., 1992). Due to the direct 
morphologic relation of the hamstrings and low back region (both are part of the superficial 
back line) relieving tension of the posterior thigh muscles could be a conceivable approach to 
alleviate pain. Overload injuries in competitive sports represent another entity of pathologies 
which possibly occur because of the presence of myofascial meridians (Wilke et al., 2016). 
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Labovitz et al. (2011) and Bolivar et al. (2013) indicate that tightness of the 
gastrocnemius and hamstrings is associated with plantar fasciitis (PF).  Since gastrocnemius, 
hamstring and the plantar aponeurosis belong to the superficial back line, they might represent 
a target of exercise therapy. The study by Labovitz et al (2011) was a prospective cohort study 
with an aim of finding if hamstring tightness was an increased risk in PF and found that patients 
with Hamstring tightness were about 8.7 times as likely to experience PF in the corresponding 
foot compared with patients without hamstring tightness. Bolivar et al., in 2013, has tested 
almost the same hypothesis with 100 subjects in a case control study and proved that tightness 
of the posterior muscles of the lower limb was significantly correlating with the incidence of 
PF. Both the studies suggested that a stretching protocol for treatment of PF should look for 
both hamstring and triceps surae tightness. Since both studies were in non-randomised format, 
caution is needed in interpreting the findings and its generalisability. It also necessitates high 
quality confirmation studies to ascertain these findings. 
A study by Wilke et al., in 2015 evaluates the remote effects of lower limb stretching 
on cervical range of motion (ROM) based on the myofascial meridians and found that lower 
extremity stretching induced improvements of cervical range of motion and proved the 
existence of strain transfer along the course of myofascial meridians. This was a pilot study 
with a matched-pairs comparison. These findings have to be verified by using randomised, 
controlled studies with adequate sample size. The authors also pointed towards the limitations 
in the outcome measure used as it could not identify whether increases in flexibility were 
attained in flexion, pointing towards a measurement bias. 
In the later part of the year 2016, Krause et al., conducted a systematic review on 
intermuscular force transmission along myofascial chains based on cadaveric studies and in-
vivo experiments. This systematic review concluded that the tension/force can be transferred 
between at least some of the investigated adjacent myofascial structures. Even though the study 
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is concluding positively, the authors quoted that the applicability of the current results to in-
vivo conditions was hampered by three factors (i) heterogeneity in methods of force 
application, (ii) variation in the assessed outcomes and methods between studies and examined 
body regions and (iii) factor relates to the use of cadaver specimen for biomechanical testing 
(Krause et al., 2016).  It is also crucial to consider anatomical variations in continuity as well 
as histological differences in the linking structures when interpreting results. The study 
conducted by Krause et al. thus gives more in-depth analysis of the possible pitfalls in the 
current researches on the myofascial meridians existence. This study ends up by suggesting 
that such experiments should be done on fresh cadavers, as fixation as well as freezing and 
thawing could alter its biomechanical properties. The study concluded that future studies on 
the in-vivo behaviour of adjacent structures should further investigate the practical relevance 
of the proposed intermuscular myofascial connections for exercise prescription, injury 
prevention and rehabilitation. 
Wilke et al., in 2017(a) conducted a medium quality (PEDro Scale: 6/10, CEBM: 2b) 
randomised controlled study on sixty three healthy participants to compare the effectiveness of 
remote stretching based on myofascial chains as with local exercise on cervical range of motion 
(ROM). The participants were randomly assigned to one of three groups: remote stretching of 
the lower limb (LLS), local stretching of the cervical spine (CSS) or inactive control (CON). 
Prior (M1), immediately post (M2) and five minutes following intervention (M3) maximal 
cervical ROM were assessed. Both LLS and CSS increased cervical ROM compared to the 
control group in all movement planes and at all measurements (P < .05). Between LLS and 
CSS, no statistical differences were found (P > .05). The study concluded that lower limb 
stretching based on myofascial chains induces similar acute improvements in cervical ROM as 
local exercise. Methodological flaws and inadequate power hinders the study’s generalisability.  
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The authors have given caution in interpretation as “attained effects do not seem to be direction-
specific, further research is warranted in order to provide evidence-based recommendations”. 
Although these reviews yield positive evidence for the existence of myofascial chains 
and myofascial force transmissions, several aspects need further clarifications and in depth 
analysis. Future research should be dedicated to the presence of the meridians and force 
transmissions which could not be evidenced entirely in these works. Another issue related to 
the function of regional specializations so far remains unclear. Depending on its localization, 
fascia in general exhibits substantial differences concerning thickness, amount of elastic fibres 
(Stecco el al., 2008) and adherence and expansions to the surrounding soft tissues including 
muscles (Stecco el al., 2009). Also, the number of connecting fibres are not uniform and shows 
considerable variation for different transitions (Snow et al., 1995). This holds particular 
significance as the structures linking the muscular stations of the meridians encompass 
tendinous, aponeurotic and ligamentous tissue as well as the deep fascia. Finally, it is of utmost 
importance to elucidate the functional significance of the myofascial chains as the capability 
for strain transfer represents the decisive criterion to justify treatment of meridians. 
Randomised controlled in-vivo studies are warranted in order to draw more precise 
assumptions on the significance of myofascial chains for the movement system. Therapists may 
use the myofascial chains as a conclusive orientation but should be aware that the functional 
implications remain to be studied (Wilke et al., 2016). 
1.3. Biomechanics of Fascia 
The importance of the fascia to normal function has been recognized by ‘hands-on’ 
practitioners for more than a century (Still, 1899; Findley & Shalwala, 2013). But it is only 
recently that it has emerged as a significant contributor to mainstream medical knowledge 
(Schleip et al., 2012). It appears that the fascia mediates an active mechanical transference role 
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as it provides dynamic connections between and among the muscles and bones (Yang et al., 
2015).  
Passive myofascial tension, independent of CNS control, furnishes a basic stabilizing 
component to aid and maintain a balanced posture (Lunghi et al., 2016). This refers to a 
skeleton of soft tissue for muscular insertions called ‘ectoskeleton’. Moreover, the phenomenon 
of neurogenic inflammation triggered by stimulation of nociceptive receptors (Deising et al., 
2012) in fascia tissues is consistent with the notion that disruption of fascia physiology can 
have notable consequences on human health.  
Fascia is also capable of transmitting electrical signals throughout the body (Findley & 
Shalwala, 2013). Collagen, which is one of the main components of fascia, has been shown to 
have semiconductive, piezoelectric and photoconductive properties in-vitro (Yang et al., 2015). 
1.3.1. Fascia-Related Mechanisms Associated to Somatic Dysfunction  
1.3.1. a. Fasciagenic Model 
The Fasciagenic model of somatic dysfunction (Tozzi, 2015a) emphasizes two main 
interacting fascial changes - structural and functional - that may underlie somatic dysfunction 
and account for its palpable features (tissue texture changes, asymmetry, restriction of motion 
and tenderness). Several dysfunctional events may produce different forms of forces and 
responses in the fascia with consequent dysfunctional processes. 
Zink & Lawson (1979) proposed that myofascial compensation pivots on four anatomical 
‘transitional areas’ (lumbopelvic, thoracolumbar, cervicothoracic and craniocervical) that play 
a major role not only in defining the spinal curves, but also in compensating regional patterns, 
both during the periods of development and learning but also in adult life. (Lunghi, 2015). 
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1.3.1. b. Fascial Architecture 
Fibroblasts display cytoskeletal remodelling as part of normal function and, in particular, 
under changes in mechanical tension, resulting in actin redistribution and actomyosin 
contractility within minutes (Langevin et al., 2006) ultimately causing an increase in the fascial 
thickening. This process of thickening and densification of the fascia may explain the reduction 
of sliding potential between involved fascial layers and adjacent structures, as observed in 
patients with non-specific neck and low back pain (Tozzi et al., 2011; Langevin et al., 2011). 
Chronic conditions may ultimately result in fibrosis and tissue adhesions (Wynn, 2008). The 
latter has been shown to potentially initiate pain in distant structures, such as myofascial pain 
in adjacent tissues (Lewit & Olsanska, 2004). Also due to fascial ‘tensegritive’ behaviour 
(Ingber, 2008), any fascial dysfunction may easily cause body-wide repercussions from a gross 
macroscopic anatomy to a molecular level, potentially creating stress on any structure 
enveloped by fascia, hence requiring progressive body adaptation at a local and global level 
(Levin & Martin, 2012). 
In 2014, Stecco et al., conducted a medium quality (PEDro: 5/10; CEBM: 2b)  randomised 
controlled trial to understand the possible role of the deep fasciae in chronic neck pain (CNP) 
and the utility of the ultrasonography in the diagnosis of myofascial neck pain by comparing 
twenty five healthy subjects and twenty eight CNP patients. The fascial thickness of the 
Sternal ending of the Sternocleidomastoid and medial scalene muscles were analysed by 
ultrasonography along with other outcome measures. The study established significant 
differences between healthy subjects and patients with CNP in the thickness of the 
sternocleidomastoid and scalene fascia and the effect of facial manipulations on it at the end 
of the treatment and follow-up. The study ends by commenting that the loose connective 
tissue inside the fascia may play a significant role in the pathogenesis of CNP. The variation 
of thickness of the fascia correlated with the increase in quantity of the loose connective 
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tissue but not with dense connective tissue. Even though the study was in an RCT format, the 
methodological flaws and small sample size makes the generalisability under shadow. It is 
still unknown how the finding of the ‘increased fascial thickness’ could be used to explain 
the role of ‘loose connective tissue in the pathogenesis of CNP’ when the reliabili ty of 
ultrasound itself is in question for fascial analysis. It should be appreciated that the fascia 
based experiments are advancing from the cadaver based anatomical observations to RCTs 
with real time observations. 
1.3.1. c. Fascial Contractility 
It has been proposed that fascia may contract in a smooth muscle-like manner (Schleip 
et al., 2005), independently of skeletal muscle activity. This is possibly related to the presence 
of smooth muscle cells found in fascial tissue (Staubesand et al., 1997) and the capacity of 
myofibroblasts to contract via intracellular alpha smooth-muscle actin (a- SMA) (Hinz & 
Gabbiani, 2003). This hypothesis was supported by in-vitro studies demonstrating an 
autonomous contraction of human lumbar fascia and a pharmacological induction of 
temporary contraction in porcine and rat fascial tissue when stimulated with various 
pharmacological agents i.e., mepyramine, angiotensine and glyceryltrinitrate (Masood & 
Naylor, 1994; Klingler et al., 2014). “An estimation of tension created by contraction of 
myofibroblasts when extrapolated to a large fascial sheet (i.e., thoracolumbar fascia) may 
produce tension within the musculoskeletal system between 30–40N” (Schleip et al., 
2005). The significance of this contractile property remains hypothetical and reproduction of 
these contractile forces in-vivo in response to efferent neural stimulus is yet to be done (Kumka 
& Bonar, 2012; Wilke et al., 2017b). 
Although, most myofibroblasts derive from regular fibroblasts modified under 
mechanical tensions and the influence of specific cytokines (Desmoulie`re et al., 2005), they 
can also originate from other tissues that include epithelial, endothelial and bone marrow-
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derived cells (Hinz et al., 2007). Regardless of their origin, myofibroblasts are able to produce 
long lasting isometric contractions (Hinz & Gabbiani, 2003), transmitted to the matrix through 
focal adhesions and connected stress fibres. It has been suggested that the force generated by 
fascial contraction may extend to intramuscular connective tissues in order to adapt muscle 
stiffness to changes in tensional demands (Schleip et al., 2006).In turn, this is likely to influence 
overall resting muscle tone and musculoskeletal dynamics (Schleip et al., 2005) through both 
a local redistribution of mechanical force and a segmental neurological influence on somatic 
motor neurons. 
Dysfunction of this apparatus may also lead to altered myofascial tonus, diminished 
neuromuscular coordination, musculoskeletal pathologies and pain syndromes (Klingler et al., 
2014). Furthermore, disregulated myofibroblastic activity may result in fibrosis formation and 
the development of chronic systemic diseases (Hinz et al., 2012). 
The whole series of these events disregulated myofascial contraction, altered 
myofascial tonus and force transmission, impaired neuromuscular coordination and fibrosis 
formation may lead to an abnormal fascial contractility and texture that underlies restriction of 
motion, functional and positional asymmetry, as found in somatic dysfunction (Tozzi, 2015b). 
1.3.1. d. Fascial Viscoelasticity 
Fascia exhibits the potential for both elastic and plastic deformation in a non-linear 
fashion, depending on the amount, duration and speed of the load (Kirilova, 2012). This 
viscoelastic property relies on the interdependence between the architecture and composition 
of connective tissue and water content (Guilak, 2000). It has been demonstrated that fibrils and 
the interfibrillar matrix may act as coupled viscoelastic systems, with a qualitatively different 
response to mechanical deformation, depending on the cross-links in between collagen 
molecular packing (Tozzi,2015a). 
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At the same time, when tension changes in connective tissue, an immediate 
reorganization of the fibroblasts cytoskeleton occurs, with a consequent change in tissue 
stiffness and viscosity (Langevin et al., 2006), through changes in cell signalling, gene 
expression, matrix adhesions and consequent modification in connective tissue tension and 
biochemistry (Tozzi,2015b). 
Human resting myofascial tone (HRMT) (Masi & Hannon, 2008); is determined by 
molecular interactions of the actomyosin filaments in myofibroblast cells and miosarcomeric 
units. This may offer a substantial contribution to the maintenance of postural stability with 
minimal energy expenditure, differently from neuromotor activation which requires higher 
levels of tone to provide the same stabilization. This is consistent with recent findings in 
pathological conditions.Persistent static load lead to viscoelastic creep of connective tissue, 
resulting in a transient alteration of neuromuscular activity (muscle spasm and 
hyperexcitability), with an intensity directly related to the load magnitude (Sbriccoli et al., 
2004). 
Similarly, prolonged repetitive cycling loading may alter viscoelastic properties of 
connective tissue by causing micro-damage of collagen fibres, necessitating increased 
muscular activation to maintain joint stability. This was a finding from a review of in-vivo 
feline studies in this area (Solomonow, 2012). Similar findings were observed in-vivo (Fung 
et al., 2009; Schleip et al., 2012c) and in controlled human laboratory studies (Sbriccoli et al., 
2005; Arampatzis et al., 2010; Olson, 2011). The ‘construal’ difficulty was the main problem 
with the ‘Solomnov’ review as the study utilized a complex hypothesis and methodology that 
is triggering an interpretation or conclusion bias in the reader. Changes in normal levels of 
HRMT would affect the tension on surrounding fascial structures and have an influence on 
joint mobility, movement control, posture stability related to different musculoskeletal 
conditions and dysfunctions (Masi et al., 2010). The combination of these events may also be 
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associated with a change in the colloidal consistency of the ground substance to a more solid 
state and lead to altered myofascial activation, increased risk of tissue damage/injury, and 
finally account for the tissue texture change, restriction of motion and asymmetry found in 
somatic dysfunction. 
1.3.1. e. Fascial Fluid Content and Dynamics 
Fascia also plays an important role in fluid balance and physiology. Water content is 
dependent on changes in interstitial fluid pressure resulting from a dynamic interaction between 
the osmotic pull exerted by negatively charged, normally under-hydrated Glycosaminoglycans 
that are abundant in fascia, and the mechanical stiffness and tension of collagen fibres that 
resist water extrusion and thus tissue swelling (Tozzi,2015a). It appears that any decrease in 
collagen tension leads to a reduction in interstitial hydrostatic pressure and causes fluids to be 
taken up by the constituents of the ECM. The role of fibroblasts is also crucial in determining 
collagen tension through cell-matrix contacts, acting as modulators of fluid dynamics by 
adjusting their size and matrix tension in response to changes in osmotic pressure (Langevin et 
al., 2013). In turn, hydrostatic pressure has been shown to act as a mechanical stimulus inducing 
cell-matrix processes of ‘mechanotransduction’ that directs cell behaviour in a variety of 
tissues, including cell movement within the ECM (Polacheck et al., 2014), cytoskeletal 
polymerization and cellular tuning of sensitivity to fluid pressure and to accommodate variable 
levels of stress (Myers et al., 2009). In particular, intermittent cyclic hydrostatic pressure 
applied to bone-derived cells induces alterations in mRNA levels for a specific subset of genes 
involved in connective tissue remodelling and differentiation (Tasevski et al., 2005). However, 
during inflammation, changes in physical properties of the connective tissue, involving 
hyaluronic complexes, may influence transcapillary exchange resulting in an increase in the 
fluid flow (Reed et al., 2010). This is caused by an integrin-mediated lowering in interstitial 
fluid pressure following a release of cellular tension exerted on the collagen network that allows 
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glycosaminoglycans to expand and take up fluids. Therefore, an inverse influence exists among 
mechanical force, cell response and interstitial fluid dynamics. This was a finding obtained 
from the study on ‘edema and fluid dynamics in connective tissue remodeling’. This review 
was a gathering of observations from studies of the loose connective tissues in skin and 
carcinomas performed in-vitro with relevant extrapolations and comparisons to the heart.  
A sustained static stretch applied to fascia may produce an extrusion of water in the 
tissue followed by a compensatory increase in matrix hydration (Schleip et al., 2012c), 
resembling a sponge-like effect that may be significant for fascial function. This study 
examined a potential cellular basis for strain hardening of fascial tissues: an increase in stiffness 
induced by stretch and subsequent rest. The study was conducted in ‘mice’ lumbodorsal fascia 
which was isometrically stretched for fifteen minutes followed by thirty minutes rest (n=16). 
An increase in stiffness was observed in the majority of samples, including the nonviable 
control samples. Investigations with porcine lumbar fascia explored hydration changes as an 
explanation (n=24). Subject to similar loading procedures, tissues showed decreases in fluid 
content immediately post-stretch and increases during rest phases. When allowed sufficient 
resting time, a super-compensation phenomenon was observed, characterised by matrix 
hydration higher than initial levels and increases in tissue stiffness. The authors have cautioned 
that, with an in-vitro result generalisation and clinical application cannot be recommended and 
merits further exploration.  
Stecco et al. (2011a) have shown that in normal physiological conditions, a layer of 
lubricating ‘hyaluronan’ (HA) is found between the deep fascia and muscle as well as within 
the loose connective tissue, dividing different fibrous sublayers of the deep fascia. These HA 
layers promote normal fascial function and sliding motion. If compromised, as following injury 
or chronic inflammation, they may underlie various types of myofascial dysfunctions and pain 
by impairing tissue sliding potential and fluid dynamics, hence tissue chemistry and structure. 
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The layers of loose connective tissue within deep fasciae were studied with particular 
emphasis on the histochemical distribution of HA. Samples of deep fascia together with the 
underlying muscles were taken from neck, abdomen and thigh from three fresh non-
embalmed cadavers. Samples were stained with hematoxylin–eosin, azan-mallory, alcian 
blue and a biotinylated HA-binding protein specific for HA. An ultrasound study was also 
performed on twenty two voluntary subjects to analyse the thickness of these deep fasciae 
and their sublayers. This study introduced the term “fasciacytes” to the cells that stained 
prominently with alcian blue stain. This study was the one which provide some evidence on 
the role of HA in fascial mobility and its role in myofascial pain. Recent in-vitro and in-vivo 
studies are supporting and confirming these findings (Wilke et al., 2017b; Manfredini et al., 
2017; e Silva et al., 2017). 
1.3.1. f. Fascial pH and Factors Influencing its Levels 
Changes in pH, ionic content and temperature may represent key environmental and 
metabolic factors influencing fascial viscosity (Thomas & Klingler, 2012). For instance, an 
increase in body temperature, as occurs during physical exercise, may reduce fascial stiffness 
by reducing tissue viscosity (Chaitow et al., 2014; Propert,2014; Pavan et al., 2014). Pavan et 
al (2014) has made an attempt to segregate evidences for the influence of temperature and pH 
in fascial properties. An in-vitro analysis by Tømmeraas et al. (2008) found that three-
dimensional superstructure of HA chains progressively breaks down when the temperature is 
increased to greater than 40 °C improving the fascial sliding. This may explain the effects of 
many physical therapies that increase temperature (laser, ultrasound etc.) and with warming up 
in general. The increased temperature breaks down superstructures, with a consequent decrease 
in viscosity. Also, alterations of pH can change the viscosity of loose connective tissue. Gatej 
et al, (2005) conducted a series of laboratory studies to analyse the behaviour of HA solutions 
at different pH values. A slight degradation is observed in acidic conditions (pH = 1.6) and 
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basic medium (pH = 12.6) from molecular weight distribution analysis, but the ‘rheological’ 
behaviour is relatively not influenced much by the pH at the exclusion of two domains: around 
pH of 2.5, a gel-like behaviour is shown and is attributed to cooperative interchain interactions 
due to the reduction of the polymer net charge and may be the protonation of the acetamido 
groups; for pH greater than 12, the decrease of viscosity is mainly attributed to a reduction of 
the stiffness of the polymeric backbone in alkaline conditions due to the partial breakage of the 
H-bond network. 
The biomechanical properties of loose connective tissue may be altered depending upon 
accumulated lactic acid content after intense exercise, with its attendant acidity (Pavan et al., 
2014). It has been demonstrated that in the muscle compartment, pH can reach a value of 6.60 
with an increase of approximately 20 % in HA viscosity, with a consequent sensation of 
momentary stiffness. This finding was based on three non-randomised small group studies (Juel 
et al., 2004; Juel et al., 1990; Neilsen et al., 2004). In future, robust and standardised studies 
can explore more on this. 
Conversely, a more acidic ECM environment seems to exert a modulating action on the 
metabolism and protein synthesis of connective tissue cells, such as fibroblasts and 
chondrocytes (Ohshima and Urban, 1992).  In conclusion, changes in breathing patterns and 
temperature, and presumably of physical activities (Shen et al., 2012) and nutrition (Arent et 
al., 2010) are able to modulate tissue pH levels through environmental and metabolic changes, 
and oscillations of these may strongly influence fascial function and dysfunction. Many fascial 
therapists believe that the fascia can alter its behaviour in relation to various chemical and 
environmental factors. But at this point, none of the findings are conclusive. Capitalising on 
the works done hitherto and the resultant findings, future studies can look more vigorously and 
systematically into this area. 
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1.3.1. g. Somatic Neuro-fascial Interaction 
A review by Benjamin (2009) describes several studies that showed the presence of 
primary afferents and nerve fibres within fascia, supporting the concept of fascia as a ‘sensory 
organ’. In particular, the presence of mechanoreceptors in fascia suggests a role in dynamic 
proprioception, force transmission and motor control (Stecco et al., 2010). Research also shows 
that fascia, rather than muscle tissue, is involved in the delayed onset of muscle soreness 
following physical exercise, suggesting a role in pain generation in normal physiological 
conditions (Gibson et al., 2009). 
However, under abnormal mechanical stimulation, a pathological change in fascial 
innervation may occur, resulting in dysfunctional ingrowth of nociceptive fibres (Sanchis- 
Alfonso & Rosello´-Sastre, 2000) that generates or maintains inflammation (Herbert and 
Holzer, 2002).  
Irritation of primary afferent fibres in the fascia is capable of initiating the release of 
neuropeptides, eventually setting up a neurogenic inflammation, with peripheral (Deising et 
al., 2012) and central sensitization, and altering the texture of surrounding connective tissue 
via the interaction of fibroblast and immune cells (Mense, 2001). This process may trigger a 
cascade of either local or global responses: chronic pain and connective tissue remodelling 
(Langevin et al., 2011), altered mechanoreceptor feedback and muscle control (Panjabi, 2006), 
followed by further connective tissue alterations, neural adaptation, and eventually cortical 
reorganization. This process may expand to include influences on endocrine and autonomic 
pathways (Benarroch, 2006), as well as on sensory, cognitive and affective areas of the brain 
that may in turn respond to control pain (Peyron et al., 2000). Schabrun et al. (2013) has 
conducted a small group healthy individual based study on somatosensory-evoked potentials 
(SSEPs) and transcranial magnetic stimulation to investigate the temporal relationship between 
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altered excitability of the primary sensory cortex and corticomotor output during and after 
muscle pain induced by hypertonic saline infusion and reported that  pain of muscular origin 
may alter the activity of related higher centres accounting for a reduction of sensory processing, 
followed by an altered motor output, together with a reorganization of the motor cortex 
associated with deficits in postural control (Tsao et al., 2011). 
Both structural and functional changes of the brain were noticed in patients with 
myofascial pain. Literature reported significant changes in grey and white matter anatomy. 
High-resolution voxel-based morphometric structural brain and brainstem scans are available 
to support this. The first report of central nervous system (CNS) changes in myofascial pain 
was in 2010, by Younger et al, Significant change (both decrease and increase) was noted in 
the grey matter volume as compared to controls mainly in the ‘trigemino-thalamocortical 
pathway’ (trigeminal sensory nuclei, thalamus and primary sensory cortex) and a decrease in 
grey matter volume was noted in the ‘limbic system’ (posterior putamen, globus pallidus and 
anterior insula). In another similar study, a regional decrease was found in white matter volume 
in the medial prefrontal cortex (PFC) bilaterally (Gerstner et al., 2011). Furthermore, a decrease 
in grey matter volume occurred in the cingulate gyrus, insular cortex, frontal gyrus, and 
superior temporal gyrus bilaterally in the temporomandibular disorder patients. When 
myofascial trigger points were stimulated (Niddam et al., 2008), enhanced activity was found 
in somatosensory (SI, SII, inferior parietal, mid-insula) and limbic regions (anterior insula) and 
suppressed activity was found in the hippocampal area. In a positron emission tomographic 
(PET) study (Kupers et al., 2004), it was shown that induced jaw-muscle pain (a chronic pain 
model that mimics fascial pain) was associated with a significant increase in regional cerebral 
blood flow in the posterior insula, anterior cingulate, prefrontal cortices, right posterior parietal 
cortex, brainstem, cavernous sinus and cerebellum indicating them as potential areas involved 
in assimilating jaw pain. 
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1.3.1. h. Autonomic Neuro-fascial Interaction 
Fascial tension may be regulated via autonomic activity, independent of skeletal muscle 
tone. This may occur through the interaction of autonomic fibres and smooth muscle cells 
found in fascia that may consequently contract in a smooth-muscle like manner (Schleip et al., 
2005). Therefore, because under mechanical tension and through a mechano-transduction 
process, fibroblasts release ‘Transforming growth factor beta-1'(TGF-b1) that in turn promotes 
myofibroblast differentiation and contractility by increasing a-SMA (alpha-smooth-muscle 
actin) expression (Wipff et al., 2007), it has been suggested that sympathetic activation may 
induce myofibroblast contraction in fascial tissue via the release of TGF-b1, as well as other 
cytokines, hence modulating fascial stiffness (Schleip et al., 2012b). In addition, they may play 
a role in pain modulation by activating sensitized primary afferent fibres, either directly or 
indirectly, and thus contributing to the development of chronic myofascial pain syndromes 
(Stecco et al., 2014). Therefore, autonomic activity may be involved in the genesis or 
maintenance of pain and somatic dysfunction in the connective tissue (Tozzi, 2015b). 
1.3.1. i. Piezoelectricity 
Piezoelectricity is a property associated with a variety of biological structures ranging 
from bones to proteins and nucleic acids (Fukada, 1982). It is based on an electromechanical 
coupling by which a mechanical force is converted into an electrical stimulus through a stress-
induced polarization and vice versa. One of the main components of fascia is collagen. 
It has already been shown proteins including collagen can display semi-
conductive, piezoelectric and photoconductive properties in vitro (Yang et al., 2015). 
Electronic currents can flow over much greater distances than ionically derived potentials. 
These electronic currents within connective tissue can be altered by external influences, and 
cause a physiologic response in neighbouring structures (Langevin, 2006). However, 
exploration of the change in bone structures in response to stress (Wolffs law) suggests that 
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fluid flow within tissue is more important than piezoelectric effects (Ahn & Grodzinsky, 2009). 
Collagen may exchange physical information from a macroscopic to a cell scale, either directly 
or via biochemical process (Stroe et al., 2013).  
Although collagen generates different piezoelectric charges based on the type and 
intensity of the stress applied (Ahn & Grodzinsky, 2009), an intrinsic piezoelectric 
heterogeneity has been shown to exist within a collagen fibril, and is related to periodic 
variations in its gap and overlap regions. Each single collagen fibril has a unipolar axis 
polarization throughout its entire length, with a piezoelectric coefficient on the order of one 
pm/V (Minary-Jolandan & Yu, 2009). The problems of these finding were that both are 
analytical reviews and these observation were regarding the collagen of bone rather than fascia. 
With regard to fascia, the piezoelectric properties of collagen fibrils were first imaged 
by Harnagea et al. (2010) with a ‘sub-twenty nm’ spatial resolution ‘piezoresponse force 
microscopy’ (PFM). A detailed analysis of the PFM signal in controlled tip-fibril geometry 
revealed shear piezoelectricity associated with piezoelectric deformation along the fibril axis, 
with the direction of the displacement being preserved along the whole fibre length, 
independently of the fibre conformation. The study has also shown that collagen fibrils in 
muscular fascia display an organization in domains, with groups of fibres with same polar 
orientations and others in the opposite one. The study has also shown that collagen fibrils in 
muscular fascia display an organization in domains, with groups of fibres with same polar 
orientations and others in the opposite one. This study was piloted in a mice tibialis anterior  
fascia harvested in situ. 
Denning et al. (2017) have conducted a similar study on the piezoelectric properties of 
rat tail tendons. The tendons were sectioned at angles of 0, 59, and 90° relative to the plane 
orthogonal to the major axis, and were measured using PFM. The piezoelectric tensor at the 
length scale of an individual fibril was determined from angle-dependent in-plane and out-of-
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plane piezoelectric measurements. The longitudinal piezoelectric coefficient for individual 
fibrils at the nanoscale was found to be roughly an order of magnitude greater than that reported 
for macroscopic measurements of the tendon and concluding that the low response to the 
macroscopic level may be due to presence of oppositely oriented fibrils. 
It seems that the physicochemical properties of collagen critically depend on its 
hierarchical structure. Tropocollagen molecules, the basic units of collagen, have been shown 
to be arranged in a crystallographic super lattice with a quasi-hexagonal symmetry (Orgel et 
al., 2006), while collagen fibres display a D-periodic spacing within fibril bundles and at 
different levels of hierarchical complexity (Fang et al., 2012). The piezoelectric response seems 
to be directly proportional to the level of order by which molecules of collagen fibrils are 
assembled, including the D-periodicity (Denning et al., 2014). 
These findings may help in understanding biological functions of fascia and the 
processes by which cells assemble collagen fibrils in response to specific directional 
mechanical forces. In fact, piezoelectric currents generated by mechanical strain on collagen 
fibres during wound formation have been proposed as driving forces in the first stages of tissue 
repair, acting in concert with TGF-b to determine collagen fibres deposition and orientation 
(Farahani & Kloth, 2008). In conclusion, it is plausible that alterations of collagen architecture 
following injury, surgery or chronic inflammation, may lead to changes in piezoelectric 
responses of the area involved, with consequent repercussions on fascial function and structure 
(Tozzi, 2015b). 
 
1.3.1. k. Water 
Sommer et al. (2008) suggest that interfacial water plays a key role in protein folding, 
cell to cell recognition and behaviour. Every collagen fibre in the body is embedded in layers 
of water molecules that, when associated with proteins, behave in a highly ordered and 
 
35 
patterned, or crystalline, manner (Pollack et al., 2006). It may also serve for bioenergy 
transport, mainly released by hydrolysis of adenosine triphosphate. In addition, the hydrophilic 
interactions of hydrogen bonds that stabilize this system may support non-linear fast transfer 
of protons through the molecular structure. It is plausible that fascial dysfunction may rise from 
dysfunctional self-reinforced circuits of proton-electron-hydrogen transfers following 
structural alteration of the collagen bound- water network, as may occur in injury, inflammation 
and scar tissue (Tozzi, 2015a). 
1.3.1. l. Myofascial Force Transmission 
Functional myofascial sequences are directly involved in the organization of movement 
and muscular force transmission (Kwong & Findley, 2014; Myers, 2009; Stecco et al., 2010). 
Dense connective tissues and tendons are predominantly aligned type I collagen and are more 
specialized for force transmission (Huijing, 2009; Maas & Sandercock, 2010). Forces exerted 
by any one muscle are known to transmit longitudinally along the myotendinous junction to 
exert an action across a joint. However, these forces may also be transmitted epimuscularly 
between muscle fibres and fascial connective tissues (Huijing, 2009; Maas & Sandercock, 
2010). In fact, up to 30 percent of muscle tension may be transmitted via extramuscular force 
transmission (Huijing et al., 2003). Myofascial connections between muscles are involved in 
the force transmission of one muscle to a neighboring one, and even to antagonistic muscles. 
Additionally, force transmission from muscles to surrounding fascia may cause 
stretching and tension (Stecco et al., 2010). It is proposed that these fascial expansions allow 
reciprocal feedback between fascia and muscles. These physical connections also suggest that 
forces and states of contraction may be transmitted and perceived not only locally but also at 
farther distances (Kwong & Findley, 2014).  
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1.3.1. m. Mechanotransduction 
The mechanical force transmission that occurs at the macroscopic level may affect tissues 
at the cellular level. Fascia contains fibroblasts which are involved in the synthesis of the 
extracellular matrix. Fibroblasts have been well studied in the wound healing literature 
(Desmoulie`re et al., 2005). Fibroblasts can develop into myofibroblasts with stretching and 
certain biochemical signalling such as transforming growth factor beta-1 and extra domain A 
fibronectin. The myofibroblast expresses more alpha smooth muscle actin and has a phenotype 
with increased contractile force capacity (Kwong & Findley, 2014). 
Morphological transformations of fibroblasts have been studied in three-dimensional in-
vitro matrices. It was found that, at rest, fibroblasts are in a dendritic state (Chiquet et al., 2009). 
When a stretching force was applied to the matrix environment, fibroblasts changed into an 
expanded lamellar morphologic state. Mechanical stimuli can modulate cell signalling, gene 
expression, matrix adhesion and connective tissue tension (Chiquet et al., 2009; Langevin et 
al., 2010). Repetitive mechanical straining of fibroblasts in a two-dimensional model induces 
changes in cellular proliferation as well as secretion of inflammatory mediators (Dodd et al., 
2006). 
Because of mechanotransduction, cellular changes of fibroblasts within fascia may occur 
in response to these external forces. Connective tissue remodeling may occur, in turn affecting 
function. Thus, the role of fibroblasts in cellular events of tissue remodeling during day-to-day 
activities, exercise, injuries, and therapies needs to be further explored (Kwong & Findley, 
2014).  
 
1.3.1. n. Sliding 
Interfaces between fascial layers and other structures can allow them to slide upon one 
another. The term “microvacuolar system” has been used to describe the types of connections 
between fascial structures visualized using fibre optic cameras under the dermatological layers 
 
37 
(Guimberteau et al., 2010) that may allow sliding. But it is not a specific structure in itself. 
These connections were also examined using electron microscopy and multiple polyhedral 
microvacuoles of different sizes and shapes were seen. This microvacuolar system is thought 
to be composed primarily of proteoglycans (Guimberteau et al., 2010). Proteoglycans, 
specifically glycosaminoglycans, have a high density of negative charges and can thereby draw 
in water molecules, forming gels at very low concentrations (Chaudhry e al., 2014). As such, 
it is proposed that this microvacuolar system contains water and has viscoelastic properties, 
behaving like a gel. It likely provides lubrication and absorbs shear stresses, which results in 
nearly frictionless musculotendinous movement. This described sliding system may actually 
be equivalent to the loose connective tissue of the extracellular matrix (Kwong &Findley, 
2014).  
A prominent layer of loose connective tissue resides between deep fascia and the 
epimysium of the underlying skeletal muscle (Stecco et al., 2011a). There are also similar and 
less prominent layers within the deep fascia itself. These layers were found to be rich in 
hyaluronic acid (Stecco et al., 2011a) which is one of several groups of glycosaminoglycans 
(Alberts et al., 2002). The density of the extracellular matrix may depend on the concentration 
of this hyaluronic acid and factors such as temperature or possibly other physical parameters. 
Based on their observations, Stecco et al. (2011a) theorized that this substance, along with 
water, might create the smooth gliding between the surfaces of fascia and muscle, between 
different fascia sublayers and also between different motor units. Any alteration of the 
hyaluronic acid can theoretically change the properties of the extracellular matrix, affecting 
sliding. This may lead to restrictions in sliding and modification of the receptors within fascia 
and is also theorized as a potential cause of myofascial pain (Stecco et al., 2013) 
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1.3.1. o. Innervation 
Studies have shown that intense local and referred pain occurs with injection of hypertonic 
saline into the tendons and fascia (Gibson et al., 2009; Schilder et al., 2014). Injections into 
tendon and tendon-bone junction sites were found to be more sensitive than injections into the 
muscle belly (Gibson et al., 2009). Sensitivity to pain was not found to be a strictly volume-
driven process because ultrasound-guided injections of isotonic saline into fascia resulted in 
less pain than hypertonic saline injections even though both fluids distended the fascia 
(Schilder et al., 2014). The innervation profile of fascia may partially explain why these 
injections result in pain. 
For example, thoracolumbar fascia plays a role in low back pain (Ranger et al., 2016). 
Although Bednar et al. found that thoracolumbar fascia was deficiently innervated (Bednar et 
al., 1995), Yahia et al. (1992) reported free nerve endings and mechanoreceptors. Tesarz et al. 
(2011) found that the thoracolumbar fascia and the overlying subcutaneous tissue are densely 
innervated, including nociceptive and sympathetic fibres. Nerve fibres were present in high 
densities in the outer and subcutaneous tissue layers, but not so in the middle layer. The 
presence of sensory fibres in the superficial layers may contribute to painful sensations 
experienced during manual therapies for back pain.  Ranger et al. (2016) concluded that a 
shorter lumbar paraspinal fascia is associated with high intensity low back pain and/or 
disability among community-based adults. Schilder et al. (2016) have found that electrical 
high-frequency stimulation of the human thoracolumbar fascia evokes long-term potentiation-
like pain amplification and concluded that spinal input from the fascia can induce long-term 
changes in pain sensitivity for at least 60 minutes making it a candidate potentially contributing 
to nonspecific low back pain 
However, fascial innervation may not only be restricted to nociceptive fibres. 
Immunohistochemical staining of ankle retinacula revealed small nerve fibres and corpuscles 
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within ankle retinacula (Stecco et al., 2010). Interestingly, the intrafascial nerves were often 
oriented perpendicular to the collagen fibres which suggests that they could be stimulated by 
stretching of the collagen fibres. Besides free nerve endings, various fascial expansions have 
been shown to have encapsulated receptors such as Ruffini and Pacini corpuscles, suggesting 
a static and dynamic proprioceptive function (Stecco et al., 2010). Furthermore, muscle spin-
dles tend to be located in areas of the muscle where the architecture suggests lateral myofascial 
force transmission, indicating there is no clear division between “muscle” and “ligamentous or 
fascial” nerve endings (van der Wal, 2009). 
If the periarticular regular dense connective tissue is thought of in series with the 
periarticular muscle, collagen fibres within fascial tissue around joints may be stretched with 
movement. Any contraction of the muscles results in a simultaneous stretch of the fascial tissue. 
If these tissues contain free nerve endings and mechanoreceptors, then any dysfunction of 
fascial structures may potentially play a large role in pain or influence proprioception 
(Kwong& Findley, 2014).  
1.3.1. p. Fibrosis and Densification 
The terms “fibrosis” and “densification” are often used to indicate alterations in fascial 
structures (Pavan et al., 2014, 2016). Fibrosis is similar to the process of scarring, with the 
deposition of excessive amounts of fibrous connective tissue, reflective of a reparative or 
reactive process. It can obliterate architecture and function of the involved tissue. Densification 
indicates an increase in the density of fascia. This is able to modify the mechanical proprieties 
of fascia, without altering its general structure. Dupuytren’s disease and eosinophil fasciitis 
could be considered typical examples of fascial fibrosis, while chronic and nonspecific neck 
pain seems to be associated with fascial densification (Stecco et al., 2014). In reality, in the 
majority of cases, it is not clear whether it is fascial densification or fascial fibrosis that is 
involved. This lack of certainty not only causes confusion in terminology, but also implies that 
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very different treatment modalities can be applied to fascia in an attempt to relieve pain (Stecco 
et al., 2014; Pavan et al., 2016). 
1.3.1. q. Hysteresis 
In general, hysteresis can be defined as the amount of energy lost during a loading– 
unloading cycle in a tissue. In fact, in relation to tendon structure, the reduction of the hysteresis 
of deep fascia with the increase of loading rate improves the capacity of elastic energy storing 
and recoiling (Martin et al., 2015). The main components of the loose connective tissue are 
water, ions and glycosaminoglycans, with a prevalence of hyaluronic acid (HA) which allows 
normal gliding of joint and connective tissue. HA is secreted by specific cells inside the fascia 
called ‘fasciacytes’ (Stecco et al., 2011a). 
Possible alterations of the deep fasciae could be at least of two different kinds: (i) 
damage of the loose component that affects the sliding system between different layers, and 
(ii) damage of the fibrous component that affects the capacity of loading transmission (Pavan 
et al., 2014).  
The complex structure of deep fasciae is associated with different kinds of pathological 
changes. If there is only an alteration of the loose connective tissue, the term ‘fascial 
densification’ is probably preferred. If there is alteration of collagen fibrous bundles, ‘fascial 
fibrosis’ is the term of choice. In reality, the two alterations are not incompatible (Chaitow, 
2014; Pavan et al., 2016). 
Pavan et al. (2014) have put forward two possibilities. (i). Diet, exercises and overuse 
syndromes may cause an alteration of the loose connective tissue inside the deep fascia, causing 
fascial densification. (ii). Trauma, surgery and diabetes can alter the fibrous layers of the deep 
fasciae, causing a fascial fibrosis. This alteration is difficult to modify because only a local 
inflammatory process can destroy the pathological collagen fibres and permit deposition of 
new collagen fibres. Mechanical tensile stimulation can significantly enhance cell proliferation 
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in the fascia. The mechanism underlying the therapeutic effect of complementary therapies 
may involve the reconstruction of the loose connective tissue and enhancement of the cell 
proliferative activity under tensile load (Pavan et al., 2014).These are hypotheses (only) which 
need future confirmation. 
1.3.1. r. Tensegrity 
The contraction of myofibres mechanically influences the endomysium, perimysium 
and epimysium and leads to shortening of the entire muscle because of their tensional 
continuity with each other and the tendinous tissues at each end. This balance between tension 
and compression acting within and between different tissues has been considered in relation to 
‘tensegrity’ (tension-integrity) (Scarr, 2011). It is a structural mechanism that potentially 
integrates anatomy from the molecular level to the entire body and is popularly recognized for 
its distinct compression elements that appear to float within a tensioned network. It is an 
attractive proposition in living organisms because such structures maintain their energy-
efficient configuration even during changes in shape. It has been described at higher levels in 
the extracellular/fascial matrix and musculoskeletal system. The helix and tensegrity are 
described in a variety of anatomical structures, suggesting their importance to structural 
biology and manual therapy (Scarr, 2014). 
 
1.3.2. Disorders of the Superficial Fascia 
1.3.2. a. Fascia and Lymphedema 
In a narrative review, Stecco et al. (2016) mentioned that there exists a strong 
relationship between lymph vessels and superficial fascia and postulated that any alteration in 
the superficial fascia can cause lymphedema or a patient with lymphedema can have an 
alteration of the superficial fascia. They suggest that any treatment that involves superficial 
fascia should improve the symptoms related to lymphedema. This narrative review was 
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performed by the principle author on articles taken from PubMed database using keywords that 
contain “fascia.” The research included articles published between 2000 and 2015 with a total 
of seventy nine articles involving various noninvasive treatments with a level of evidence of 
3b or above as per the CEBM Scale. Since this study does not fit in a systematic review 
category, the conclusions and findings need to be read with caution. 
Tassenoy et al. (2009) published a case study on irreversible post-mastectomy 
lymphedema by comparing histological findings with Magnetic Resonance and Ultra 
sonographic imaging. The study found that the adipose tissue, inferior to the superficial fascia, 
has a honeycomb appearance as established by magnetic resonance imaging (MRI). This 
corresponds to fluid associated with the fibrosis. In particular, the skin septa or fibrous 
retinacula cutis increase their thickness, the area and perimeter of fat cells is significantly 
increased (P <.05) and fluid is associated with or close to the muscle fascia. 
Marotel et al (1998) conducted a retrospective analysis of the computer tomography 
(CT) data from eleven patients with isolated unilateral lower limb lymphedema (clinical criteria 
confirmed by isotope lymphography). This study hasfound an increase in the frequency of skin 
thickening, increase in the subcutaneous tissues area, muscular fascia thickening, fat infiltration 
and oedema relate to lymph stasis.  The reliability of CT images in detecting such micro details 
of the soft tissue made this study finding in question.  
Hauck and Castenholz (1992) through their microscopic analysis demonstrated the 
existence of a “low-resistance pathway” along connective tissue fibres for the trans-interstitial 
fluid movement, from the capillaries to the initial lymphatics. One part of this pre-lymphatic 
system is represented by submicroscopical spaces along the connective tissue fibres between 
ground substance (high resistance pathway) and fibre surface. The other part is represented by 
a network of pre-lymphatic tissue channels which are open connected with the initial lymphatic 
system. 
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Based on this finding, Stecco et al. (2016) concluded that the disposition of the collagen 
and elastic fibres inside the superficial fascia could guide lymphatic flux in the correct direction 
and any alteration in the superficial fascia can compromise the lymphatic drainage. Even 
though these findings are based on low to medium quality laboratory and imaging studies, the 
findings can be used to explain the positive results reported in a few randomised controlled 
studies on the effectiveness of myofascial release in post mastectomy patients (Castro-Sánchez 
et al., 2011a,b; De Groef et al.,2017). It is worth mentioning that the ultrasound measurement 
of dermal thickness is a reliable option to assess lymphedema following mastectomy as per the 
study by Dylke et al. (2017) and can help in facilitating, in future, high-quality studies in this 
field. 
1.3.3. Disorders of the Deep Fascia 
1.3.3. a. Myofascial Pain 
Deising et al. (2012) injected nerve growth factor into the fascia of the erector spinae 
muscles at the lumbar level and observed a long-lasting sensitization to mechanical pressure 
and to chemical stimulation. This suggests that sensitization of fascial nociceptors to 
mechanical and chemical stimuli may contribute to the pathophysiology of chronic 
musculoskeletal pain. 
Schilder et al. (2014) have also demonstrated that injections of hypertonic saline into 
the thoracolumbar fascia result in a significantly protracted time of pain intensity, compared to 
injections into the subcutis or into muscle. Stecco et al. (2014) documented a correlation 
between a decrease in range of motion and an increase in neck deep fasciae thickness. In 
particular, a value of 0.15 mm of the sternocleidomastoid fascia is proposed as a cut-off value 
that allows the clinician to make a diagnosis of myofascial disease in subjects with chronic 
neck pain.  
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1.3.3. b Alterations in Proprioception 
The first to suggest a possible role of the deep fasciae in proprioception was Viladot et 
al. (1984). This was a pure anatomical study done on 118 ‘tali and calcanei’ obtained from 
cadavers and collections. The authors affirmed that as the ankle retinacula (which represent 
specialization of the deep fascia) are thin and flexible, they have a modest effect on the 
mechanical stability of the joint, whereas they have a far more important role in proprioception. 
Pisani (1990), in a similar study, concluded that the histological features of the retinacula are 
more suggestive of a perceptive function, whereas the tendons and ligaments are structured for 
a mechanical role. The retinacula are the most highly innervated fascial tissues. Sanchis-
Alfonso & Rosello-Sastre (2000) demonstrated an increase in free nerve endings and nerve in-
growth in the shortened compressed lateral retinaculum in patients with patellofemoral 
malalignment and anterior knee pain. Samples of lateral knee retinacula were excised at the 
time of proximal realignment or isolated lateral retinacular release. 
The first in-depth focus on the role of fascia in proprioceptive function came from 
Stecco et al. (2004, 2006). They, with the cadaveric analysis details, suggested that “the 
presence of many free and encapsulated nerve terminations indicates that the deep muscular 
fascia probably plays a proprioceptive role” (Stecco et al., 2006, p 5). Stecco et al., in 2007(b), 
published yet another cadaveric analysis study based on specimens taken from the deep fascia 
from 20 human upper limbs. The main aim was to find out type of nerve fibres and endings in 
the deep muscular fascia. This study demonstrated an abundant innervation of the fascia 
consisting in both free nerve endings and encapsulated receptors, in particular, Ruffini and 
Pacini corpuscles. The study verified the differences in innervation as the flexor retinaculum 
was found more innervated than ‘lacertus fibrosus’ and the pectoralis major expansion. The 
authors suggest that these findings point out the role of the retinaculum in peripheral motor 
coordination and proprioception whereas the tendinous expansions onto the fascia with a 
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mechanical role in the transmission of tension. In the conclusion session, the authors were 
attempting to expand the fascial role in dynamic proprioception along with the static one. The 
team quotes the laboratory based works of Grigg & Greenspan (1977), Clark et al. (1975 a,b) 
and Rossi & Grigg (1982) to explain how joint receptors are activated only at maximum flexion 
and extension, placing doubts on the exclusive role of articular receptors in kinaesthesia. This 
fact further implicates intramuscular and fascial receptors as indicators of the intermediate 
grades of movement. This study puts forward an advanced hypothesis that all the fascia and/or 
the myofascial unit has a role in proprioception, particularly in dynamic proprioception (Stecco 
et al., 2004). The drawback of this study was that the hypothesis was too advanced beyond the 
scope of a cadaveric study so that the role of fascia in ‘dynamic proprioception’ should be 
interpreted with caution. 
In 2010, Stecco et al conducted a study by dissection, histological and 
immunohistochemical analysis of twenty seven cadaveric legs along with an in-vivo 
radiological study by MRI on seven healthy volunteers, seventeen patients with outcomes of 
ankle sprain and three amputated legs. The aim was to anatomically ascertain the role of the 
retinacula in proprioception and their possible damage in patients with ankle sprain. The study 
specified that the retinacula are not static structures for joint stabilisation but a specialisation 
of the fascia for local spatial proprioception of the movements of foot and ankle. Their 
anatomical variations and accessory bundles may be viewed as morphological evidence of the 
integrative role of the fascial system in peripheral control of articular motility. Once again it is 
to be noted that, taking in to account of the complicated structure of the study, its assumption 
should be taken as preliminary and warrants more structured high quality biomechanical based 
human studies. Stecco et al. (2011b) re-demonstrated with MRI and static posturography in 
twenty five patients with ankle sprain that ankle sprain leads to damage to ankle retinacula 
(adherences and formation of new fibrous bundles into the deep fasciae of the foot and 
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interruption of the retinacula). Damage to the retinacula and their embedded proprioceptors 
result in inaccurate proprioceptive afferentation, leading to functional ankle instability (Stecco 
et al., 2011b). This may result in poorly coordinated joint movement and eventual inflammation 
and activation of nociceptors. The study concluded that a treatment focused on restoring normal 
fascial tension may improve the outcome of ankle sprain. This study falls in low 
methodological quality due to the methodological flaws and non-randomised design but the 
results can be used to create hypothesis for future scientifically robust studies (Stecco et al., 
2011b). 
1.3.4. Epimysial Fascia and Peripheral Motor Coordination 
The epimysial fascia plays a key role in proprioception and peripheral motor 
coordination due to their close relationship with muscle spindles.  Due to these connections, it 
is evident that tension developed inside the deep fascia is also able to lengthen the muscle 
spindles connected with it, activating them by passive stretch. If epimysial fascia is 
overstretched, it is possible that the muscle spindles connected to this portion of the fascia 
could become chronically stretched and over activated. This implies that the associated 
muscular fibres will be constantly stimulated to contract (Stecco et al., 2016). This could 
explain the increased amount of acetylcholine found in myofascial pain and, in particular, in 
trigger points (McPartland, 2004). This passive stretch situation could be responsible for 
muscular imbalances and recurrent cramps and could result in incorrect movement of joints. 
This may represent a typical case in which there is limitation of joint range of motion and 
associated joint pain. Palpation of the proximal muscle belly will often reveal an area of a 
painful localization of dense tissue. If epimysial fascia is too rigid, the muscle spindle may not 
be activated, some parts of a muscle will not function normally during movement, causing an 
unbalanced movement of the joint, with resulting uncoordinated movement and eventual joint 
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pain. This emphasizes the fact that normal muscular function is dependent on normal, well-
hydrated and functioning fascia (Stecco et al., 2016). 
Jafri (2014) presented a comprehensive descriptive overview of the underlying 
hypothesis, theories and evidence for the mechanisms of myofascial pain and trigger points 
(TrPs). According to this review, the mechanisms that induce the onset and maintenance of 
TrPs are unknown. Jafri postulates a new mechanistic hypothesis for the initiation and 
maintenance of TrPs. This hypothesis identifies an increased microtubule density, eventually 
leading to an increase in reactive oxygen species (ROS) levels and calcium in the TrP region.  
 
1.4. Defining Myofascial Release 
Myofascial release (MFR) is a form of manual medicine which involves the application of 
a low load and long duration stretch to the myofascial complex, intended to restore optimal 
length, decrease pain and improve function (Barnes, 1990). It has been hypothesized that fascial 
restrictions in one part of the body cause undue tension in other parts of the body due to fascial 
continuity. This may result in stress on any structures that are enveloped, divided, or supported 
by fascia (Schleip, 2003).  
Myofascial practitioners believe that by restoring the length and health of restricted 
connective tissue, pressure can be relieved on pain sensitive structures such as nerves and blood 
vessels. MFR generally involves slow, sustained pressure (120-300 s) applied to restricted 
fascial layers either directly or indirectly. Three main manual approaches that are directed 
towards the fascia are (i) direct approach - the affected tissue is brought against the restrictive 
barrier, described as a “functional limit that abnormally diminishes the normal physiologic 
range” (E.C.O.P., 2011a). This is maintained until tensions modify. (ii) indirect approach - 
tissues are brought away from the restrictive barrier while a position of ease (a balanced tension 
in all planes and directions) is found and maintained up to a release. (iii) combined approach - 
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both the point of ease and the restrictive barrier are consecutively engaged in an interactive 
fashion (Ward, 2003).  Direct technique MFR is thought to work directly on restricted fascia; 
practitioners use knuckles or elbow or other tools to slowly sink into the fascia, and the pressure 
applied is a few kilograms of force to contact the restricted fascia, apply tension, or stretch the 
fascia. Indirect MFR involves application of gentle stretch- the pressure applied is a few grams 
of force and the hands tend to follow the direction of fascial restriction, hold the stretch and 
allow the fascia to ‘unwind’ itself. The rationale for these techniques can be traced to various 
studies that investigated plastic, viscoelastic and piezoelectric properties of connective tissue 
(Schleip, 2003; Greenman, 2003; Pischinger, 1991). 
Treatment of fascia has shown to be effective for a wide variety of conditions, from 
local musculoskeletal causes, such as acute joint injury (Eisenhart et al., 2003) to general mood 
disorders such as depression (Plotkin et al., 2001) thought to be because of the common 
therapeutic influence and stimulation of the myofascial complex (Simmonds et al., 2012).  
William Neidner, in the early ’20s, was the first to describe fascial torsion patterns in 
healthy and unhealthy individuals and one of the first to introduce to the osteopathic field a 
specific fascial approach, defined as fascial twist (Centers et al., 2003). By observing and 
palpating the entire fascial organization of the body, he noticed that people in good health tend 
to show clockwise fascial torsional patterns from head to feet (Frymann, 2004). He then 
proposed that various types of direct manipulative techniques could globally release such 
myofascial torques, through the use of the limbs as long levers for the untwisting manoeuvre 
(DeStefano, 2011). Still’s concept of fascia continued to be developed by the early osteopaths 
and created the basis for much of our clinical understanding of this tissue which is increasingly 
recognized as the unifying structural element of the body and key to understanding the 
reciprocal interrelation between structure and function and the body’s innate ability to self-
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regulate (Snyder, 1956). These principles then led to the development of manual approaches 
that went beyond the structural model of treating articular joints. 
In the 1980s, Ward’s biomechanical model emphasized the muscular-fascial 
relationship and their interdependent neural influences and led to myofascial release and 
integrated neuromusculoskeletal release techniques (Ward, 2003) while Chila’s (2003) fascial 
continuum model of the ‘big bandage’ introduced fascial release and fascial ligamentous 
release techniques based on the integrity of the fascial continuum (Chila, 2003). The same 
period also saw a gradual shift towards other methods based on oscillatory motion as an 
intrinsic tissue property with Sutherland’s model of cranial and balanced ligamentous tension 
treatment (Sutherland, 1998) and Frymann’s approach to fascia as the primary tissue to unwind 
any traumatic force imposed in the organism. Fulford’s vibratory model (Fulford and Stone, 
1997) and Becker’s fluid approach then developed these further: “allow the fluid to resume its 
normal tidal mechanism ‘bend to the oar’ through the fascia and ‘ride the tide to the shore’ by 
way of the fluid” (Becker, 2000). In addition, the respiratory-circulatory model of Zink (1977) 
implied the assessment of compensated and uncompensated fascial patterns together with the 
opening of fascial pathways to restore and maintain homeostatic balance (Zink and Lawson, 
1979). The bioenergetic model of O’Connell considered the bioresponsive electric potentials 
of fascia as changing holographically, as a result of the intention, attention and activation 
processes that occur during assessment and treatment (O’Connell, 2000). 
The effects of manual fascial interventions can be local (as tissue texture changes), 
segmental (as via neurological response) and global (as through hormonal effects) in extent, 
and may occur at different intervals—ranging from minutes to weeks—after a given input, with 
many interacting mechanisms influencing tissue properties and behaviours, including placebo.  
Some of these factors are strongly supported by the available evidence whereas others need 
further investigation (Tozzi, 2015b). 
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1.4.1. Fascia-related Mechanisms Involved in the Treatment of Somatic Dysfunction 
1.4.1. a. Structural Changes 
In 2009, Langevin et al. performed an ultrasound-based comparison of perimuscular 
connective tissue structural variation in the lumbar region in a group of 60 human subjects with 
chronic or recurrent low back pain (LBP) compared to a group of 47 subjects without LBP. 
The study was set with good internal validity but with questionable external validity. The study 
was neither designed in a randomised format nor with blinding or concealing. The non-
interventional format can be a justifiable answer to such arguments but no details of the 
possible biases were explained in the study. The authors were pointing out that this finding 
cannot be generalised to the patients who have had low back pain for less than twelve months 
and recommends future longitudinal studies. Nevertheless, this study concluded that LBP 
group had around 25% greater perimuscular thickness and echogenicity compared with the no-
LBP group. In a similar quality study with one hundred and twenty one human subjects with 
and without LBP, Langevin et al. (2011) proved that thoracolumbar fascia (TLF) shear strain 
was almost 20% lower in human subjects with chronic low back pain. The authors were 
attributing this to the abnormal trunk movement patterns and/or intrinsic connective tissue 
pathology. There appears to be some sex-related differences in thoracolumbar fascia shear 
strain that may also play a role in altered connective tissue function. In a porcine model study, 
Bishop et al. (2016) has performed an ultrasound based evaluation of the combined effects of 
TLF injury and movement restriction and found that the combination of injury plus movement 
restriction had additive effects on reducing fascia mobility with a 52% reduction in shear strain 
compared to controls and a 28% reduction compared to movement restriction alone. These 
results suggest that a back injury involving fascia, even when healed, can affect the relative 
mobility of fascia layers away from the injured area, especially when movement is also 
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restricted. Robust quality human subject research in this area may enlighten the role of fascia 
and fascial release in the low back pain. 
In a conference proceeding, Blanquet et al. (2010) concluded that ultrasound evaluation 
could be used to measure and explain the changes in the TLF post MFR. The study was carried 
out to find out the effectiveness of fascial release in TLF on ten human subjects with chronic 
LBP with readings taken before, immediately after and 24 hours after the treatment. Release of 
the thoracolumbar fascia in patients with chronic LBP has shown an increase in thickness of 
fascial layers that remained for at least 24 hours. The authors implied that the findings of the 
study can be used to explain the fascial changes in response to treatments and ultrasound 
evaluation can be a better tool to reflect these changes. The structure of the conference abstract 
without details like randomization and blinding along with a low sample size restricts the 
study’s quality and generalisability. A study by Pohl (2010) has shown that ultrasound 
measurements applied immediately before and after manual intervention resulted significant 
differences in collagen fibre density and orientation in the structure of the matrix in the dermis, 
reflecting palpable differences in tension and regularity. Thirty patients were measured with 
high frequency ultrasound immediately before and after the first treatment in the area of pain 
or movement restriction.  The result of the study is not foolproof due to the limitations 
associated with its validity and issues related to sampling. We need to conduct 
methodologically strong studies to ascertain such findings. All these findings are consistent 
with the assumption of re-organization and remodelling of collagen fibres, as suggested by 
Martin, (2009) explained as due to the breakdown of abnormal collagen cross-links and an 
increase in the matrix hydration which needs to be confirmed experimentally. 
  Wong et al. (2017) has conducted a cross sectional study with ten healthy participants 
to evaluate the mechanical deformation of TLF with myofascial release. An ultrasound 
evaluation was conducted before and after a press-down to maximal voluntary contraction 
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(MVC) in the prone position with three one minute procedure resembling to indirect 
Myofascial release techniques (IDTMFR). The study found that after MFR, the stiffness of the 
TLF decreased in healthy men. This was the first study to quantify fascial properties and 
deformation of the TLF and the effects of MFR on the TLF. The authors mentioned that they 
have conducted a pilot study with five participants in order to explore the reliability of each 
parameters and claims moderate to good reliability. A number of limitations were mentioned 
in the study including inability in the exclusion of isometric contraction and the measures taken 
for it, lack of control group, ultrasound image variability due to individual differences 
questioning test retest reliability and low sample size affecting generalisability. It cannot be 
possible to say that the TLF of healthy persons and one with chronic LBP behaves in a same 
way. It is doubtful whether one minute of IDTMFR is an ideal dosage to find a result as the 
minimum dosage used in this method is about three minutes. The data and limitations from this 
study can be used to design future methodologically robust randomised controlled studies on 
MFR. Future studies can analyse the effect of various forms of MFR with varying duration and 
frequency to ascertain and clarify these findings. 
1.4.1. b. Cell-based Mechanisms 
Various forms of manual loading, whether sustained or cyclical, that differ in direction, 
speed, magnitude and frequency appear to exert a strong impact on cell behaviour, gene 
expression and tissue remodelling through growth factors and enzyme activation 
(Tozzi,2015a). 
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Fibroblasts in-vitro and in-vivo have shown an almost immediate response to traction, pressure 
and shear forces, followed by a series of changes in chemical signalling pathways and gene 
activation, ATP release, actin polymerization, and also differential stretch-activated calcium 
channel signalling. Some of them may take place within minutes from the starting point of a 
therapeutic manoeuvre (Langevin et al., 2013). This article titled ‘cellular control of connective 
tissue matrix tension’ reviews the evidence supporting possible mechanisms underlying the 
response including ‘autocrine purinergic signalling’ and fibroblast regulation of connective 
tissue tension with respect to lymphatic flow, immune function and cancer. This review 
proposed that areolar “loose” connective tissue functions under normal physiological 
conditions as an “adjustable sponge”. This article will give a comprehensive idea about the in-
vitro findings in cellular mechanisms but take reader to a positive bias by exploring only the 
positive findings without mentioning any of the negative findings or limitations of the studies 
they have reviewed. In a similar review, Ciobanasu et al. (2013) stated that fibroblasts could 
remodel their cell-matrix contacts (focal adhesions) along the direction of tissue stretch. Again 
these are inferences reached from limited in-vitro studies in this field super integrated with 
theoretical assumptions, not a confirmatory conclusion to ascertain that the cellular mechanism 
exactly functions in this way. 
Tensional load appears to be perceived by the cell at a nuclear level too. Ex-vivo and 
in-vivo studies demonstrated that fibroblasts respond within minutes to mechanical stretching 
by actively remodelling their cytoskeleton with perinuclear redistribution of alpha-actin 
(Langevin et al., 2006; 2010). The ex-vivo study with subcutaneous tissue fibroblasts harvested 
from the abdomen of either mice or Wistar rats immediately after their death. They were 
dissected, fixed with suitable agents and stretched between stainless steel grips and elongated 
at a rate of 1 mm/s. Controls without load were placed in grips as described above and incubated 
for 30 min without tissue elongation (Langevin et al., 2006). This study was first of its kind to 
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show the cellular changes to mechanical stress by emphasising a- and b-actin role in cellular 
mechanotransduction mechanisms. Even though these findings cannot be integratable to the 
properties of fascia in living beings, the findings can be used to explain the possible cellular 
changes during MFR. In the second study, Langevin et al. (2010) have hypothesised that tissue 
stretch would cause nuclear remodelling with a reduced amount of nuclear invagination, 
measurable as a change in nuclear concavity. They have taken subcutaneous areolar connective 
tissue samples from 28 mice and then randomised to either tissue stretch or no stretch for 30 
minutes, then examined with histochemistry and confocal microscopy. In stretched tissue (vs. 
non-stretched), fibroblast nuclei had a larger cross sectional area (p<.001), smaller thickness 
(p<.03) in the plane of the tissue, and smaller relative concavity (p<.005) indicating an increase 
in nuclear convexity, thus accepting the alternative hypothesis. The authors argued that the 
stretch-induced loss of invaginations may have important influences on gene expression, RNA 
trafficking and/or cell differentiation. This study has to be appreciated for its adherence to 
randomisation protocols and scientifically solid design. Although this property of rapidly 
responding to mechanical stress appears to be specific to areolar connective tissues only, it 
remains significant for fascial work because loose connective tissues form the interface 
between subcutaneous and perimuscular layers and are potentially engaged in manual 
interventions(Tozzi,2015b). 
 
1.4.1. c. Possible Cellular Mechanisms 
Appropriate mechanical loading stimulates protein synthesis at the cellular level, 
promoting tissue repair and remodelling (Wang et al., 2012) as well as cell proliferation and 
migration in wound healing, by sensitizing fibroblasts to nitric oxide (Cao et al., 2013b) 
During manual fascial techniques, the operator may feel various tissue responses to the 
applied load that are described as ‘resistance’ or ‘give’ to the stretch. Interestingly, the 
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mechanical loading of fascia causes changes through activation of fibroblast response and the 
different receptors present in the fascial tissue, leading to modulation of myofascial contraction 
(Hicks et al., 2014).  
The existence of a-smooth muscle actin (ASMA) in human fascia was discussed in an 
article by Schleip et al. in 2005 and hypothesised that fascia can undergo spontaneous 
contractions to create a pre-stress in the collagen scaffold, while no quantitative 
immunohistochemical examination has yet been published for cells containing ASMA in 
normal fascial sheets, the existence of cells resembling smooth muscle cells was accidentally 
discovered by Staubesand (1997) in normal crural fascia and has been documented with 
electron microscopy. Since the crural fascia has a similar morphology to the lumbar fascia or 
to the muscular epimysial envelopes, it seems reasonable to extrapolate that the crural fascia is 
not the only fascial sheet with this property (Schleip et al., 2005). It, therefore, can be cautiously 
assumed that contractile cells are probably also present in other dense human fascial sheets as 
have already been found in tendons, ligaments and in the crural fascia.  
Masood and Naylor (1994 a, b; 1995) reported that superficial and deep lumbar fascia 
from rats as well as from guinea pigs contracted in response to in-vitro application of the 
myofibroblast stimulant mepyramine as well as to the smooth muscle agonists adenosine and 
angiotensine II. Contractions started within several minutes and were in a dose dependent, 
reproducible and reversible manner. The smooth muscle relaxing substances nifedipine and 
EDTA (ethylene diamine tetra acetic acid) as well as the microtubule disrupting substance 
cytochalasin-D exhibited a relaxing effect. A relaxing response in porcine lumbar fascia to the 
substance glyceryltrinitrate (a nitric oxide donor and smooth muscle relaxant) has been 
reported by Schleip et al. (2004). Malata et al. (1994) found that mepyramine-induced 
contractions in rat subcutaneous fascia were enhanced by previous incubation with heparin. 
Using an immunohistochemical analysis of 39 tissue samples from the thoracolumbar fascia of 
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11 human donors (ages 19–76 years), Schleip et al. (2004) demonstrated the widespread 
presence of myofibroblasts in all samples, with an average density of 79 cells/mm2 in this 
longitudinal sections. In-vitro experiments with human lumbar fascia by Yahia et al. (1993) 
reported that with a tissue strip of 1.5 mm x1.0 mm x 30 mm, the maximal measured force 
increase during an isometric stretch was 1.5 N. If we hypothetically apply the same force ratio 
to whole fascial sheets in the human body, it seems clear that such fascial contractions could 
have substantial biomechanical influences (Schleip et al., 2006).  
Cao et al (2013) conducted an in-vitro scratch wound strain model analysis to determine 
the effects of modeled myofascial release on fibroblast wound healing and to investigate the 
potential role of nitric oxide (NO) in mediating these responses. They found that fibroblasts 
that received repetitive motion strain (RMS) resulted in reduced wound closure rates (vs 
nonstrain, P<.05), which were partially attenuated by a single dose of MFR. Fibroblasts and 
myofibroblasts are both highly responsive to magnitude (Cao et al., 2013; Hicks et al., 2014), 
direction, frequency and duration (Standley & Meltzer, 2008) of a therapeutic load and can 
regulate cell activity, proliferation or apoptosis (Meltzer et al., 2010), mainly by influencing 
ion conductance, gene expression and secretion of inflammatory mediators. In particular, the 
secretion of IL-6 and IL-1 by fibroblasts under equibiaxial stretch can exert powerful pro or 
anti-inflammatory responses, potentially leading towards beneficial or detrimental matrix 
remodelling and cell behaviour (Tsuzaki et al., 2003). A concomitant autocrine and paracrine 
release of ATP may also serve as a negative feedback mechanism to limit activation of 
destructive pathways (Tsuzaki et al., 2003) and all of these factors may influence the clinical 
efficacy of fascial treatment. 
The fascial tissue may respond better to balanced and sustained stretch rather than 
intermittent and unequal loads, including apoptotic rate (Meltzer et al., 2010).The force and 
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duration of tension applied may also be relevant. It has been shown that high magnitude 
(therapeutic) load (from 9% to 12% elongation) can produce an upregulation of ECM proteins 
while increasing magnitude and duration (one to five minutes) loads induce cytokine and 
growth factors secretions (Cao et al., 2013). These results are consistent with those obtained 
by Yang et al. (2005) where large-magnitude loads caused pro-inflammatory responses and 
cyclic (0.5 Hz per 4 h), uniaxial and small-magnitude stretching produced anti-inflammatory 
reactions in human tendon fibroblasts. Similarly, brief, moderate amplitude (20-30% strain), 
static stretching of connective tissue in-vivo and ex-vivo has been shown to decrease TGF-
b1and collagen synthesis, thus preventing soft tissue adhesions (Bouffard et al., 2008). 
In conclusion, brief, light/moderate, balanced, static or slow cyclic strains appropriately 
applied to fascia may be sensed at the cellular level and transduced in normalizing tissue 
structure and function (Tozzi 2015b). 
The therapeutic loads applied differently with respect to tissue tension (that presumably 
corresponds to cell orientation) may produce different cell and tissue responses. Finally, 
secretion of IL-6 was significantly induced by 15 min of cyclic biaxial mechanical stretching 
after 4 and 8 h in human tendon fibroblasts, suggesting that inflammatory reactions following 
manual intervention may be partially caused by IL-6 secretion (Skutek et al., 2001). 
 
1.4.1. d. Neuromuscular Interaction 
Fascial oriented work may produce beneficial effects by activating various receptors in 
the connective tissues that elicit a series of neuromuscular reflexes. According to Schleip’s 
neurobiological model (2003), these types of events occur together with concomitant 
autonomic and viscoelastic changes, and are more likely to explain the fast tissue responses 
that a therapist perceives during fascial techniques. 
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Although the dermis is the first tissue to be loaded during manual treatment, evidence 
suggests that therapeutic effects such as inhibition on hypertonic muscle and presumably on 
the myofascial complex do not originate from mechanical stimulation of superficial cutaneous 
mechanoreceptors (Merkel, Meissner receptors) during manual therapy (Morelli et al., 1999). 
Similarly, deep receptors such as Golgi tendon organs mainly exist in the myofascia, joint 
capsules and myotendinous junctions and are unlikely to come into play during fascial 
treatment because they have a high threshold that makes them respond to strong and fast 
manual stimulus to which they quickly adapt (Pickar & Wheeler, 2001). This is why Golgi 
organs have been mostly implied as being involved in neurophysiological explanations that 
underlie the efficacy of spinal manipulation (Pickar, 2002) and not of fascial treatment. In 
contrast, Pacinian corpuscles are present in dense connective tissue and deep fascia (Benjamin, 
2009) and tend to quickly adapt to stimuli, hence they respond better to rapid or intermittent 
compression and vibrations applied to the myofascia, myotendinous junctions and deep 
capsular layers. They are thought to respond to such stimuli by enhancing proprioceptive 
feedback and by maintaining muscle tone. The type of therapeutic force needed to activate 
Pacinian corpuscles may be applied in some manual interventions such as in high velocity 
manipulation or vibratory techniques (Tozzi2015a).  
Finally, Ruffini’s endings are mainly located in joint capsules and in the dense 
connective tissue including fascia (Yahia et al., 1992). They have a slow adaptation to the 
stimuli being applied and are thus generally sensitive to slow, sustained or rhythmic deep 
pressures and in particular to lateral (perpendicular) tissue stretches (Van der Wal, 2012). These 
kinds of forces are normally applied in most fascial techniques, such as myofascial release. 
The classical nociceptive model, instead, proposes that indirect fascial techniques may 
modulate muscle tone and related fascial tension by decreasing mechanical stress and neural 
inputs (Van Buskirk, 1990). This may in turn reduce the activity of nociceptors and of the 
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correspondent facilitated spinal level that by neurological reflex may produce a consequent 
modulation of autonomic activity on blood and lymphatic flow. Finally, in response to the 
proprioceptive input, the central nervous system may change muscle tone, allowing the 
therapist to follow myofascialpaths of least resistance until a palpable release is perceived 
(Minasny, 2009). 
1.4.1. e. Autonomic Influence 
Somatic dysfunction has been traditionally related to correspondent facilitated spinal 
levels and aberrant autonomic activity that in turn influences various visceral functions (Beal, 
1985). Interestingly, autonomic adrenergic fibres have been found in fascia with a plausible 
major role on vasomotor control of intrafascial blood vessels (Tesarz et al., 2011). It has been 
suggested that therapeutic touch may produce stimulation of pressure-sensitive 
mechanoreceptors in the fascia (Ruffini’s and interstitial receptors) followed by a 
parasympathetic response (Schleip, 2003). This in turn may induce a change in local 
vasodilatation and tissue viscosity, together with a lowered tonus of intrafascial smooth muscle 
cells, and such a response has been partially demonstrated. 
Both massage therapy and myofascial osteopathic treatment have been shown to 
produce an increase in vagal efferent activity, as shown by changes in heart rate (Field et al., 
2010) even in healthy subjects (Giles et al., 2013). A modulation of hypersympathetic activity 
may take place (Henley et al., 2008).  
1.4.1. f. Viscolelastic Changes 
Biological structures exhibit viscoelastic properties and responses under mechanical 
loads (Kucharova´ et al., 2007) with significant changes depending on chronological age 
(Doubal & Klemera, 2002). Generally, the stronger and more rapidly that a load is applied to 
organic materials, the more rigidly will the tissue respond, up to the point when the elastic 
potential of tissues is exceeded and a plastic deformation occurs (Jager, 2005). 
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Traditionally, it has been suggested that most of the immediate tissue changes following 
manual fascial work may be the result of a colloidal change in the fascia, which means a 
transformation of the ground substance from a dense solid-like state (gel) to a more fluid (sol) 
state (Rolf, 1962). However, a 3D mathematical model for fascial deformation has rejected the 
idea that palpable sensations of tissue release following manual therapy may be due to plastic 
deformations of firm type of fascia, such as the fascia lata and plantar fascia, whereas this may 
be possible in thin and more elastic types of fasciae (Chaudhry et al., 2012).  
Schleip’s neurobiological model has instead proposed that following proprioceptive 
stimulation the Ruffini’s endings and interstitial fascia mechanoreceptors may be involved in 
efferent control of the vasodilation and increase of plasma extravasation via autonomic 
activation (Schleip, 2003). This would initiate ECM viscosity changes. Nevertheless, there is 
evidence that a similar phenomenon may take place within minutes of a tensional load being 
applied and as the result of cell matrix- induced regulation of fluid flow that is independent of 
neurological activation. Langevin et al. (2011) have demonstrated that static tissue stretch of 
areolar connective tissue causes fibroblast cytoskeletal remodelling via activation of focal 
adhesion complexes and initiation signalling pathways. 
This in turn leads to remodelling of the cell’s focal adhesions and actomyosin activation 
that develops counter tension. The latter process allows surrounding tissue to relax further and 
achieve a lower level of resting tension. The fibroblasts can dynamically modulate the 
viscoelastic behaviour of areolar connective tissue through cytoskeletal mechanisms (Tozzi 
2015b). 
1.4.1. g. Fluid Dynamics 
The flow of water in the ECM depends on the opposing forces between the osmotic pull 
of under-hydrated glycosaminoglycans and the active restraint of the tensioned collagenous 
network as the result of fibroblast activity. Therefore, as long as the tension in the matrix is 
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maintained by fibroblasts, water is prevented from entering the tissue. During the acute onset 
of inflammation, however, the matrix swells as inflammatory mediators disrupt the cell-matrix 
contacts, causing a drop in matrix tension and interstitial fluid pressure, and allowing water to 
be ‘sucked into’ the matrix (Reed et al.,2010). A therapeutic stretch lasting for a few minutes 
could then potentially un-restrain the matrix and promote transcapillary fluid flow and 
temporary matrix swelling. Fibroblasts, in turn, can either release their matrix contacts - 
resulting in a further drop of interstitial fluid pressure - or remodel the contractile cytoskeleton 
and adhesive matrix contacts, so as to develop a counter-tension sufficient to restore tension 
equilibrium (Langevin et al., 2013). This model would also fit with the fascial hydrodynamic 
response reported by Schleip et al. (2012). In response to mechanical stimuli, such as 
compression and stretch, fascia may exhibit a sponge-like behaviour, showing a squeezing and 
refilling response under the opposing forces of the restraint of collagen network and the osmotic 
pull of proteoglycans complex. 
Interestingly, the fluid pressure might increase more during tangential oscillation (2-4 
Hz) and perpendicular vibration (15-60 Hz) with respect to the fascial layer than during 
constant sliding or back-and-forth motion, as predicted by 3D mathematical modelling methods 
(Roman et al., 2013; Chaudhry et al., 2013). This would cause the flow to occur more around 
the edges of the area under manipulation - due to an increased pressure gradient - producing an 
enhanced lubrication and an improved sliding potential between fascial layers and muscle 
tissue. Thus, the use of vibratory and oscillatory techniques—and not just constant sliding 
motions—should be considered, especially when interstitial fluid dynamics need to be 
improved such as in the case of fibrotic tissue. Interstitial flow also induces fibroblast-to-
myofibroblast differentiation as well as collagen alignment and fibroblast proliferation, playing 
an important role in fibrogenesis and tissue repair (Ng et al., 2005). Furthermore, it appears to 
affect intracellular processes (calcium signalling, protein secretion) and influence fibroblast 
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activities such as growth, proliferation, differentiation, alignment, adhesion and migration (Dan 
et al., 2010) including tissue morphogenesis, remodelling and embryonic development 
(Rutkowski and Swartz, 2007) through mechanisms such as direct shear stress, matrix-cell 
transduction and autologous gradient formation. Interstitial flow may also be enhanced by the 
interplay of calcium ion concentration and unbound water oscillations (Lee, 2008), whose 
respective electric and pressure gradients improve the transport of oxygenation and nutrients 
in the tissues. Since fluid flow in the ECM is likely to transport metabolic and messenger 
substances (Meert, 2013), it may indeed play a role in restoring homoeostasis where it has been 
compromised. For instance, it could improve drainage of inflammatory mediators. So, 
decreasing chemical irritation and nociceptive stimuli to nerve endings, hence leading to a reset 
of aberrant reflexes underlying somatic dysfunction. 
1.4.2. Mechanical Model 
In other words, the effectiveness of MFR can be explained under two broad 
classifications: mechanical and neurophysiological (Schleip, 2003; Simmonds et al., 2012). 
Mechanical mechanisms of MFR include thixtrophy (Schleip, 2003), piezoelectricity 
(O’Connell, 2003; Schleip, 2003), fascial adhesions (Hedley, 2010; Martınez Rodrıguez & 
Galandel Rı´o, 2013), cellular responses (Tozzi, 2012), fluid flow (Chaitow, 2009; Schleip & 
Muller, 2013), fascial inflammation (Bednar et al., 1995; Findley et al., 2012) and myofascial 
trigger points (Gerwin, 2010; Bron and Dommerholt, 2012). Many of these mechanical 
mechanisms have been criticized on the basis that pressures outside of normal human 
physiological ranges would be required in order to induce tissue deformations in most tissues 
(Chaudhry et al., 2008).  
1.4.2. a. Piezoelectric Model 
In the piezoelectric model, it is suggested that fibroblasts and fibroclasts, which create and 
digest the collagen fibres that are important for the biomechanical properties of the fascia, 
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respond to electric charges created through pressure (O’Connell, 2003). While piezoelectric 
effects have been observed in collagen fibres for many years (Facade&Yasuda, 1964), it has 
been argued that they cannot explain the quick effects that clinicians observe (Schleip, 2003) 
which typically occur within 90-120 seconds (Barnes, 1997). In the fascial adhesions model, it 
is suggested that different fascial layers that would normally slide relative to each other alter 
such that they now stick to one another (Hedley, 2010; Martınez Rodrıguez & Galandel Rıo, 
2013). These fascial adhesions are thought to be released by moving the body part through a 
full ROM under traction (Hedley, 2010). A detailed explanation of the piezoelectric model is 
presented in page 32; Session 1.3.1. i. 
1.4.2. f. Myofascial Trigger Points 
Myofascial Trigger Points (MTrPs) are discrete and hyperirritable nodule in a taut band 
of skeletal muscle which is palpable and tender during physical examination (Shah et al., 2015). 
An active MTrP is clinically associated with spontaneous pain in the immediate surrounding 
tissue and/or to distant sites in specific referred pain patterns. Strong digital pressure on the 
active MTrP exacerbates the patient's spontaneous pain complaint and mimics the patient's 
familiar pain experience. MTrPs can also be classified as latent, in which case the MTrP is 
physically present but not associated with a spontaneous pain complaint. However, pressure on 
the latent MTrP elicits local pain at the site of the nodule. Both latent and active MTrPs can be 
associated with muscle dysfunction, muscle weakness and a limited range of motion (Shah et 
al., 2015).  
In a survey conducted in 2000, the vast majority of American Pain Society members 
believed MPS to be a distinct clinical entity characterized by the finding of MTrPs (Harden et 
al., 2000). By applying the clinical criteria developed by Travell and Simons (1999), the 
diagnosis of myofascial pain has historically relied heavily on the clinical history and a careful 
physical examination of the soft tissue by a trained clinician. Sikdar et al. (2009) reported local 
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milieu, as well as the nature of the tissue and whether its classification as pliable, stiff, 
homogeneous or nodular may be important for evaluation and treatment response. 
The Cinderella Hypothesis (Hägg et al., 1991) provides a possible explanation for the 
role of muscle in MTrP development. This hypothesis describes how musculoskeletal disorder 
symptoms may arise from muscle recruitment patterns during sub-maximal level exertions with 
moderate or low physical load. According to Henneman's Size Principle, smaller type I muscle 
fibres are recruited first and de-recruited last during static muscle exertions. As a result, these 
“Cinderella” fibres are continuously activated and metabolically overloaded, in contrast to 
larger motor muscle fibres that do not work as hard and spend less time being activated. This 
property makes the “Cinderella” fibres more susceptible to muscle damage and calcium 
dysregulation, key factors in the formation of MTrPs (Shah & Gilliams, 2008). An observation 
study on sixteen female computer professionals by Treaster et al, (2006) demonstrated that 
low-level, continuous muscle contractions in office workers during 30 minutes of typing 
induced formation of MTrPs and thus supports the Cinderella Hypothesis. Though 
generalizability of a small observational study is often in question, this study gives a direction 
in which future scientifically and methodologically high quality trials can travel. 
MTrPs can also develop as a result of muscle overuse in cervical and postural muscles 
during the performance of low-intensity activities of daily living and sedentary work (Treaster 
et al., 2006). An intriguing possible mechanism involves sustained low-level muscle 
contractions routinely used in tasks requiring precision and postural stability of the cervical 
spine and shoulder. As a result of sustained low-level contractions, a decrease in intramuscular 
perfusion has been postulated. Thus, it is conceivable that ischemia, hypoxia and insufficient 
ATP synthesis in type I motor unit fibres may occur and are responsible for increasing acidity, 
Ca2+ accumulation and subsequent sarcomere contracture. This increased and sustained 
sarcomere contracture may lead to decreased intramuscular perfusion, increased ischemia and 
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hypoxia, a vicious cycle that may possibly lead to the development of MTrPs. As a result, 
several sensitizing substances may be released, leading to local and referred pain in addition to 
muscle tenderness which are clinical hallmarks of MPS (Shah et al., 2015). Electromyographic 
studies have revealed spontaneous electrical activity (SEA) generated at MTrP loci that was 
not seen in surrounding tissue (Hubbard & Berkoff, 1993). Originally attributed to 
dysfunctional muscle spindles, the excess electrical activity was later identified as an increase 
in miniature endplate potentials and excessive acetylcholine (ACh) release (Hubbard & 
Berkoff, 1993). Using ultrasound imaging and elastography, Sikdar et al. (2009) in a small 
group (nine subjects) descriptive study demonstrated for the first time that there are 
abnormalities in the milieu of the muscle containing palpable MTrPs. They found nodular 
regions of hypoechogenicity on sonography. 
In the presence of persistent nociceptive bombardment, the dorsal root ganglion will 
release ‘substance P’ and calcitonin gene-related peptide (CGRP) antidromically into the 
peripheral tissue. The peripheral secretion of these substances can lead to a cascade of events 
including the degranulation of local mast cells, local vasodilation, plasma extravasation and 
the development of a sensitizing biochemical soup. This process of ‘neurogenic inflammation’ 
leads to the enhanced release of endogenous substances, such as bradykinin, serotonin, 
norepinephrine, nerve growth factor and adenosine gradually leading to peripheral and central 
sensitization (Shah et al., 2015).  
Whether muscle or fascia can alter pathologically in this way is unclear but there are 
indications that MFR and manual therapy in general can affect blood flow by increasing nitric 
oxide production (Quere´ et al., 2009; Okamoto et al., 2014). Such fascial inflammation may 
be related to the concept of myofascial trigger points, which have been proposed to occur when 
motor endplates release excessive acetylcholine, shortening sarcomeres locally, disrupting cell 
membranes, damaging the sarcoplasmic reticulum and causing inflammation (Bron & 
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Dommerholt, 2012). However, the phenomenon of myofascial trigger points has been drawn 
into question by concerns over the reliability of their clinical identification (Myburgh et al., 
2008) and conclusions drawn from low methodological quality studies. 
1.4.3. Neurophysiological Model 
There are two main branches of neurophysiological mechanisms, one involving the 
Golgi reflex arc and another involving other mechanoreceptors.  
1.4.3. a. Golgi Reflex Arc Model 
In the Golgi reflex arc model, it is noted that Golgi receptors are found in all connective 
tissues, although they are only called Golgi tendon organs (GTOs) at the muscle-tendon 
junction. When a muscle is stretched, GTOs provide afferent feedback to the spinal cord. It is 
thought that pressure exerted during MFR might stimulate the GTOs, reduce motor unit firing 
rate and subsequently decrease muscle tension (Tozzi, 2012). However, it seems likely that 
muscles must be active in order for GTOs to be stimulated (Jami, 1992). It has been argued 
that this may be because the GTO is in series with the muscle (Schleip, 2003). During a passive 
stretch, the muscle likely absorbs most of the change in length of the muscle tendon unit 
whereas during an active stretch, this does not occur (Schleip, 2003).  
1.4.3. b. Mechanoreceptor Model 
The other main neurophysiological mechanism involves Ruffini and Pacini corpuscles 
and interstitial muscle receptors which are mechanoreceptors commonly found in fascia 
(Stecco et al., 2007a). Pressure applied to mechanoreceptors might stimulate the nervous 
system and thereby lead to reduced muscular tension (Schleip, 2003). Some investigations have 
shown that massage causes H-reflex inhibition (Morelli et al., 1999) which is an indirect 
measure of alpha motorneuron excitability. This phenomenon has also been attributed to the 
activation of mechanoreceptors, which are believed to inhibit the central nervous system during 
massage (Morelli et al., 1999).  
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1.4.3. c. Other Mechanisms  
In contrast to the above mechanisms that have traditionally been put forward to explain 
the effects of MFR, static stretching is thought to be effective primarily by means of its effects 
on stretch tolerance (Weppler and Magnusson, 2010). It is possible that MFR may also prove 
to be effective through a similar mechanism, as manual therapies in general are typically 
reported as having a number of potentially pain-relieving effects (Bialosky et al., 2009; Voogt 
et al., 2015). Such analgesic effects have been described as being mediated by either peripheral, 
spinal, or supraspinal mechanisms (Bialosky et al., 2009). Peripheral mechanisms might 
involve the release of local inflammatory mediators (Bialosky et al., 2009). Spinal mechanisms 
could involve signals along large, primary afferent nerve fibres interfering with pain signals 
transmitted along slow-conducting, tertiary fibres. 
These could then inhibit pain feedback in the spinal cord (Bialosky et al., 2009). Both 
peripheral and spinal mechanisms might be expected to occur based on the gate control theory 
of pain (Melzack, 1982). Supraspinal mechanisms are much less clear. Bialosky et al. (2009) 
suggested they might involve alterations in those parts of the brain responsible for the pain 
experience, such as the anterior cingular cortex, the amygdala, periaqueductal gray and rostral 
ventromedial medulla. In whatever way they are affected, the analgesic effects that very likely 
arise following MFR could potentially produce an increase in stretch tolerance immediately 
following the application of the therapy, which could account for acute changes in flexibility. 
Although there has been substantial discussion of the potential mechanisms by which MFR 
might exert their effects, the research has until very recently been limited in respect of the acute 
and chronic clinical effects of MFR and self MFR (Beardsley& Škarabot, 2015). 
Manual therapy theoretically restores mobility by re-optimizing the distribution of lines of 
force within fascia (Stecco et al., 2013; Day et al., 2009). Simulated myofascial release on in-
vitro fibroblasts originally injured by repetitive motion strain results in normalization of cell 
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morphology and attenuation of inflammatory responses (Meltzer et al., 2010). There appears 
to be an important balance between the amount and type of strain resulting in cellular 
destruction and apoptosis versus cellular proliferation (Dodd et al., 2006; Meltzer et al., 2010). 
Recent studies have started to document immediate and delayed changes at the cellular level 
to manual treatments in-vivo (Crane et al., 2012). 
Additionally, there have been theories regarding the myofascial connective tissue 
planes and acupuncture meridians (Langevin & Yandow, 2002). Acupuncture needles, with 
rotation, induce winding of connective tissue around the needle point (Langevin & Churchill, 
2002). In-vitro models may be able to elucidate the response of acupuncture depending on the 
mechanostructural characteristics such as collagen concentration and formation (Julias et al., 
2008). Mechanical stimuli by acupuncture may induce remodeling of the extracellular matrix. 
Targeted remodeling may counteract any dysfunction in fascia. Further research is needed to 
identify how acupuncture helps treat myofascial pain at sites distant from the needle insertion 
(Kwong & Findley, 2014) 
Further research is also needed about how fascia may be affected by other current treatment 
regimens such as therapeutic modalities, exercise, medications, interventional injections and 
surgery. 
 
1.5. Fascia and Myofascial Release  
The fascial system consists of the three-dimensional continuum of soft, collagen 
containing, loose and dense fibrous connective tissues that permeate the body. It incorporates 
elements such as adipose tissue, adventitiae and neurovascular sheaths, aponeuroses, deep and 
superficial fasciae, epineurium, joint capsules, ligaments, membranes, meninges, myofascial 
expansions, periostea, retinacula, septa, tendons, visceral fasciae and all the intramuscular and 
intermuscular connective tissues including endo-/peri-/epimysium (Adstrum et al., 2017). The 
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fascial system interpenetrates and surrounds all organs, muscles, bones and nerve fibres, 
endowing the body with a functional structure, and providing an environment that enables all 
body systems to operate in an integrated manner (Adstrum et al., 2017).  As fascia is able to 
modify its tensional state, strain transmission along the meridians might occur in response to 
changes of muscle activity. (Wilke et al., 2016). It not only lubricates the fibres but gives 
nourishment to all parts of the body. The fascial system is considered as a “tensegrity” or 
tensional integrity structure to manage the balance between tension and compression around 
the organs, joints and muscles (Chen et al., 2016). Repetitive mechanical straining of 
fibroblasts can also result in secretion of inflammatory mediators (Dodd et al., 2006). All of 
these changes could affect the normal functions of force transmission or sliding in the 
musculoskeletal system. This dysfunction could lead to pain or proprioceptive issues.  
As fascia is able to modify its tensional state, strain transmission along the meridians 
might occur in response to changes of muscle activity. (Wilke et al., 2016). The central rule for 
the selection of a meridian’s components is a direct linear connection between two muscles. 
Myers (2014) defined eleven myofascial meridians connecting distant parts of the body by 
means of muscles and fascial tissues. Wilke et al. (2016), first showed that there is good 
evidence for the existence of three myofascial chains proposed by Myers (2009, 2014) through 
a systematic review. The results yielded strong evidence for myofascial transitions in three of 
the six examined myofascial meridians: Superficial back line, back functional line and front 
functional line. In the superficial back line there was moderate evidence for the meridians and 
transitions of the spiral line (five of nine verified transitions, based on twenty one studies) and 
the lateral line (two of five verified transitions, based on ten studies). Because fascia can 
transmit tension (Norton-Old et al., 2013) and in view of its proprioceptive and nociceptive 
functions, existence of myofascial meridians could be responsible for disorders and pain 
radiating to remote anatomic structures (Myers, 2009). 
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Myofascial release (MFR) is a form of manual therapy which involves the application 
of a low load, long duration stretch to the myofascial complex, intended to restore optimal 
length, decrease pain and improve function (Barnes, 1990). MFR is being used to treat patients 
with a wide variety of conditions, but there is scarcity of evidence to support its efficacy.  
The effects of manual fascial interventions can be local (as tissue texture changes), 
segmental (as via neurological response) and global (as through hormonal effects) in extent, 
and may occur at different intervals—ranging from minutes to weeks—after a given input, with 
many interacting mechanisms influencing tissue properties and behaviours, including placebo.  
Some of these factors are strongly supported by the available evidence whereas others need 
further investigation (Tozzi, 2015b). 
Three main manual approaches that are directed towards the fascia: i) direct approach 
- the affected tissue is brought against the restrictive barrier, described as afunctional limit that 
abnormally diminishes the normal physiologic range (E.C.O.P., 2011a). This is maintained 
until tensions modify; ii) indirect approach - tissues are brought away from the restrictive 
barrier while a position of ease is found and maintained up to a release; iii) combined approach 
- both the point of ease and the restrictive barrier are consecutively engaged in an interactive 
fashion (Ward, 2003).  Direct technique MFR is thought to work directly on restricted fascia; 
practitioners use knuckles or elbow or other tools to slowly sink into the fascia, and the pressure 
applied is a few kilograms of force (up to four kilograms) to contact the restricted fascia, apply 
tension or stretch the fascia. Indirect MFR involves application of gentle stretch- the pressure 
applied is in a lower range (up to half a kilogram)  and the hands tend to follow the direction 
of fascial restriction, hold the stretch, and allow the fascia to ‘unwind’ itself. The rationale for 
these techniques can be traced to various studies that investigated cellular, viscoelastic and 
neurological properties of the fascial tissue (Schleip, 2014; Tozzi, 2015a, b).  Fascial therapies 
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theoretically restores mobility by re-optimizing the distribution of lines of force within the 
fascia (Stecco et al., 2013; Day et al., 2009). 
 
1.6. Objective of this Study 
To critically analyse three published randomised controlled trials (RCTs) and one 
systematic review on the effectiveness of myofascial release in various conditions. 
 
1.7. Need and Significance of the Study 
MFR is being used to treat patients with a wide variety of conditions. But there is a lack 
of evidence to support its efficacy. Studies are emerging in this field with varying results and 
conclusions. Analysis of the recent research trials and reviews will be a better way to appraise 
the quality and reliability of such work. This work attempts to critically analyse three published 
randomised controlled trials (RCTs) and one systematic review on the effectiveness of 
myofascial release on various conditions with an aim of facilitating the creation of a more 
homogenous and reputable base for future trials in the field. A critical appraisal of the 
conducted studies and reviews to pin point this strengths and weaknesses can help to fine tune 
future studies. This type of approach and its findings can be highly useful for a manual therapy 
technique having lots of practice variations and applicability to set more controlled and 
methodologically superior studies in the future.  
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Chapter 2 
 Methodology at a Glance 
 
2.1. Methodology at a Glance  
This work attempts to critically analyse three published randomised controlled trials 
(RCTs) and one systematic review on the effectiveness of myofascial release on various 
conditions with an aim to facilitate in creating a respectable base for future trials in the field. 
Three published randomised controlled trials (RCTs) and a systematic review on the 
effectiveness of MFR during the period of 2010 to 2015 were selected and analysed. The three 
RCTs selected were primarily evaluating the effectiveness of MFR on tension type headache 
(TTH), lateral epicondylitis (LE) and chronic low back pain (CLBP). The RCTs were analysed 
under subheadings like article title, technical details, synopsis, need and significance of the 
study, the principal research question and answer to it, demographic and methodological 
characteristics, risk of bias analysis, major findings, limitations and implications of the study. 
A conclusion was drawn at the end of each analysis 
The systematic review was a comprehensive analysis of all the published RCTs in the 
MFR field till 2014. The systematic review was reviewed under the headings of criteria of 
selection, data analysis process, data synthesis and review of randomised controlled trials on 
Myofascial Release with a conclusion at the end. Since the three RCTs analysed here were 
already included in the systematic review, the in-depth analysis of the systematic review was 
merged with the thesis discussion part.  
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2.2. Outcome Measures 
The outcome measures used in this thesis to analyse the quality and level of evidence 
were the PEDro Scale and the Centre for Evidence-Based Medicine’s (CEBM’s) Levels of 
Evidence Scale. Additionally, a risk of bias analysis was included in the analysis of the RCTs 
and AMSTAR 2 tool was used to grade the quality of systematic review. 
2.2. a. PEDro Scale 
Although there are many scales which are used to assess the quality of clinical trials, 
the ‘PEDro Scale’ is commonly employed in rating researches in the physiotherapy area 
(Maher et al., 2003). The PEDro Scale (Table 2.1) assesses methodological quality and consists 
of a checklist of 11 criteria, 10 of which are scored. For each criterion the study met, one point 
was awarded. The points were tallied and presented as a score out of 10. The scale applies only 
to experimental studies. The PEDro Scale considers two aspects of trial quality, the “internal 
validity” of the trial and whether the trial contains sufficient statistical information to make it 
interpretable. It does not rate the “meaningfulness”, “generalisability” or “external validity” of 
the trial, or the size of the treatment effect. To assess the “internal validity” criteria, including 
random allocation, concealment of allocation, comparability of groups at baseline, blinding of 
patients, therapists and assessors, analysis by intention to treat and adequacy of follow-up were 
checked. Interpretability was measured by taking between-group statistical comparisons and 
reports of both point estimates and measures of variability. Trials are rated on the basis of what 
they report. If a trial does not report that a particular criterion was met, it will be scored as the 
criterion was not met. For this review, investigations with PEDro scores of 6-10 were 
considered high quality, of 4-5 were considered moderate quality, and of 0-3 were considered 
low quality (McKenney et al., 2013). The PEDro Scale does not evaluate clinical usefulness. 
In the past few years the PEDro Scale has undergone substantial psychometric validation 
(Maher et al., 2003; Bhogal et al., 2005; Foley et al., 2006; de Morton, 2009) and many 
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systematic reviews use it to rate the quality of the trials they include. Maher et al, (2003) 
reported an inter-rater reliability generalised kappa statistic of between 0.4 and 0.8 for the 
PEDro Scale which is in an acceptable range at individual item level and in total PEDro scores 
(Foley et al., 2006). The results of Rasch analysis indicated that the PEDro Scale measures only 
one construct – the methodological quality of clinical trials. Since there was no redundancy of 
PEDro Scale items, it is valid to combine PEDro item scores to obtain a total PEDro score as 
an indicator of methodological quality. Furthermore, the finding that there were no redundant 
items amongst the 10 PEDro Scale items, suggests that the PEDro Scale assesses a reasonable 
breadth of methodological quality. Clinicians and researchers can therefore confidently use the 
PEDro Scale to assess the methodological quality of clinical trials of physiotherapy 
interventions (de Morton, 2009). 
Table 2.1.  Physiotherapy Evidence Database (PEDro) Scale 
Item Criteria 
1 Eligibility criteria were specified (no points awarded)  
2 Subjects were randomly allocated to groups  
3 Allocation was concealed  
4 
 
The groups were similar at baseline regarding the most important prognostic 
indicators 
5  There was blinding of all subjects  
6 There was blinding of all therapists who administered the therapy  
7 There was blinding of all assessors who measured at least one key outcome  
8 Measures of at least one key outcome were obtained from more than 85% of the 
subjects initially allocated to groups 
9 All subjects for whom outcome measures were available received the treatment 
or control condition as allocated 
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10 The result of between-group comparisons are reported for at least one key 
outcome  
11 The study provides both point measures and measures of variability for at least 
one key outcome 
TOTAL Sum of scores for items 2-11 
 
Since it is developed to assess the quality of the physiotherapy studies, the scale 
contains physiotherapy oriented components like the therapist and subject blinding. Unlike in 
drug trials, both therapist blinding and subject blinding are difficult to achieve in complex 
intervention trials. In most clinical trials of physiotherapy intervention, it is not possible to 
blind the therapist providing the intervention. Similarly, it is also difficult to blind participants 
to the physiotherapy intervention that they are receiving except in trials of electrotherapeutic 
interventions. One can say that PEDro Scale gives better methodological details of 
physiotherapy researches. 
In 2005, Bhogal et al. systematically compared the PEDro Scale and the Jadad scale by 
applying to the stroke rehabilitation literature and concluded that the PEDro Scale provides 
more comprehensive measure of methodological quality in this field. The authors stated that in 
rehabilitation research, where double-blinding studies are often not possible due to the nature 
of the interventions, breaking down the levels of blinding and accounting for concealed 
allocation, intention-to-treat and attrition could be important and PEDro Scale is able to 
provide that. 
In conclusion, the PEDro Scale is a reliable and valid measure of methodological 
quality of clinical trials with specific details that are main concerns of physiotherapy 
researches. Its items were ranked hierarchically from the least to the most adhered to item 
without redundancy. Since there was a high correlation between original PEDro ordinal scores 
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and transformed PEDro interval scores, PEDro data can be treated as interval level 
measurement. These findings support the use of the PEDro Scale for assessing the 
methodological quality of clinical trials (Maher et al., 2003; de Morton, 2009; Elkins et al., 
2013) 
2.2. b. The CEBM Levels of Evidence Scale  
In 1999, the Oxford Centre for Evidence-Based Medicine (OCEBM) developed a 
grading guideline to serve the needs of its junior medical staff (Atkins et al., 2004) with 
adaptions from other guidelines, notably from Canadian Task Force on Preventive Health Care 
(CTFPHE) and the Australian National Health and Medical Research Council (ANHMRC), 
and expanded the number of levels of evidence to five, including numerous sublevels. 
However, unlike previous guidelines, the OCEBM also developed a method for adjusting the 
level of evidence based on the quality with which the study was conducted (Gugiu & Gugiu, 
2010). 
The CEBM Levels of Evidence Scale (Phillips et al., 2009) (Table 2.2) assesses quality 
based on study design. Systemic reviews with homogeneity of RCTs are ranked in the highest 
levels while expert opinions rank the least. In both scales, RCTs receive higher rankings, 
particularly with long-term follow-up and narrow confidence intervals. Finding the levels of 
evidence is an important component of evidence based practice. Understanding the levels and 
why they are assigned to publications and abstracts helps the reader to prioritize information. 
The levels of evidence provide a guide and the reader needs to be cautious when interpreting 
these results (Burns et al., 2011). Bhandari et al. (2004) concluded that epidemiology and non-
epidemiology-trained reviewers can apply the levels of-evidence to published studies with 
acceptable inter-observer agreement. The CEBM Scale is a simple and fast way to categorise 
the research publications so that both readers and investigators can use the logic of selecting 
the best evidences (McKeon et al., 2006; Medina et al., 2006). 
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Table 2.2.  Centre of Evidence-based Medicine: Levels of Evidence 
Level  Definition 
1a   Systematic reviews of randomised controlled trials 
1b  Individual randomised controlled trial 
1c  All-or-none studies 
2a  Systematic reviews of cohort studies 
2b  Individual cohort studies or low-quality randomised 
controlled trials 
2c  Outcomes research 
3a Systematic reviews of case-control studies 
3b  Individual case-control studies 
4 Case series, poorly designed cohort or case-control studies 
5  Animal and bench research, expert opinion 
 
2.2.c. Risk of Bias Tool 
A bias is a systematic error or deviation from the truth in results or inferences. Biases can 
operate in either direction: different biases can lead to underestimation or overestimation of the true 
intervention effect. Biases can vary in magnitude: some are small (and trivial compared with the 
observed effect) and some are substantial (so that an apparent finding may be entirely due to bias). 
Differences in risks of bias can help explain variation in the results of the studies included in a 
systematic review. It is important to assess risk of bias in all studies in a review irrespective of the 
anticipated variability in either the results or the validity of the included studies. 
The Cochrane 'Risk of Bias tool (RoB) is one of the most widely used tools for assessing 
the risk of bias (RoB) of clinical trials (Xy et al., 2016). The Risk of Bias tool covers six 
domains of bias: selection bias, performance bias, detection bias, attrition bias, reporting bias 
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and other bias. Within each domain, assessments are made for one or more items, which may 
cover different aspects of the domain or different outcomes (Table 2.3). The Risk of Bias tool 
is one of the most comprehensive approaches to assessing the potential for bias in randomised 
trials included in systematic reviews or meta-analyses. Inclusion of details of trial conduct, on 
which judgments of risk of bias are based, provides greater transparency than previous 
approaches, allowing readers to decide whether they agree with the judgments made. There are 
continuing uncertainty and great variation in practice over how to assess potential for bias in 
specific domains within trials, how to summarise bias assessments across such domains and 
how to incorporate bias assessments into meta-analyses (Higgins et al.,2011). 
 
Table 2.3. Cochrane Risk of Bias Assessment 
Bias domain Source of bias Support for 
judgment 
Review authors’ 
judgment (assess as 
low, unclear or high 
risk of bias) 
Selection bias Random sequence 
generation 
Describe the method 
used to generate the 
allocation sequence in 
sufficient detail to 
allow an assessment of 
whether it should 
produce comparable 
groups 
Selection bias (biased 
allocation to 
interventions) due to 
inadequate generation 
of a randomised 
sequence 
Allocation 
concealment 
Describe the method 
used to conceal the 
allocation sequence in 
sufficient detail to 
determine whether 
intervention 
allocations could have 
been foreseen before 
or during enrolment 
Selection bias (biased 
allocation to 
interventions) due to 
inadequate 
concealment of 
allocations before 
assignment 
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Performance bias Blinding of 
participants and 
personnel* 
Describe all measures 
used, if any, to blind 
trial participants and 
researchers from 
knowledge of which 
intervention a 
participant received. 
Provide any 
information relating to 
whether the intended 
blinding was effective 
Performance bias due 
to knowledge of the 
allocated interventions 
by participants and 
personnel during the 
study 
Detection bias Blinding of outcome 
assessment* 
Describe all measures 
used, if any, to blind 
outcome assessment 
from knowledge of 
which intervention a 
participant received. 
Provide any 
information relating to 
whether the intended 
blinding was effective 
Detection bias due to 
knowledge of the 
allocated interventions 
by outcome assessment 
Attrition bias Incomplete outcome 
data* 
Describe the 
completeness of 
outcome data for each 
main outcome, 
including attrition and 
exclusions from the 
analysis. State whether 
attrition and 
exclusions were 
reported, the numbers 
in each intervention 
group (compared with 
total randomised 
participants), reasons 
for attrition or 
Attrition bias due to 
amount, nature, or 
handling of incomplete 
outcome data 
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exclusions where 
reported, and any 
reinclusions in 
analyses for the review 
Reporting bias Selective reporting State how selective 
outcome reporting was 
examined and what 
was found 
Reporting bias due to 
selective outcome 
reporting 
Other bias Anything else, ideally 
pre-specified 
State any important 
concerns about bias 
not covered in the 
other domains in the 
tool 
Bias due to problems 
not covered elsewhere 
 
*Assessments should be made for each main outcome or class of outcomes. 
 
A recent study has found that the tool takes longer to complete than other tools (the 
investigators took a mean of 8.8 minutes per person for a single predetermined outcome using 
our tool compared with 1.5 minutes for a previous rating scale for quality of reporting) 
(Hartling et al., 2009).The reliability of the tool has not been extensively studied, although the 
same authors observed that larger effect sizes were observed on average in studies rated as at 
high risk of bias compared with studies at low risk of bias (Hartling et al., 2009). By explicitly 
incorporating judgments into the tool, one can acknowledge that the agreements between 
assessors may not be as high as for some other tools. However, we also explicitly target the 
risk of bias rather than reported characteristics of the trial. It would be easier to assess whether 
a drop-out rate exceeds 20% than whether a drop-out rate of 21% introduces an important risk 
of bias, but there is no guarantee that results from a study with a drop-out rate lower than 20% 
are at low risk of bias. Preliminary evidence suggests that incomplete outcome data and 
selective reporting are the most difficult items to assess; kappa measures of agreement of 0.32 
(fair) and 0.13 (slight) respectively have been reported for these (Hartling et al., 2009).  
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The widespread adoption and implementation of the Risk of Bias tool, both within and 
outside the Cochrane Collaboration, will facilitate improved appraisal of evidence by 
healthcare decision makers and patients and ultimately lead to better healthcare. Improved 
understanding of the ways in which flaws in trial conducted may bias their results should also 
lead to better trials and more reliable evidence. Risk of bias assessments should continue to 
evolve, taking into account any new empirical evidence and the practical experience of authors 
of systematic reviews (Higgins et al., 2011). The Cochrane Risk of Bias tool for randomised 
clinical trials was introduced in 2008 and has frequently been commented on and used in 
systematic reviews. Jørgensen et al. (2016) have concluded that the Cochrane RoB tool has 
become the standard approach to assess risk of bias in randomised clinical trials but is 
frequently implemented in a non-recommended way.  
 
2.2. d. AMSTAR 2 
AMSTAR is a popular instrument for critically appraising systematic reviews of 
randomised controlled clinical trials. The revised instrument (AMSTAR 2) retains 10 of the 
original domains, has 16 items in total (compared with 11 in the original), has simpler response 
categories than the original AMSTAR, includes a more comprehensive user guide and has an 
overall rating based on weaknesses in critical domains (Appendix 10.5).  
AMSTAR 2 is a major revision of the original AMSTAR instrument, which was 
designed to appraise systematic reviews that included randomised controlled trials (Shea et al., 
2009). The main modifications include simplified response categories; a more detailed 
consideration of risk of bias with included studies, better alignment with the PICO (P – patient, 
problem or population; I – intervention; C – comparison, control or comparator; O – outcome) 
framework for research questions; a more detailed justification of selection of study designs 
for inclusion in a review; and more information on studies that were excluded from reviews. In 
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addition, emphasize on defining critical domains before starting an appraisal of a systematic 
review. Identification of weaknesses in these domains should undermine confidence in the 
results of a systematic review. 
The responses to AMSTAR 2 items should not be used to derive an overall score 
(Greenland & O’Rourke, 2001). An overall score may disguise critical weaknesses that should 
diminish confidence in the results of a systematic review and AMSTAR 2 allows the users to 
adopt the rating process based on identification of critical domains or some variation based on 
these principles (Juni et al., 1999).  
The consideration of risk of bias in individual studies is equally important for 
randomised and non-randomised studies of healthcare interventions but is generally better 
understood with the former. Large non-randomised studies, often conducted in large 
administrative databases, are increasingly being used to assess the real-world impact of a wide 
range of healthcare technologies and practices. Although such studies often use sophisticated 
methods, residual confounding or failure to deal with other sources of bias may lead to 
inaccurate estimates of effect. Inclusion of large observational studies in meta-analyses may 
generate precise but biased estimates of intervention effects (Egger et al., 1998). The items in 
AMSTAR 2 that deal with risk of bias identify domains specified in the Cochrane risk of bias 
instruments for randomised and non-randomised studies (Sterne et al., 2016). However, 
AMSTAR 2 does not currently specify which risk of bias instruments review authors should 
have used to assess non-randomised studies included in a systematic review. AMSTAR 2, as a 
critical appraisal instrument for systematic reviews, joins several published instruments 
designed for this purpose (Shea et al., 2017). 
  AMSTAR 2 provides a broad assessment of quality, including flaws that may have 
arisen through poor conduct of the review. In this respect it differs from the other instrument 
of this category, the ‘Risk Of Bias In Systematic reviews’ (ROBIS), which focuses more on 
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the risk of biases (Whiting et al., 2016). AMSTAR 2 is intended to be used for reviews of 
healthcare interventions. There is overlap in the items considered by ROBIS and AMSTAR 2; 
indeed, same investigators were involved in the development of both.  
AMSTAR 2 is intended to be used for reviews of healthcare interventions. In its 
development, ten domains were retained from the original validated tool, albeit with some 
wording changes based on feedback and extensive experience of using it. Two domains were 
given more detailed coverage: duplicate study selection and data extraction now have their own 
items. An additional, more detailed and separate risk of bias for randomised and non-
randomised studies are there. In total, four domains were added. Two of these come directly 
from the ROBINS-I. 
The levels of agreement achieved by the three pairs of raters varied across items, but 
they were moderate to substantial for most items. Notably, the agreement between two raters 
involved in the development of AMSTAR 2 was no higher than that achieved by experienced 
raters who had not been involved its development. The average completion time ranges from 
15-32 minutes.  
The inter-rater reliability of AMSTAR 2 was measured with three pairs of raters and 
three sets of systematic reviews. The values varied substantially across items and between pairs 
of raters. Most values were in an acceptable range, with 46 of the 50 κ scores falling in the 
range of moderate or better agreement and 39 displaying good or better agreement (Shea et al., 
2017). 
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2.3. Structure of the Thesis 
This thesis begins with Abstract, list of published works and statement of original authorship. 
The Introduction chapter has 7 sessions explaining Myofascial pain syndrome, defining 
myofascial release, fascia, MFR and myofascial dysfunction, objective of the study and need 
and significance of the study. The second chapter is Methodology at a Glance with sessions 
of outcome measures and structure of the thesis. 
The third to fifth chapters explain the three RCTs analysed in this review-tension head ache, 
lateral epicondylitis and chronic low back pain- under various sub headings. They are title, 
link to journal abstract, technical details, synopsis, need and significance of the study, principal 
research question, demographic and methodological characteristics, risk of bias analysis, major 
findings of the study, answer to the principal research question, study limitations, Implications 
of the study with a conclusion at the end. The sixth chapter categorizes the selected systematic 
review for analysis under the sections review process, criteria of selection, data analysis 
process, data synthesis, other randomised controlled trials on MFR, AMSTAR analysis and 
conclusion.  
 The seventh chapter is prepared with an in-depth analysis of the three RCTs and one 
systematic review as the discussion. This is the prime focus of this thesis and analysed the 
RCTs and systematic review separately and in detail. The eighth chapter is the conclusion 
drawn from the analysis and contain the ending comment from the reviewers. The references 
and the appendices relevant to this thesis follows the eighth chapter. 
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Chapter 3 
Direct vs Indirect Myofascial Release for Tension 
Headache 
 
 
3.1. Online Title 
Myofascial release in the management of tension type headache 
3.2. Article Title 
Effectiveness of direct vs indirect technique myofascial release in the management of tension 
type headache 
3.3. Link to journal abstract 
http://www.bodyworkmovementtherapies.com/article/S1360-8592(11)00022-2/abstract 
3.4. Technical details  
3.4.1. Journal 
Journal of Bodywork & Movement 
Therapies 
3.4.2. Published date 
October 2011 
3.4.3. Specialty 1 
General Orthopaedics 
3.4.4. Specialty 2 
Physical Therapy & Rehabilitation 
3.4.5. PMID# 
21943616 
3.4.6. Type of Study 
Interventional (Therapy) 
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3.4.7. Quality of the study (PEDro) 
Moderate (6/10) 
3.4.8. Level of Evidence (CEBM) 
Level 2b Randomised controlled Trial 
3.4.9. All Authors 
M.S. Ajimsha 
3.4.10. Conflicts 
None disclosed 
 
3.5. Synopsis 
Tension-type headache (TTH) is essentially defined as bilateral headache of a pressing 
or tightening quality without a known medical cause. Myofascial release (MFR) is currently 
being applied for patients with TTH. But its efficacy was not been evaluated formally. Sixty 
three patients with episodic or chronic tension-type headache were given direct MFR 
technique, indirect MFR and a sham treatment and were compared. The study was of moderate 
quality (6/10) on PEDro with 2b level of evidence in CEBM Scale. The techniques were applied 
for 24 sessions per patient over 12 weeks with the difference in number of days with headache 
at baseline and post-test as the outcome measure. Patients in the direct MFR group, the indirect 
MFR group and the control group reported a 59.2%, 54% and 13.3% reduction respectively in 
their headache frequency in post-test compared to the baseline. The number of days with 
headache per four weeks decreased by 7.1 (2.6) [mean (SD)] days in the DT-MFR group 
compared with 6.7 (1.8) days in the IDT-MFR group and 1.6 (0.5) days in the control group (P 
<0.001). Patients in the DT-MFR group, IDT-MFR group and control group reported a 59.2%, 
54% and 13.3% reduction in their headache frequency in weeks 17-20 compared to that in 
weeks 1-4. This study proved that direct technique or indirect technique MFR is more effective 
than the control intervention for tension headache. Lack of follow up, blinding of the therapists 
and the patient were the major limitations of the study. 
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3.6. Need and Significance of the Study 
A survey from the United States found a one-year prevalence of 38% for episodic 
tension-type headache and 2% for chronic tension-type headache (Schwartz et al., 1998). 
Present pain models for tension-type headache suggest that nociceptive inputs from peripheral 
tender muscles can lead to central sensitization in chronic tension-type headache (De-Las-
Penas et al., 2007). Myofascial Trigger Points are highly prevalent in patients with tension-
type headache (Couppe´ et al., 2007). It has been hypothesized that fascial restrictions in one 
part of the body cause undue tension in other parts of the body, due to fascial continuity. In 
turn, this may create stress on any structures that are enveloped, divided or supported by fascia 
(Schleip et al., 2003). Myofascial practitioners believe that by restoring the length and health 
of restricted connective tissue, pressure can be relieved on pain sensitive structures such as 
nerves and blood vessels. Myofascial release (MFR) is currently being applied for patients with 
TTH but its efficacy has not been evaluated formally. The goal of the study was to investigate 
whether direct technique myofascial release (DT-MFR) reduces the frequency of headache 
more effectively than the indirect technique myofascial release (IDTMFR) in comparison to a 
control group receiving slow soft stroking. 
 
3.7. The Principal Research Question 
Does direct technique myofascial release (DT-MFR) reduces the frequency of headache more 
effectively than the indirect technique myofascial release (IDTMFR) in comparison to a control 
group receiving slow soft stroking when assessed during weeks 1-4 and 17-20 of treatment? 
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3.8. Demographic and Methodological Characteristics 
3.8.1. Population  
Individuals aged 18-50 years with a diagnosis of episodic or chronic TTH lasting at 
least 12months, and who had completed 4-week baseline headache diaries were included. 
Those with a history of additional migraine headache, secondary headaches, age >50 years, 
used analgesics on more than10 days a month, had prophylactic headache treatment with drugs 
in the four weeks prior to randomization, and any other treatment for TTH during the previous 
12 months were excluded. Between July 2008 and February2009, 76 patients were referred to 
‘Myofascial therapy and research foundation’, India, with a diagnosis of TTH. Of these, 63 
individuals who met the inclusion criteria and provided written informed consent were 
randomised to DT-MFR, IDT-MFR, or control using a 2:2:1 list (Tully et al., 2007; Sherman 
et al., 2011). 
3.8.2. Intervention  
All three interventions were provided twice weekly for 12 weeks (weeks 5-16); the 
duration of each treatment session was one hour. The technique used was the same for all the 
patients in (DT-MFR -Stanborough,2004; IDT-MFR- Manheim,2001). All techniques were 
performed bilaterally, 3 min on each side. (DT-MFR: Mean age: 43.7 +/- 5.6 n=24, 22 
completed the study, 7M/15F; IDT-MFR: Mean age: 44.7 +/- 5.2, n=23, 22 completed the 
study, 8M/14F). 
3.8.3. Comparison  
Patients in the control group received slow soft stroking with finger pads all over the 
head in the same areas as the application of MFR (in the other groups) for the same duration (1 
h per treatment session), twice a week for 12 weeks. After the completion of the study, patients 
in the control arm were provided MFR therapy, as advised by the ethics committee. (Mean age: 
43.0 +/- 5.4, n=13, 12 completed the study, 5M/7F). 
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3.8.4. Outcomes  
Difference in numbers of days with headache between weeks 1-4 (i.e.four weeks prior to start 
of intervention) and weeks 17-20, following 12 weeks of intervention between weeks 5-16 as 
recorded by participants in headache diaries. 
3.8.5. Time  
Outcomes were assessed at baseline (weeks 1-4) and in week 17-20, following 12 weeks of 
intervention 
3.9. Risk of Bias Analysis (Table 3.1) 
Bias Authors’ 
judgment 
Support for judgment 
Random sequence 
generation (selection 
bias) 
Low risk Computer based randomisation using a 
2:2:1 approach  
Allocation 
concealment 
(selection bias) 
Unclear risk The randomisation list was created by a 
blinded statistician, but further description 
of allocation was not included 
Blinding of 
participants and 
researchers 
(performance bias) 
High risk Participants and therapists were not blinded 
Blinding of outcome 
assessment (detection 
bias) 
Low risk Two evaluators blinded 
to the group to which the participants 
belonged analyzed 
headache diaries 
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Incomplete outcome 
data (attrition bias) 
High risk Losses to follow-up were disclosed and 
were less than 5% 
No sample size calculation mentioned 
Selective reporting 
(reporting bias) 
Low risk All pre-specified outcomes were reported 
Other bias Low risk Expertise of treating therapists including 
training and experience mentioned  
 
3.10. Major Findings of the Study 
3.10.1. There were no statistically significant differences between the groups for any of 
the baseline characteristics 
3.10.2. From weeks 1-4 to weeks 17-20, the number of days with headache per four 
weeks decreased by 7.1 (SD 2.6) days in the DT-MFR group compared with 6.7 
(SD 1.8) days in the IDT-MFR group and 1.6 (SD 0.5) days in the control group 
(difference: DT-MFR vs IDT-MFR, 0.6 days, 95% confidence interval -2.4 to1.2 
days, P=0.51; DT-MFR vs Control Group, 5.8 days, -7.6to -4.0 days, P < 0.001, 
IDT-MFR vs Control Group, 5.4 days, -7.2 to -3.7 days, P < 0.001)  
3.10.3. The proportion of responders, defined as participants who had at least 50% 
reduction in headache days between weeks1-4 and weeks 17-20, was 81.8% in the 
DT-MFR Group, 86.4%in the IDT-MFR Group, and 0% in the control group.  
3.10.4. Patients in the DT-MFR group reported a 59.2% reduction in their headache 
frequency; IDT-MFR group reported 54% reduction whereas control group 
reported 13.3% reduction in their pain frequency per four weeks in the weeks 17-
20.  
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3.10.5. Differences in headache frequency between the DT-MFR and the IDT-MFR 
groups were statistically insignificant. 
3.10.6. No serious adverse events occurred in any of three groups as a result of 
treatment.  
3.10.7. Three patients from the DT-MFR group and one from the IDT-MFR group 
reported headaches in the first week following initiation of treatment and this was 
reported to have subsided within a week without any medication. 
3.11. Answer to the Principal Research Question 
3.11.1. This study provides evidence that direct technique or indirect technique MFR is 
more effective than the control intervention for tension headache. 
3.11.2. The proportion of responders, defined as participants who had at least 50% 
reduction in headache days between weeks1-4 and weeks 17-20, was 81.8% in the 
DT-MFR group, 86.4%in the IDT-MFR group, and 0% in the control group. 
3.12. Study Limitations 
Participants and treating physiotherapists were not blinded to the intervention they were 
randomised to. Another limitation was the absence of long-term follow up of study participants. 
A slight improvement over time occurred in the control group; this could be due to a “meaning 
response” (Moerman and Jonas, 2002). 
3.13. Implications of the Study 
Prevalence of episodic/ chronic tension type headache is very high across the globe and directly 
influencing the burden of care. MFR can be a non-invasive, non-pharmacological and low cost 
alternative for its management. A significant proportion of patients with TTH might benefit 
from the use of MFR. 
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3.14. Conclusion 
Both the direct and indirect techniques of MFR investigated in this trial were more effective 
than a control intervention consisting of slow soft stroking with finger pads for the treatment 
of tension-type head ache. A significant proportion of patients with TTH might benefit from 
the use of Myofascial Release. The mechanisms underlying these responses merit investigation. 
Table 3.2:  Headache diary readings (17-20 weeks) following completion of three months 
intervention. Data are the means (SD). 
Headache diary reading DTMFR 
 
IDTMFR 
 
Control group 
 
 
Headache frequency (weeks 1-
4) 
 
12 (2.8) 
 
12.4 (2.8) 
 
12 (2.5) 
 
Headache frequency (weeks 
17–20)  
 
4.9 (1.7) 
 
5.7 (1.3) 
 
10.4 (2.7) 
Mean (SD) of difference in 
days with headache between 
weeks 1-4 and weeks 17-20 
7.1 (2.6) 6.7 (1.8) 1.6 (0.5) 
 
Comparison of headache 
frequency scores of the 
DTMFR, IDTMFR and the 
control groups of the weeks 17-
20. (95% Confidence Interval) 
 
P value by unpaired t-test 
DTMFR  
Vs  
IDTMFR 
DTMFR  
Vs  
Control group 
IDTMFR  
Vs  
Control Group 
−0.6 (−2.4 to 1.2) 
 
 
0.51 
−5.8 (−7.6 to −4.0) 
 
 
< 0.001 
−5.4 (−7.2 to 
−3.7) 
 
 
< 0.001 
 
 
 
 
 
95 
 
 
Chapter 4 
Myofascial Release for Lateral Epicondylitis 
 
4.1. Online Title 
4.2. Article Title 
4.3. Link to Journal Abstract 
4.4. Technical Details 
4.5. Synopsis 
4.6. Need and Significance of the Study 
4.7. The Principal Research Question 
4.8. Demographic and Methodological Characteristics 
4.9. Risk of Bias Analysis 
4.10. Major Findings of the Study 
4.11. Answer to the Principal Research Question 
4.12. Study Limitations 
4.13. Implications of the Study 
4.14. Conclusion 
 
 
 
 
96 
 
Chapter 4 
Myofascial Release for Lateral Epicondylitis 
 
4.1. Online Title 
Myofascial release as a treatment for lateral epicondylitis 
4.2. Article Title 
Effectiveness of Myofascial Release in the Management of Lateral Epicondylitis in Computer 
Professionals 
4.3. Link to Journal Abstract 
http://www.archives-pmr.org/article/S0003-9993(11)00914-2/abstract 
4.4. Technical details  
4.4.1. Journal 
Archives of Physical Medicine &  
Rehabilitation 
4.4.2. Published date 
April 2012 
4.4.3. Specialty 1 
General Orthopaedics 
4.4.4. Specialty 2 
Physical Therapy & Rehabilitation 
4.4.5. PMID# 
22236639 
4.4.6. Type of study 
Interventional (Therapy) 
4.4.7. Quality of the study (PEDro) 
Moderate to high (7/10) 
4.4.8. Level of evidence (CEBM) 
Level Ib-  (Randomised controlled Trial) 
4.4.9. All authors 
Ajimsha MS, Thulasyammal RP, ChithraS 
4.4.10. Conflicts 
None disclosed 
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4.5. Synopsis 
The study investigated whether MFR reduces pain and functional disability of lateral 
epicondylitis (LE) in comparison with a control group receiving sham ultrasound therapy 
(SUST) in computer professionals (N = 68) for 12 sessions per client over four weeks with the 
Patient-Rated Tennis Elbow Evaluation (PRTEE) as the main outcome measure taken after the 
treatment (four weeks) and in follow up (12 weeks). The study was of a moderately high quality 
on the PEDro Scale (7/10) with 1b- level in CBEM. The MFR group performed better than the 
control group at weeks 4 and 12. Patients in the MFR and control groups reported a 78.7% and 
6.8% reduction, respectively, in their pain and functional disability in week four compared with 
that in week one, which persisted as 63.1% in the follow-up at week 12 in the MFR group. 
Lack of therapist blinding was the major limitation of the study. A slight improvement over 
time occurred in the control group at week four and the authors are attributing this to a meaning 
response. This study provided evidence that MFR is more effective than a control intervention 
for LE in computer professionals. 
4.6. Need and significance of the study 
Musculoskeletal complaints in the neck and upper extremity because of computer work 
are common in modern society and both show an increasing trend (Waersted et al., 2010). 
Lateral epicondylitis is characterized by pain in the external aspect of the elbow exacerbated 
during elbow extension with the wrist in flexion or by resisted extension of the wrist with the 
elbow in extension(Evans 2001). LE is the most commonly diagnosed elbow condition, 
affecting approximately 1% to 3%of the general population each year (Nirschl 1992; Verhaar 
1994), with workplace activities contributing to 35% to 64% of all cases (Dimberg 1987). 
Myofascial release (MFR) is a form of manual therapy that involves the application of a low 
load and long duration stretch to the myofascial complex, with the intention of restoring length, 
decreasing pain, and improving function. MFR is being used to treat patients with LE, but there 
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are few formal reports of its efficacy. The goal of this study was to evaluate the efficacy of 
MFR in the management of LE in computer professionals, treating fascia in the extensor aspect 
of the forearm in accordance with the fascial meridians proposed by Myers (2009). 
4.7. The Principal Research Question 
Does myofascial release (MFR) reduce the pain and functional disability of lateral 
epicondylitis (LE) in comparison with a control group receiving sham ultrasound therapy in 
computer professionals after eight weeks of treatment with four week follow-up? 
 
4.8. Demographic and Methodological Characteristics 
4.8.1. Population  
The sample included 68 computer professionals, aged 20 to 40 years with a diagnosis 
of LE on the mouse-operating arm based on the Southampton examination criteria for LE 
(Walker-Bone 2004; Palmer et al.,2007); pain lasting ≥1 day in the last 7 days in the lateral 
elbow region, tenderness over the lateral elbow region, and pain occurring over the lateral 
elbow region during resisted active extension of the wrist; pain lasting at least 3 months; those 
working with a personal computer, computer terminal or equivalent device with a computer 
mouse; those using a computer for 50% or more of the workday; and those who had completed 
a baseline PRTEE Scale (Overend et al.,1999). Those with a history of trauma to the affected 
elbow in the preceding 6 weeks, history of elbow instability, previous elbow surgery, any other 
pathology involving the affected upper limb or cervical spine, use of oral/systemic steroids, 
use of analgesics on more than 10 days a month and any other treatment for LE during the 
previous 6 months were excluded from the study. 
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4.8.2. Intervention  
MFR Group: Patients received direct MFR treatment 3 times/week for four weeks, with a 
minimum of one day between sessions. All techniques were performed on the affected 
extremity for 30 minutes. The MFR procedure consisted of: i. treating from the common 
extensor tendon to the extensor retinaculum of the wrist (5min x 2 repetitions). ii. treating 
through the periosteum of the ulna (5min x 2 repetitions), iii. spreading the radius from the ulna 
(5min x 2 repetitions). (Details of protocol provided in full within the publication) (Mean age: 
35.8 +/-8.4) (n=34, 33 completed final follow up, 13M/20F). 
4.8.3. Comparison  
Control Group: Patients in the control group received sham ultrasound therapy (SUST) over 
the extensor aspect of the forearm in the same 3 areas as the application of MFR (in the other 
group) for 30 minutes per treatment session (10min x 3areas), three times a week for four 
weeks. SUST units were prepared by removing the ultrasound producing quartz crystal from 
the treatment transducer head of the ultrasound therapy units. After the completion of the study, 
patients in the control arm were provided MFR therapy, as advised by the ethics committee. 
(Mean age: 29.3 +/- 4.9) (n=34, 32 completed final follow up, 14M/18F) 
4.8.4. Outcomes  
The Patient-Rated Tennis Elbow Evaluation (PRTEE) scale was used to assess pain severity 
and functional disability. The primary outcome measure was the difference in PRTEE scale 
scores between week one (pre-test score), week four (post-test score), and follow-up at week12 
after randomization. 
4.8.5. Time  
Outcomes were assessed at baseline, four weeks, and follow-up at week12 after 
randomization. 
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4.9. Risk of Bias Analysis (Table 4.1) 
Bias Authors’ 
judgment 
Support for judgment 
Random sequence 
generation (selection 
bias) 
Low risk Computer generated randomisation  
Allocation concealment 
(selection bias) 
Unclear risk The randomisation list was created at 
the blinded statistician, but further 
description of allocation is not included 
Blinding of participants 
and researchers 
(performance bias) 
High risk Participants were blinded but the 
therapists were not blinded 
Blinding of outcome 
assessment (detection 
bias) 
Low risk Two evaluators blinded to the group 
to which the participants belonged 
analyzed scores 
Incomplete outcome data 
(attrition bias) 
High risk Losses to follow-up were disclosed and 
were less than 5% 
No sample size calculation mentioned 
Selective reporting 
(reporting bias) 
Low risk All pre-specified outcomes were 
reported 
Other bias Low risk Expertise of treating therapists including 
training and experience mentioned  
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4.10. Major Findings of the Study 
4.10.1. The mean differences between groups vary by time. This indicates the possible 
existence of their interaction effect  
4.10.2. The patients in the MFR group reported a 78.7% reduction in their pain and 
functional disability as shown in the PRTEE scale score in week four, whereas 
patients in the control group reported a 6.8% reduction in their PRTEE scale score 
in week4, which persisted as a 63.1% reduction in the follow-up at week 12 in the 
MFR group, whereas the control group showed a 2.2% increase in their symptoms 
during follow-up (week 12) in their PRTEE scale score.  
4.10.3. The proportion of responders, defined as participants who had at least a 50% 
reduction in pain and functional disability between weeks 1 and 4, was100% in 
the MFR group and 0% in the control group. 
4.10.4. The simple main effects analysis showed that the MFR group significantly 
performed better than the control group in weeks 4 and 12(P<.001). 
4.10.5. The interactions between time and group were significant based on univariate 
and multivariate methods for all repeated-measures ANOVAs. Significant pairs 
of MFR and control groups vary at weeks 4 and 12 due to the interaction effect 
between group type and time. 
4.10.6. One participant from the MFR group and two from the control group dropped 
out of the study without providing any specific reason and their data were 
excluded from the results.  
4.10.7. Within the study period, no serious adverse events occurred in either of the 
groups as recorded in the patient diary. Five patients from the MFR group reported 
an increase of pain in the first week after initiation of treatment, and this was 
reported to have subsided within a week without any medications. 
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4.11. Answer to the Principal Research Question 
The simple main effects analysis showed that the MFR group performed better than the 
control group in weeks4 and 12 (P<.005). Patients in the MFR and control groups reported a 
78.7% and 6.8% reduction, respectively, in their pain and functional disability in week four 
compared with that in week one, which persisted as 63.1% in the follow-up at week 12 in the 
MFR group. 
4.12. Study Limitations 
Practitioners in this trail could not be blinded. A slight improvement over time occurred 
in the control group at week four; this could be due to a meaning response. 
4.13. Implications of the Study 
The results of the study suggest that MFR is a beneficial tool for managing LE in computer 
professionals. This study was limited by a short follow up period, and very few outcome 
measurements. Future studies with larger sample sizes and longer follow up periods should be 
completed to verify these results. 
4.14. Conclusion 
The MFR investigated in this trial was more effective than a control intervention with SUST 
for the treatment of LE. A significant proportion of computer professionals with LE might 
benefit from the use of MFR. The mechanisms underlying these responses merit further 
investigation. 
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Table 4.2: Pair-wise comparisons of group and time 
Time Group I   
Group II 
Mean 
Difference 
(I-J) 
Std. Error Sig.a 95% Confidence 
Interval for difference a 
Baseline MFR               
Control 
.819 1.135 .472 -1.42 to 3.06 
MFR 
Control 
-.819 1.135 .472 -3.06 to 1.42. 
Week 4 MFR 
Control 
-.46.185* 1.135 .000 -48.42 to -43.95 
MFR 
Control 
.46.185* 1.135 .000 43.95 to 48.42 
Week 12 MFR 
Control 
-41.739* 1.135 .000 -43.98 to -39.5 
MFR 
Control 
41.739* 1.135 .000 39.5 to 43.98 
Based on estimated marginal means 
*The mean difference is significant at the .050 level 
a. Adjustment for multiple comparisons: Least significant Difference (equivalent to no adjustment) 
12 WEEKS 4 WEEKS Baseline 
TIME 
70.00 
60.00 
50.00 
40.00 
30.00 
20.00 
10.00 
Group B 
Estimated Marginal Means of VALUE 
Group A 
Figure 4.1: Effects of group and time on value (Group A=MFR & Group B=Control  
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5.5. Synopsis 
Eighty nursing professionals (aged 20 to 40 years) with chronic low back pain (CLBP) 
(pain for three or more months) were randomly assigned into one of two groups to determine 
if MFR effectively reduces CLBP. The study was a high quality one (PEDro score of 7/10 and 
CBEM level of1b). The aim was to investigate whether MFR when used as an adjunct to 
specific back exercises (SBE) reduces pain and disability in CLBP in comparison with a control 
group receiving a sham MFR and SBE among nursing professionals. The McGill Pain 
Questionnaire (MPQ) was employed to assess subjective pain experience and Quebec Back 
Pain Disability Scale (QBPDS) was employed to evaluate the disability associated with CLBP. 
The primary outcome measure was the difference in MPQ and QBPDS scores between week 
one (pre-test score), week 8 (post-test score), and follow-up at week 12 after randomization. 
The patients in the MFR group reported a 53.3% diminution in their pain and 29.7% decrease 
in functional disability as evidenced in the MPQ and QBPDS scores in week 8, whereas patients 
in the control group reported a 26.1% and 9.8%decrease in their MPQ and QBPDS scores in 
week 8, which persisted as a 43.6% reduction of pain and 22.7% reduction of functional 
impairment in the follow-up at week 12 in the MFR group compared to the baseline. The 
proportion of participants responding to treatment (i.e. at least a 50% reduction in pain from 
week 1 to 8) was 73% in the MFR group and 0% in the control. No patient within the MFR or 
control groups exhibited a50% reduction in functional disability within the first 8 weeks. The 
authors advocated examining other outcomes such as pain beliefs, mood, and quality of life in 
future studies. 
5.6. Need and Significance of the Study 
Chronic Low Back Pain (CLBP) affects roughly 60% to 80% of the general population at some 
point in their lives(Maul et al.,2003).Work-related CLBP among nurses is suggested to be even 
more prevalent, estimated at 73% to 90%(Maul et al., 2003; Knibbe and Friele, 1996; Smedley 
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et al., 1995).Myofascial release(MFR) is a form of manual medicine that has become 
increasingly popular for patients with low back pain, although high-quality evidence on its 
efficacy remains scarce. The goal of this study was to determine if a direct MFR technique 
could effectively reduce back pain in nursing professionals with CLBP. 
5.7. The Principal Research Question 
Does direct MFR, in combination with SBE, effectively reduce CLBP among nursing 
professionals in comparison to a sham treatment when assessed after 8 weeks of treatment with 
four weeks of follow-up? 
5.8. Demographic and Methodological Characteristics 
5.8.1. Population  
Eighty nursing professionals, aged 20 to 40 years, diagnosed with CLBP (duration of 3 
or more months), and who were judged to have musculoskeletal pain (based on evaluation by 
physician or physical therapist). All patients took part in SBE regardless of treatment 
allocation. The participants were educated on musculoskeletal pain and SBE with the help of 
an informational video. 
5.8.2. Intervention  
MFR Group: Patients received direct MFR treatment 3 times/week for 8 weeks, with a 
minimum of one day between sessions. The duration of each treatment session was 60 min (40 
min MFR and 20 min SBE). The MFR procedure consisted of: MFR of the lower 
thoracolumbar fasciae and gluteus maximus, MFR of the myofasciaof the posterior hip & 
piriformis, lower back work in the prone position, pressure application while seated for the 
deeper muscles of the lower back, and fascia release of the trunk (Stanborough 2004) (details 
of protocol provided in full within the publication) (Mean age: 35.8 +/-8.4) (n=40, 38 
completed final follow up, 9M/29F). 
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5.8.3. Comparison  
SMFR (sham) Group: Patients in this group received sham MFR (SMFR) treatment 
3times/week for 8 weeks, with a minimum of one day between sessions. The duration of each 
treatment session was 60 min (40 min SMFR and 20 min SBE). SMFR was applied to the same 
areas as the MFR group. The sham treatment was completed by gently placing a hand over the 
area that was to be treated but never applying enough pressure to elicit an effect (Mean age: 
34.2 +/- 9.3) (n=40, 36completed final follow up, 8M/28F) 
5.8.4. Outcomes  
Outcome measures included the McGill Pain Questionnaire (MPQ) for pain (Melzack 
1975) and Quebec Back Pain Disability Scale (QBPDS) score for functional disability (Kopec 
et al., 2004). 
5.8.5. Time  
Outcomes were assessed at baseline, 8 weeks, and 12 weeks. 
5.9. Risk of Bias Analysis (Table 5.1) 
Bias Authors’ judgment Support for judgment 
Random sequence 
generation (selection 
bias) 
Low risk Computer generated randomisation  
Allocation concealment 
(selection bias) 
Unclear risk The randomisation list was created by 
the blinded statistician, but further 
description of allocation was not 
included 
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Blinding of participants 
and researchers 
(performance bias) 
High risk Participants were blinded but the 
therapists were not blinded 
Blinding of outcome 
assessment (detection 
bias) 
Low risk Two evaluators blinded to the group 
to which the participants belonged 
analyzed scores 
Incomplete outcome 
data (attrition bias) 
High risk Losses to follow-up were disclosed and 
were less than 5% 
No sample size calculation mentioned 
Selective reporting 
(reporting bias) 
Low risk All pre-specified outcomes were 
reported 
Other bias Low risk Expertise of treating therapists including 
training and experience mentioned  
 
5.10. Major Findings of the Study 
5.10.1. Patients in the MFR group reported a 53.3% reduction in pain and 29.7% reduction in 
functional disability at week 8, compared to 26.1% and 9.8% reduction in the control. 
These findings persisted at the 12 week follow up, with the MFR group experiencing a 
43.6% reduction in pain and 22.7% reduction in functional disability, compared 
to20.4% and 7.7% reduction in the SMFR group. 
5.10.2. Proportion of participants who had at least a 50% reduction in pain between weeks 1 
and 8 was 73% in the MFR group and 0% in the control. 0% of individuals in the MFR 
or control group experienced at least a 50% reduction in functional disability from week 
1 to 8. 
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5.10.3. Two-way ANOVA testing demonstrated a significant interaction between the effects of 
group and time on MPQ and QBPDS values (p<0.001), and a simple main effects 
analysis indicated that the MFR group performed significantly better than the control 
group in the 8 and 12 week follow ups (p<0.001). 
5.10.4. Ten patients in the MFR group and one from the control group reported an increase in 
pain after the first week of treatment. This finding subsided within a week where no 
medication was consumed by the participants. 
5.10.5. No serious adverse events occurred in either group as a result of treatment. 
 
5.11. Answer to the Principal Research Question 
A main effects analysis indicated that the MFR group performed better in all measured 
outcomes, at 8 and 12 week follow up, when compared to the control group. The proportion of 
participants who had at least a 50% reduction in pain between weeks 1 and 8 was 73% in the 
MFR group and 0% in the control. None of the individuals in the MFR and control group 
experienced at least a 50% reduction in functional disability from week 1 to 8. 
 
5.12. Study Limitations 
One limitation of this trial was that practitioners could not be blinded. Second, long-
term outcomes were not assessed, and it is not known whether the differences observed at post-
treatment can be maintained over a long time. Other important treatment outcomes such as pain 
beliefs, mood and quality of life are not studied 
 
5.13. Implications of the Study 
The results of the study suggest that MFR is a beneficial adjunct to SBE when treating 
nursing professionals with CLBP. This study was limited by a short follow up period, and very 
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few outcome measurements. Future studies with larger sample sizes and longer follow up 
periods should be completed to verify these results. 
 
 
5.14. Conclusion 
This study provides evidence that MFR when used as an adjunct to SBE is more 
effective than a control intervention for CLBP in nursing professionals. A significant 
proportion of nursing professionals with CLBP might benefit from the use of MFR. The 
mechanisms underlying these responses merit further investigation. 
 
Table 5.2: Pair-wise comparisons of group and time 
 Time Group 
I 
Group 
II 
Mean Difference  
(Group I value – 
Group II value) 
SE P* 
 
MPQ 
Baseline Control MFR 1.000 0.548 0.133 
Week 8 Control MFR 4.813ʄ 0.810 0.000 
Week 12 Control MFR 3.250 ʄ 0.624 0.000 
 
QBPDS 
Baseline Control MFR 0.971 0.435 0.472 
Week 8 Control MFR 3.413 ʄ 0.688 0.000 
Week 12 Control MFR 2.023 ʄ 0.532 0.000 
NOTE: Based on estimated marginal means  
*Adjustment for multiple comparisons: least significant difference (equivalent to no adjustment) 
* The mean difference is significant at the .05 level 
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Chapter 6 
Systematic Review of Myofascial Release 
 
6.1. Systematic Review of Myofascial Release 
 
The systematic review of the effectiveness of MFR included here was a comprehensive 
one, analysing most the MFR RCTs published in peer reviewed journals until 2014.  An in-
depth analysis of the published RCTs was done in succession. A total of nineteen RCTs 
covering 1228 patients were included in this systematic review. The sample size varied from 
10 to 200 with an average of 65 (SD ± 42.68). The methodological qualities of the included 
RCTs were moderate to high. Seventeen studies were of higher methodological quality and the 
remaining 2 of moderate quality. The authors were commenting that this fact is appreciable for 
a relatively new approach with considerable amount of practice variations (Fig 6.1 & 6.2). The 
literature regarding the effectiveness of MFR was mixed in both quality and results. Though 
the quality of the RCT studies varied greatly, the results of the studies were encouraging, 
particularly with the recently published studies. In many RCT’s the MFR was adjunctive to 
other treatments and the potential-specific MFR effect cannot be judged. 
From the review, nine studies concluded that MFR may be better than no treatment or 
sham treatment for various musculoskeletal and painful conditions. Seven studies demonstrated 
that MFR with a conventional therapy was more effective than a control group receiving no 
treatment (three studies), sham treatment (one study) or with a conventional therapy. Two other 
 
114 
studies highlighted MFR to be equally effective to conventional or “alternative” treatments 
(e.g., joint manipulation, back school or hot packs). The review concluded that the MFR can 
be a useful adjunct to the conventional therapies for various conditions. 
6.2. Review Process 
The systematic review clearly explains the review process and procedures. The review was 
performed by selecting RCTs using a detailed electronic database search on MEDLINE, 
CINAHL, Academic Search Premier, Cochrane library and Physiotherapy Evidence Database 
(PEDro) by adhering to the systemic review process followed by Mc Kenney et al. (2013) in 
their study and without any date limitation. Two reviewers performed independent searches, in 
September 2013 which was later updated in May 2014. Key words used for the search were 
‘myofascial release’ and ‘myofascial release therapy’. Each reviewer identified articles as 
relevant based on the use of the term myofascial release in the abstract or key words. The lists 
were compared, and articles identified by both reviewers were collected in full text.  
6.3. Criteria of Selection 
The systematic review was with clear inclusion and exclusion criteria for the selection 
of the RCTs. (1) RCTs published in a scientific peer-reviewed journal, (2) studies with 10 or 
more participants, (3) contained sufficient information to complete an analysis, (4) used direct 
or indirect and passive MFR as an experimental treatment, (5) published in English, (6) studied 
human participants and (7) adult participants only (18 years and older). The exclusion criteria 
were (1) published articles as case studies, editorials, expert opinions or instructive articles, (2) 
used trigger point therapy, (3) not use MFR as defined, (4) Studies on myofascial trigger-point 
therapy, proprioceptive neuromuscular facilitation (PNF) and MFR used as a conventional 
treatment without distinct explanations. This can be considered as a comprehensive criterion 
for isolating and selecting trials studying the therapeutic effectiveness of MFR. The reviewers 
 
115 
collected the number of participants, condition being treated, treatment used, control group, 
outcome measures and results as the data for analysis.  
6.4. Data Analysis Process  
In the systematic review, a total of 133 articles were identified as relevant for a review 
and 19 were found eligible as per the inclusion criteria. The selected studies were then analysed 
using PEDro and CEBM Scales for quality and level of evidence. No risk of bias analysis was 
carried out for this review.  A detailed discussion was formatted based on the key characteristics 
and methodological details of the studies. 
6.5. Data Synthesis 
The authors have done an in-depth discussion following the data synthesis in the 
review.  The comprehended summary is added here. “The quality of research on MFR as a 
treatment varies widely. The recent published studies are appreciable in their adherence to near 
normal RCT guidelines. The PEDro score for the said RCTs were seven for two studies and 
six and eight for the remaining two, indicating high quality design. Of the 19studies included 
in the systemic review, five RCTs were ranked at levels 1b and 14 at level 2b on the CEBM 
Scale, indicating relatively high-quality studies. Scores on the PEDro Scale indicated 
moderate-to-high methodological standards. The lowest score was five out of 10 and the 
highest was eight out of 10”. 
Possible limitations and suggestions for the future trials were given at the end of the 
discussion and conclusion which is significant for the quality of the analysis. 
A brief summary of the RCTs included in the review is given below excluding the 3 
RCTs analysed in this thesis earlier. Table 1 briefly explains the studies, their outcomes and 
scores.  Figure 6.1 and 6.2 represents the analysis of PEDro and CEBM score of all the studies 
included. 
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6.6. Randomised Controlled Trials on Myofascial Release: Others 
6.6.1. MFR in the Management of Hamstring Tightness 
Hanten and Chandler (1994) conducted a moderate quality study that was rated at level 
2b on the CEBM Scale and 6 of 10 on the PEDro Scale. The purpose of the study was to 
compare the effect of MFR and PNF in increasing the straight leg raise (SLR) in the 
management of hamstring tightness. The study highlighted the point that, though MFR is 
effective in increasing the SLR angle against a control group receiving no treatment, the effect 
is inferior to a PNF treatment. The study itself had positive outcomes, but it lacked random 
selection of participants and follow-up. 
6.6.2. MFR and Pelvic Symmetry 
The study by Barnes (1997) on pelvic symmetry was ranked as level 2b and earned a 
PEDro score of 8 of 10. Only 10 participants were involved, and the authors acknowledged 
that 23 participants were needed in the treatment group and 15 in the control group to meet the 
assumptions for parametric data analysis. Despite these limitations, the 8 of 10 ranking on the 
PEDro Scale indicated that the study was well designed. 
6.6.3. MFR for Subacute Low Back Pain 
Hsieh et al. (2002) investigated the relative effectiveness of three manual treatments 
including MFR for patients with Subacute Low Back Pain (SALBP). The study was rated as a 
high-quality one, ranked at level 1b on the CEBM Scale and earned 7 of 10 points on the PEDro 
Scale. The back pain improved in all groups, but there were no differences between the groups. 
This study concludes that MFR may be used as an adjunct to a formal treatment for SALBP. 
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6.6.4. MFR for Plantar Fasciitis 
Another level 2b study was performed by Kuhar et al. (2007), who used MFR to treat 
plantar fasciitis. This study scored 7 of 10 points on the PEDro Scale. Significant reduction in 
pain and improvement in foot function was reported as the short term effect. 
6.6.5. Effects of MFR after High-intensity Exercise 
Arroyo-Morales et al. (2008) in their RCT studied the effects of MFR after high-
intensity exercise which scored level 2b in CEBM Scale with a quality of 6/10 on the PEDro 
Scale. The study included 62 healthy, active individuals. Holter recording and BP 
measurements were taken after the exercise protocol and after the intervention and found that 
MFR favours the recovery of heart rate variability and diastolic BP after high-intensity exercise 
to pre exercise levels. Short duration and lack of follow up along with a normal healthy sample 
were considered as the limitations of the study since the assumption that high-level sports 
people might possibly show a different behaviour dropped the study into the 2b level. 
6.6.6. MFR and Fascial Mobility 
Tozzi et al. (2011) studied pain perception and the mobility of fascial layers by using a 
dynamic ultrasound (US) in patients with neck pain (NP) and low back pain (LBP). The groups 
were evaluated by ‘Dynamic US Topographic Anatomy Evaluation’, before and after MFR 
treatment, in the corresponding painful region. The result highlighted that MFR can be effective 
in releasing areas of impaired sliding fascial mobility and to improve pain perception over a 
short term duration in people with non-specific NP or LBP. The study obtained 2b level 
evidence with a quality of 7/10. Main limitations noted were the short term follow up and a 
relatively small study population. 
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6.6.7. MFR in Temporo-Mandibular Disorders 
A study of30 chronic myogenous Temporo-Mandibular Disorder (TMD) patients by 
Kalamir et al. (2010) investigated the effectiveness of intra-oral MFR therapy (IMT) by 
randomising into three groups; IMT, IMT plus ‘self-care’ and a wait list control with pain and 
range of motion (ROM) as the primary outcome measures. They concluded that IMT with or 
without self-care may be beneficial in chronic TMD over the short and medium term and 
advocated a larger scale study over a longer term. The study obtained a high quality rating on 
the PEDro Scale (8/10) and a 2b rating on the CEBM rating. 
6.6.8. MFR for Gleno-humeral Joint Range of Motion 
Kain et al., in 2011, compared an indirect tri-planar MFR technique and a hot pack for 
increasing gleno-humeral joint ROM in 31 healthy individuals. Both the hot pack application 
and the MFR technique were found to be as efficacious in increasing passive ROM of the 
gleno-humeral articulation. Improper blinding, concealing and follow-up grade the quality of 
the study as moderate (5/10 on the PEDro) and level 2b on the CEBM. 
6.6.9. MFR for Fibromyalgia 
Castro-Sanchez et al. conducted two (2011 a, b) high quality studies in fibromyalgia. 
Both studies were rated as 7/10 on the PEDro Scale and 1b on the CEBM Scale due to their 
methodological standards. The first one was to determine whether MFR therapy can improve 
pain, anxiety, quality of sleep, depression and quality of life in patients with fibromyalgia. 
Right away after treatment and at 1 month, anxiety levels, quality of sleep, pain and quality of 
life were improved in the experimental group over the placebo group. In the second study 86 
fibromyalgia patients were measured to find out the effect of a 20 week MFR on pain, physical 
function and postural stability over a placebo group. MFR improved pain, sensory and affective 
dimensions without change in postural stability. They concluded that MFR techniques can be 
a complementary therapy for fibromyalgia syndrome.  
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6.6.10. MFR in Breast Cancer Survivors 
Two moderate to high quality studies were found on quality of life of breast cancer 
survivors (BCS). The first study was by Fernandez-Lao et al. (2012) on the influence of patient 
attitude towards massage on pressure pain sensitivity and immune system after application of 
MFR. Twenty BCS, in a two week study, received MFR or control (special attention) 
intervention. Salivary flow rate, immunoglobulin A concentrations & the attitude toward 
massage scale were the outcome measures. MFR led to an immediate increase in salivary flow 
rate in BCS with cancer-related fatigue. Lack of therapist blinding and follow ups were the 
main drawbacks of the study.  
The second study was conducted by Cantarero- Villanueva et al. (2012). Seventy eight 
BCS participated in a study of the effectiveness of core stability exercises and recovery MFR 
on fatigue with the ‘profile of mood state questionnaire’ as the main outcome measure. The 
experimental group received core stability exercises & MFR while the control group received 
usual health care advice for a period of 8 weeks. The multimodal program with MFR reduced 
fatigue, tension, depression, improved vigour and muscle strength. The study was of moderate 
to high quality (7/10) with level 2b evidence. The main drawback was that the control group 
was allowed to freely increase physical activity during the study.  
6.6.11. MFR for Venous insufficiency in Postmenopausal Women 
A comparative study was performed on the effectiveness of MFR and PT for venous 
insufficiency in postmenopausal women by Ramos-Gonzalez et al. (2012), which is of high 
quality (8/10) with a 2b level of evidence. Sixty five postmenopausal women with stage I or II 
venous insufficiency were enrolled into two groups. The control and experimental group 
patients underwent physical venous return therapy (kinesiotherapy) for a 10-week period, 
during which the experimental group patients also received 20 sessions of MFR. The main 
outcome measures were blood pressure, cell mass, intracellular water, basal metabolism, 
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venous velocity, skin temperature, pain and quality of life. The combination of MFR and 
kinesiotherapy improved the venous return, pain and quality of life in postmenopausal women 
with venous insufficiency. Lacks of follow up and non-blinding of the researchers were the 
primary limitations. 
6.6.12. Lateral Epicondylitis  
Khuman et al. (2013) carried out a study on a smaller sample size of chronic lateral 
epicondylitis (CLE) subjects. They concluded that a four weeks MFR program was effective 
in improving pain, functional performance and grip strength in CLE subjects compared to the 
control group. Lack of follow up and improper blinding were the major limitations. The study 
scored 2b level of evidence with a quality of 7/10. 
6.6. 13. MFR and reaction time 
Kuruma et al., conducted a study (2013) on the effects of MFR and stretching technique 
on range of motion (ROM) and reaction time (RT) with a medium quality procedure (5/10 in 
PEDro) and 2b level in CBEM. Passive ROM was significantly increased by MFR in the 
quadriceps and stretching groups. Premotor time was significantly reduced by MFR in the 
quadriceps and hamstrings groups. Compared to controls, RT was significantly lower after the 
interventions in the quadriceps and hamstrings groups. Lack of blinding, concealing and follow 
up were the main limitations of the study. 
6.6.14. MFR and Plantar Heel Pain 
A study by Ajimsha et al. (2014) investigated whether MFR reduces the pain and 
functional disabilities associated with plantar heel pain (PHP) in comparison with a control 
group receiving sham ultrasound therapy. Sixty six PHP patients, in a 4 week study, received 
MFR or control intervention. The study was ranked level 2b on the CEBM Scale and scored 
8/10 on the PEDro Scale. The simple main effects analysis showed that the MFR group 
performed better than the control group in weeks 4 and 12 (P < 0.001). A significant ‘pressure 
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pain threshold’ (PPT) changes over the gastrocnemii and soleus muscles and over the calcaneus 
compared to the control group was reported. The short term follow up was mentioned as the 
major limitation of the study. The authors recommended future studies to compare the MFR 
with established treatments like arch supports, self-stretching or even with surgical procedures. 
6.7. AMSTAR 2 Analysis 
Analysis of the AMSTAR-2 tool (Appendix 10.5) revealed moderate methodological 
quality of the systematic review. There was ‘partial yes’ for the protocol as there was no meta-
analysis and analysis of heterogeneity done. This was justifiable as the study was purely a 
systematic review. The comprehensive research strategy also met with ‘partial yes’ as the study 
did not attempt to find out the grey literature and articles in press. No details of excluded studies 
were given the review. The review did not emphasize the study setting or time frame for follow 
up. The review had positive findings regarding the inclusion criteria, method of selection of 
eligible studies and the consensus between the reviewers. The major flaw with this review was 
the noncompliance with the risk of bias analysis. Few details were given regarding lack of 
blinding but details like sequence generation, allocation and data reporting were not clearly 
mentioned. 
6.8. Conclusion 
This systematic review demonstrated moderate methodological quality as per the 
AMSTAR tool. Omission of a risk of bias analysis was the major limitation of this review. 
Lack of heterogeneity testing, missing components in the ‘comprehensive research strategy’ 
and study setting details were the other limitations found. The authors concluded that the 
literature regarding the effectiveness of MFR was mixed in both quality and results. Although 
the quality of the RCT studies varied greatly, the result of the studies were encouraging, 
particularly with the recently published studies. The review ends by stating that MFR is 
 
122 
emerging as a strategy with a solid evidence base and tremendous potential and the studies in 
this review may serve as a good foundation for the future trials. 
 
Fig 6.1: PEDro Scale for MFR RCTs (Max value=10) 
 
 
Fig 6.2: CEBM level of evidence score for MFR RCTs  
 
 
 
 
Fig 8.1: PEDro scale for MFR RCTs (Max value=10)
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Table 6.1: Study results & grading included in the systematic review 
First 
Author 
Year 
Conditio
n 
Sample 
Size 
Treatme
nt 
Control Treatme
nt 
Schedule 
Main 
Outcome 
Measure
s 
Results PEDro 
Score 
Level of 
Evidence 
(CEBM) 
Hanten 
WP 
1994 
Hamstring
s tightness 
75 MFR to 
leg x 10-
15 min, 
Contract- 
relax PNF 
x 4 min 
Supine 
rest x 5 
min 
Single 
session 
Passive 
hip flexion 
ROM 
Post 
treatment 
gains 
PNF: 
10.40 
MFR: 6.60 
Control: 
0.90 
6/10 2b 
Barnes 
MF 
1997 
Unilateral 
Pelvic 
Rotation 
10 MFR  
pelvic 
region, 10 
min 
Rest x 10 
min 
Single 
session 
Pelvic 
Position 
Better 
pelvic 
alignment  
post MFR 
8/10 2b 
Hsieh CY 
2002 
Sub-acute 
Low Back 
Pain 
200 Back 
school 
program, 
MFR, 
joint 
manip or 
combined 
MFR + 
joint 
manip 
NA Back 
school 
:1/week x 
3, 
MFR , 
joint 
manip & 
combined 
MFR + 
joint 
manip: 
3/week x 3 
 
VAS, 
Roland 
Morris 
activity 
scale 
Back pain 
improved 
in all. No 
difference 
between 
groups 
7/10 1b 
Kuhar S 
2007 
Plantar 
fasciitis 
30 Ultrasoun
d x 5 min, 
contrast 
bath 20 in, 
exercises, 
MFR x 15 
min 
Ultrasoun
d x 5 min, 
contrast 
bath 20 in, 
exercises 
10 
consecutiv
e days 
FFI, VAS Significan
t reduction 
in VAS 
and FFI 
7/10 2b 
Arroyo-
Morales 
2008 
healthy 
active 
individual
s 
62 MFR x 40 
min 
sham 
treatment 
with 
disconnect
ed 
ultrasound 
and 
magnetoth
erapy x 40 
min 
Single 
session 
HRV & 
BP 
favours 
the 
recovery 
of HRV 
and 
diastolic 
BP after 
high-
intensity 
exercise 
6/10 2b 
Tozzi P  
2010 
non-
specific 
cervical(N
P) or 
lumbar 
pain 
(LBP) 
120 NP: MFRx 
6 min 
LBP: 
MFR x 12 
Min 
NP: Sham 
MFR x 6 
Min 
LBP: 
Sham 
MFR x 12  
in 
Single 
session 
dynamic 
ultrasound 
(US) 
MFR 
improved 
fascial 
mobility& 
pain in 
people 
with non-
specific 
NP or 
LBP. 
 
7/10 2b 
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Kalamir 
A 
2010 
chronic 
myogenou
s 
temporom
andibular 
disorders 
30 MFR x 15 
min, MFR 
15 min 
with self-
care& 
exercises 
Waist list 2 
sessions/w
eek x 5 
ROM & 
Pain 
MFR 
alone or 
with self-
care is 
beneficial 
8/10 2b 
J. Kain 
2011 
Healthy 
individual 
31 indirect 
tri-planar 
MFR x 3 
min 
hot pack x 
20 min 
Single 
session 
passive 
shoulder 
range of 
motion 
MFR is as 
effective 
as hot 
packs in 
increasing 
range of 
motion 
5/10 2b 
Castro-
Sánchez, 
AM 2011 
Fibromyal
gia 
74 MFR x 90 
min 
Disconnec
ted 
Maganetot
herapy x 
30 min 
1 
session/we
ek x 20 
VAS, 
STAI, 
BDI, PSQI 
MFR 
improved 
pain 
& quality 
of life in 
patients 
with 
fibromyal
gia 
7/10 1b 
Castro-
Sánchez, 
AM 2011 
Fibromyal
gia 
86 MFR x 60 
min 
sham 
short-
wave and 
ultrasound 
treatment 
x 
30 min 
2 
sessions/w
eek x 20 
number of 
tender 
points, 
MPQ and 
postural 
stability. 
MFR 
improved 
pain, 
sensory, 
and 
affective 
dimension
s without 
change in 
postural 
stability 
 
7/10 1b 
Ajimsha 
MS 2011 
tension 
headache 
63 Direct 
MFR x 60 
min 
Indirect 
MFR x 60 
min 
Slow soft 
stroking x 
60 min 
2 
sessions/w
eek x 12 
numbers 
of days 
with 
headache 
MFR is 
effective 
than a 
control 
interventio
n 
6/10 2b 
Fernánde
z-
Lao2012 
Breast 
cancer 
20 Neck  and 
shoulder 
MFR x 40 
min 
Special 
attention 
& 
Education 
x 40 min 
2 sessions 
separated 
by 2 
weeks 
Salivary 
flow rate, 
immunogl
obulin A 
(IgA) 
concentrat
ions, 
immediate 
increase in 
salivary 
flow rate 
&  IgA 
6/10 2b 
Cantarer
o-
Villanuev
a, I 2012 
Breast 
cancer 
78 Multimod
al exercise 
and MFR 
x 90 min 
 
usual care 
advises 
3 
sessions/w
eek x 8 
POMS multimoda
l program 
with MFR 
reduced 
fatigue, 
tension, 
depression
, & 
improved 
vigour& 
muscle 
strength 
7/10 2b 
Ramos-
González  
E 2012 
venous 
insufficien
cy in 
postmeno
pausal 
women 
65 MFR x 50 
min x 2 
session/we
ek Venous 
return 
kinesiothe
Venous 
return 
kinesiothe
rapy 2 
times daily 
10 weeks blood 
pressure, 
venous 
velocity, 
skin 
temperatur
e, pain 
Improvem
ent in 
venous 
return 
blood 
flow, pain 
and 
8/10 2b 
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rapy 2 
times daily 
quality of 
life noted 
Ajimsha 
MS 2012 
Lateral 
Epicondyl
itis (LE) in 
Computer 
Profession
als 
68 MFR x 30 
Min 
sham 
ultrasound 
therapy x 
30 min 
3 
sessions/w
eek x 4 
PRTEE MFR is 
effective 
for LE in 
Computer 
Profession
als 
7/10 Ib- 
Ajimsha 
MS 2014 
chronic 
low back 
pain(CLB
P) in 
nursing 
profession
als 
80 specific 
back 
exercises 
(SBE) & 
MFR x 60 
min 
SBE & 
Sham 
MFR x 60 
min 
3 
sessions/w
eek x 8 
MPQ, 
QBPDS 
MFR with 
SBE is 
effective 
for CLBP 
7/10 1b 
Kuruma 
H 
2013 
Healthy 
individual
s 
40 MFR to 
hamstring 
x 8 Min. 
MFR to 
Quadricep
s x 8 Min. 
stretch for 
quadriceps 
8 min, 
Lay supine 
x 8 min 
Single 
session 
ROM, 
muscle 
stiffness, 
and 
Reaction 
Time 
improved 
ROM & 
ease of 
movement 
5/10 2b 
Khuman 
PR 
2013 
Chronic 
Lateral 
Epicondyl
itis 
30 MFR 
forearm x 
30 min, 
Ultrasoun
d x 5 min 
Stretching 
and 
strengthen
ing 
exercise 
Ultrasoun
d x 5 min 
Stretching 
and 
strengthen
ing 
exercise 
3 
sessions/w
eek x 4 
pain, 
functional 
performan
ce & grip 
strength 
significant 
decrease 
in pain, 
improvem
ent in 
functional 
performan
ce & grip 
strength 
7/10 2b 
Ajimsha 
MS  2014 
plantar 
heel pain 
(PHP) 
66 MFR x 30 
Min 
sham 
ultrasound 
therapy x 
30 min 
3 
sessions/w
eek x 4 
FFI & PPT significant 
decrease 
in pain& 
functional 
disability, 
improvem
ent in 
pressure 
pain 
threshold 
8/10 2b 
Abbreviations: Myofascial Release (MFR), Not Applicable (NA), Range  of Motion (ROM), State- Trait Anxiety Inventory 
(STAI), Beck Depression Inventory (BDI), Pittsburgh Quality of Sleep Index Questionnaire (PSQI), McGill Pain 
Questionnaire, (MPQ), Profile of Mood State (POMS) questionnaire, Quebec Back Pain Disability Scale (QBPDS), Chronic 
Low Back Pain (CLBP), Patient-Rated Tennis Elbow Evaluation (PRTEE). Minutes (Min), Manipulation (Manip), Centre for 
Evidence-Based Medicine (CEBM), Proprioceptive Neuromuscular Facilitation (PNF), Visual Analogue Scale (VAS), Foot 
Function Index (FFI), Heart rate variability (HRV), Blood Pressure (BP), Foot function index (FFI), Pressure pain threshold 
(PPT). 
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Chapter 7 
 
Discussion 
 
7.1. Introduction 
Recent studies have demonstrated the role of fascia in various musculoskeletal 
dysfunctions as the fascial tissues connect the skeletal muscles forming a body-wide web with 
some pattern called as myofascial meridians. As fascia is able to modify its tensional state, 
strain transmission along the meridians might occur in response to changes of muscle activity. 
(Wilke et al., 2016). 
Fascia is a ubiquitous tissue permeating the entire body. It surrounds, supports, 
suspends, protects, connects and divides muscular, skeletal and visceral components of the 
organism (Kumka and Bonar, 2012). It not only lubricates the fibres but gives nourishment to 
all parts of the body. The fascial system is considered as a “tensegrity” or tensional integrity 
structure to manage the balance between tension and compression around the organs, joints and 
muscles (Chen et al., 2016).  Its continuity aids in force transmission both longitudinally and 
epimuscularly through mechanotransduction. These forces may be transmitted at a cellular 
level, altering gene expression of fibroblasts and thereby changing the extracellular matrix 
composition (Chaitow, 2016). Repetitive mechanical straining of fibroblasts can also result in 
secretion of inflammatory mediators (Dodd et al., 2006). All of these changes could affect the 
normal functions of force transmission or sliding in the musculoskeletal system. This 
dysfunction could lead to pain or proprioceptive issues, considering that fascia has been shown 
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to be innervated. Thus, treatment of disorders affecting the musculoskeletal system may need 
to be focused on this fascial network (Kwong and Findley, 2014). 
The fascia plays different physiological and functional roles related to joint stability, 
general movement coordination, proprioception and nociception and is associated with wound 
healing, tissue repair and many connective tissue pathologies. The myofascia, as a fibrous 
specialization of fascial/ECM tissues that surround and interpenetrate muscles is then a 
complex hierarchy of helically-reinforced tubes contained within larger tubes that surround the 
muscles, the limbs and entire body. The cross helical model of fascial fibre arrangement are 
indeed contributing to the coordination of changes in muscle shape. It appears that the fascia 
mediates an active mechanical transference role as it provides dynamic connections between 
and among the muscles and bones (Yang et al., 2015). Functional myofascial sequences are 
directly involved in the organization of movement and muscular force transmission (Kwong 
and Findley, 2014) 
Studying fascia objectively at the basic science and clinical levels will provide 
important information that may change clinical practice. Once the structure and functions of 
fascia in the musculoskeletal system are further elucidated, the pathophysiology of many 
disorders and their consequences may be better explained. 
Myofascial release (MFR) is a form of manual therapy which involves the application 
of a low load and long duration stretch to the myofascial complex intended to restore optimal 
length, decrease pain, and improve function (Barnes, 1990). The rationale for these techniques 
can be traced to various studies that investigated plastic, viscoelastic and piezoelectric 
properties of connective tissue (Schleip, 2003; Greenman, 2003; Pischinger, 1991). MFR is 
being used to treat patients with a wide variety of conditions, but there is scarcity of evidence 
to support its efficacy.  
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The effects of manual fascial interventions can be local (as tissue texture changes), 
segmental (as via neurological response) and global (as through hormonal effects) in extent, 
and may occur at different intervals—ranging from minutes to weeks—after a given input, with 
many interacting mechanisms influencing tissue properties and behaviours, including placebo.  
Some of these factors are strongly supported by the available evidence whereas others need 
further investigation (Tozzi, 2015b). 
Various forms of manual loading, whether sustained or cyclical, that differ in direction, 
speed, magnitude and frequency, appear to exert a strong impact on cell behaviour, gene 
expression and tissue remodelling through growth factors and enzyme activation (Tozzi, 
2015a). MFR brings sustained change in the architecture and/or hydration of the fascia being 
worked on. The mechanical loading of fascia causes changes through activation of fibroblast 
response and the different receptors present in the fascial tissue, leading to modulation of 
myofascial contraction (Hicks et al., 2014). The fascial tissue may respond better to balanced 
and sustained stretch rather than intermittent and unequal loads (Meltzer et al., 2010). 
Brief, light/moderate, balanced, static or slow cyclic strains appropriately applied to 
fascia may be sensed at the cellular level and transduced in normalizing tissue structure and 
function (Tozzi 2015b). Fascial oriented work may produce beneficial effects by activating 
various receptors in the connective tissues that elicit a series of neuromuscular reflexes. These 
types of events occur together with concomitant autonomic and viscoelastic changes and are 
more likely to explain the fast tissue responses that a therapist perceives during fascial 
techniques. Fascial therapy theoretically restores mobility by re-optimizing the distribution of 
lines of force within fascia (Stecco et al., 2013; Day et al., 2009). Encouraging explanations 
and evidence are accumulating day by day regarding the effectiveness of MFR and an attempt 
to merge the clinical effectiveness with physiological alterations of fascial manipulation will 
improve the understanding of the fascial functions and its significance in health and wellbeing. 
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Studies are emerging in this field with varying results and conclusions. Analysis of the 
recent research trials and reviews will be a better way to appraise the quality and reliability of 
such work. This work attempts to critically analyse three published randomised controlled trials 
(RCTs) and one systematic review on the effectiveness of myofascial release on various 
conditions with an aim of facilitating the creation of a more homogenous and reputable base 
for future trials in the field. A critical appraisal of the conducted studies and reviews to pinpoint 
their strengths and weaknesses can help to fine tune future studies. This type of approach and 
its findings can be highly useful for a manual therapy technique having lots of practice 
variations and applicability to set more controlled and methodologically superior studies in the 
future. 
7.2. The Randomised Controlled Trials 
Three RCTs on MFR were analysed in this review. The three published RCTs were 
appreciable in their adherence to near normal RCT guidelines. Among the RCTs reviewed, one 
study was ranked at level I b in CEBM and 7/10 in PEDro Scale, the second one ranked as I b- 
in CEBM and 7/10 in PEDro rating. The third one was ranked as 2b level in the CEBM Scale 
with a PEDro rating 6/10. 
The effectiveness of MFR on tension type headache (TTH) was the first among the 
studies reviewed as this was the first published study (2011) in the list. TTH is a bilateral 
headache of a pressing or tightening quality without a known medical cause. MFR is currently 
being applied for patients with TTH but its efficacy was not been evaluated formally. Sixty 
three patients with episodic or chronic tension-type headache were given direct MFR 
technique, indirect MFR and a sham treatment and were compared. The study was of moderate 
quality (6/10) on PEDro with 2b level of evidence in CEBM Scale. The techniques were applied 
for 24 sessions per patient over 12 weeks with the difference in number of days with headache 
at baseline and post-test as the outcome measure. Patients in the direct MFR group, the indirect 
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MFR group and the control group reported a 59.2%, 54% and 13.3% reduction respectively in 
their headache frequency in post-test compared to the baseline with decrees of the number of 
days with headache per four weeks by 7.1 (2.6) [mean (SD)] days in the direct MFR group 
compared with 6.7 (1.8) days in the indirect MFR group and 1.6 (0.5) days in the control group 
(P <0.001). Both the direct and indirect techniques of MFR investigated in this trial were more 
effective than a control intervention consisting of slow soft stroking with finger pads for the 
treatment of TTH. The authors were optimistic that a significant proportion of patients with 
TTH might benefit from the use of MFR. This study proved that direct technique or indirect 
technique MFR was more effective than a control intervention for TTH. Lack of follow up, 
blinding of the therapists and the patient were the major limitations of the study. A risk of bias 
analysis identified the blinding of patients and sample calculation as the major draw backs. 
There was no attempt made to explain or discuss the mechanisms underlying these responses 
as the principle objective of the study was to find the clinical efficacy. 
 
The second RCT studied MFR as a treatment for lateral epicondylitis (LE) which was 
completed with 68 patients. The study investigated whether MFR reduces pain and functional 
disability of LE in comparison with a control group receiving sham ultrasound therapy (SUST) 
in computer professionals for 12 sessions per client over four weeks with the Patient-Rated 
Tennis Elbow Evaluation (PRTEE) as the main outcome measure taken after the treatment 
(four weeks) and in follow up (12 weeks). The study was of a moderately high quality on the 
PEDro Scale (7/10) with 1b- level in CBEM. The study found that the MFR group performed 
better than the control group at weeks 4 and 12. Patients in the MFR and control groups reported 
a 78.7% and 6.8% reduction, respectively, in their pain and functional disability in week four 
compared with that in week one, which persisted as 63.1% in the follow-up at week 12 in the 
MFR group. Lack of therapist blinding was the major limitation of the study. A slight 
improvement over time occurred in the control group at week four and the authors were 
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attributing this to a ‘meaning response’. The results of the study suggest MFR as a beneficial 
tool for managing LE in computer professionals. This study was limited by a short follow up 
period and very few and self-rating outcome measurements. Future studies with sufficiently 
powered sample sizes and longer follow up periods should be completed to verify these results. 
The third RCT was on chronic low back pain. Eighty nursing professionals (aged 20 to 
40 years) with chronic low back pain (CLBP) (pain for 3 or more months) were randomly 
assigned into 1 of 2 groups to determine if MFR effectively reduces CLBP. The study was a 
high quality one (PEDro score of 7/10 and CBEM level of1b). The aim was to investigate 
whether MFR when used as an adjunct to specific back exercises (SBE) reduces pain and 
disability in CLBP in comparison with a control group receiving a sham MFR and SBE among 
nursing professionals. The McGill Pain Questionnaire (MPQ) was employed to assess 
subjective pain experience and Quebec Back Pain Disability Scale (QBPDS) was employed to 
evaluate the disability associated with CLBP. The primary outcome measure was the difference 
in MPQ and QBPDS scores between week one (pre-test score), week 8 (post-test score), and 
follow-up at week 12 after randomization. The patients in the MFR group reported a 53.3% 
diminution in their pain and 29.7% decrease in functional disability as evidenced in the MPQ 
and QBPDS scores in week 8, whereas patients in the control group reported a 26.1% and 
9.8%decrease in their MPQ and QBPDS scores in week 8, which persisted as a 43.6% reduction 
of pain and 22.7% reduction of functional impairment in the follow-up at week 12 in the MFR 
group compared to the baseline. The proportion of participants responded to treatment (i.e. at 
least a 50% reduction in pain from week 1 to 8) was 73% in the MFR group and 0% in the 
control. No patient within the MFR or control groups exhibited a 50% reduction in functional 
disability within the first 8 weeks. The authors advocated examining other outcomes such as 
pain beliefs, mood, and quality of life in future studies. The major limitations quoted were lack 
of blinding of the practitioners, lack of long term outcomes and over dependence on self-rating 
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scales as explained in the previous RCTs. This study provides evidence that MFR when used 
as an adjunct to SBE was more effective than a control intervention for CLBP in nursing 
professionals. A significant proportion of nursing professionals with CLBP might benefit from 
the use of MFR. The mechanisms underlying these responses merit further investigation. 
7.1.1. Strength and Weakness 
Even though the RCTs analysed were methodologically superior with higher quality 
compared to many studies in this field, there were many limitations to be pointed out. The 
primary research aim to undertake the MFR RCT trials was to create a respectable base for the 
future trials in this field. An attempt to convert the ‘practice based evidence’ to evidence based 
practice starting from the anecdotal evidences was challenging in many ways. The involved 
studies were published during the period 2011-2014 in reputed journals of health and 
rehabilitation.  
The main limitations of all the RCTs were that the samples were underpowered as none 
of the studies have attempted a sample size calculation. It is to be noted that most of RCT trials 
were ‘proof of concept trials’ in those conditions. No previous evidence was available other 
than anecdotal evidence for most of the studies and most of the conditions under the clinical 
picture of Myofacial pain syndrome does not have any clear prevalence to go for any sort of 
power calculation and was the main concern of many of the researchers in this field. With the 
sufficient number of emerging good quality RCTs and systematic reviews, we believe that the 
sample size calculation sufficient enough to achieve external validity will be comparatively 
achievable for the forthcoming studies.  
The allocation sequence was adequately generated for all the three RCTs by utilizing a 
computer generated randomization list by blinded statisticians who were not a part of the study 
and without any information of the treatment procedures. The allocation was adequately 
concealed too. The RCT on the effectiveness of MFR on TTH was affected with a performance 
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bias as the patients were aware of the treatment that they are going to get. This was the first 
study in the MFR–RCT series and few patients accidently exchanged the information on the 
waiting area on the initial days, the authors reported that, this was managed by giving specific 
date and time for each patient for their sessions. Such incidents and biases were not reported in 
the later trials. 
The blinding of the assessors was mentioned in all the RCTs, with two assessors having 
no knowledge of the study process or randomisation for all the three studies. Blinding of the 
therapists was an issue in all the RCTs. Blinding of the therapist and the patients in manual 
therapy is a much-debated topic in the physical therapy research and it is mainly due to the type 
of approach the physical therapy field generally has. The missing of outcome data was 
mentioned in all the RCTs. In the study of MFR in TTH, it was mentioned, 2 participants from 
the DT-MFR group and one participant each from the remaining two groups dropped out of the 
study without providing any specific reason for this. The authors of the study found that the 
total number of recruited individuals was 60 but was mentioned as 63 in the printed version.  
In the study published in 2012, the MFR in LE, 65 participants out of 68 completed the study 
protocol. One from the MFR group and two from the control group dropped out during the 
study.  In the third RCT on CLBP, two participants from the MFR group 4 from the control 
group dropped out of the study without providing any specific reason and this data were 
excluded from the results. The main reason for this drop out was reported as due to the inability 
to attend the sessions on the scheduled day and time as a minimum one day gap was advised 
between the treatments in the protocol.  
All the three RCTs and most of the RCTs reviewed in the systematic review were 
relying primarily on patient rated outcomes measures (PROMs). Whilst this reflects the 
contemporary model of technical rationalism in manual therapy practice (Thomson et al., 2014) 
to provide a more balanced view, more objective and sensitive outcome measures which can 
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measure more clinically beneficial outcomes are advocated. This is in fact, a highly debated 
topic in current clinical research. According to Kyte at al. (2015), the use of PROMs is set to 
rise in physiotherapy as high-quality clinical care requires patients to provide information 
regarding how they are feeling, their symptoms and any effects of prescribed treatment.  The 
medical outcomes study was at the forefront of this concept as patient outcomes were examined 
and differences in care, clinicians and communication styles were reported for both patient and 
clinical outcomes (Tarlov et al., 1989). The separation between health outcomes and treatment 
outcomes became clearer when research into health services began to focus on improving the 
patients’ health-related quality of life, particularly when patients were undergoing optimal 
medical therapy (Wilke et al., 2004).  This, in turn, created the need for identifiable, valid and 
reliable PROMs. Traditional survival, disease, and physiological outcomes may demonstrate 
the physiological benefits of treatment; however, the patient perspective provides a more 
holistic interpretation and a comprehensive assessment of the benefits of the treatment under 
investigation (Black, 2013; Rathert et al., 2011). PROMs provide additional ‘patient-centred’ 
data which are unique in capturing the patient's own opinion on the impact of their disease or 
disorder and its treatment on their life. Thus, PROMs are increasingly used by clinicians to 
guide routine patient care or for the purposes of audit and are already firmly embedded in 
clinical research (Kyte et al., 2015). This review supports the view of Weldring and Smith 
(2013) that when clinical trials involve conditions in which there is no objective outcome 
measurement, such as the degree of morbidity or biomarkers for symptoms, and in which 
outcomes can only be observed subjectively to the patient in terms of impact; PROMs can be 
used as primary outcome measures. We believe that disease specific PROMs are more idealistic 
as primary outcome measures as they have greater face validity and credibility than generic 
PROMs, but these comparisons cannot always be made across a variety of conditions. The 
inclusion of PROMs with clinical outcomes in research and clinical practice can provide a more 
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complete understanding of the impact of an intervention, therapy, and/or service on the patient 
(Weldring & Smith, 2013). 
The outcome measures used in the studies, difference in headache days from headache 
diaries in TTH trial, Patient Rated Tennis Elbow Evaluation (PRTEE) Scale for LE trial, 
McGill Pain Questionnaire (MPQ) and Quebec Back Pain Disability Scale (QBPDS) in CLBP 
were the commonly used scales in this area of research with acceptable reliability, validity and 
sensitivity. Reliance on PROMs often makes the outcome validity questionable especially with 
recall bias. The three trials included have reported that the outcome objective and patient 
improvement were assessed in a manner to limit bias even though the details were not present. 
Factors such as quality of life, patient perceptions of change and impact on patients’ believe 
and moods could have been also included in these trials. 
Details about the expertise/experience of the practitioners were mentioned in all RCTs, 
as MFR trained with a median MFR experience of 12 months or more.  All the studies were 
emphasizing the implementation of protocol based treatments. Protocols were   mentioned for 
all the patients in the MFR or control groups. It was pointed that after the base line assessment 
by the blinded assessor, the participants were handed over to a therapist with a protocol that he 
has to follow as per the said frequency, duration and timing and need to report any adverse 
events through the adverse event reporting system. 
All the studies plotted the blinding of the practitioner as the main problem that they 
encountered. Another major limitation identified was the inability of long-term follow up of 
study participants. Few of the earlier pilot studies with long term follow up failed to get 
sufficient data to have a statistical analysis attributable to the geographical area of the study 
where people stay mainly for education and jobs. So it was difficult to understand whether the 
differences observed at post-treatment were maintained over a longer time period. In the LBP 
trial, the author was mentioning their inability to include other outcome measures such as pain 
 
137 
beliefs, mood and quality of life as one of their limitations. Although there have been many 
scientific advances in the understanding of the neurophysiology of pain, precisely assessing 
and diagnosing a patient's chronic pain problem is not straightforward or well-defined. How 
chronic pain is conceptualized, its influences, how it is evaluated are the factors considered 
when a chronic pain diagnosis is made. There is no one-to-one relationship between the amount 
or type of organic pathology and pain intensity, but instead, the chronic pain experience is 
shaped by a myriad of biomedical, psychosocial (e.g. patients' beliefs, expectations, and mood) 
and behavioural factors (e.g. context, responses by significant others). Assessing each of these 
three domains through a comprehensive evaluation of the person with chronic pain is essential 
for treatment decisions and to facilitate optimal outcomes (Dansie & Turk, 2013). 
The other major issue with the result interpretation was the effect in the control group. 
The authors believed that the therapeutic touch, feeling of care and treatment have an effect on 
the participant, and they were attributing this as due to “meaning response” (Moerman & Jonas 
2002). None of the studies attempted an effect size calculation. Reporting effect sizes or 
estimates is considered good practice when presenting empirical research findings in many 
fields. It is recommendable for the future studies to have effect size or estimate of effect [EE] 
as part of their statistical analysis. 
The authors maintained a common theme for most of the introduction and discussion 
part as according to them, the aim was to prove the MFR effectiveness on different conditions 
than conducting studies for analysing different variables. As the need and significance of this 
analysis mentioned, the main idea of the conducted researches were to create respectable base 
for the future trial in this field. Since MFR practices vary from clinician to clinician or studies 
to studies, the authors mentioned that there emphasize was on the ‘uniformity of the practice’.  
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7.3. The Systematic Review 
A systematic review was an exhaustive review of the literature addressing a clearly 
defined question, which uses a systematic and explicit methodology to identify, select and 
critically evaluate all the relevant studies and collect and analyse the data emerging from the 
studies included in it. Systematic reviews establish whether the scientific findings of research 
studies are consistent and whether these findings can be generalised to different populations, 
limiting the various possible forms of bias and increasing the reliability and precision of the 
estimates. 
The systematic review on MFR which was published in 2015 assessed the quality, 
results and limitations of 19 RCTs found in a multi-database literature search of peer-reviewed 
articles in the English language. Analysis was completed using the Physiotherapy Evidence 
Database (PEDro) scale and the Centre for Evidence-Based Medicine’s (CEBM) Levels of 
Evidence scale. Of the 133 studies identified, 19 RCTs were eligible as per the inclusion 
criteria. The selected RCTs assessed a total of 1228 patients with the sample sizes varying from 
10 to 200 with a mean (SD) of65 (44) patients. Of 19 RCTs, 17 were of high methodologic 
quality and 2 with moderate methodologic quality, with the lowest score of 5/10 and the highest 
of 8/10 in PEDro Scale. CEBM Scale categorised14 RCTs in the 2b level of evidence (ie, small 
sample size and no long-term follow-up) and the other 5 as 1b. In many of these trials, the MFR 
treatment was adjunctive to other treatments and the potential specific MFR effect could not 
be determined.  MFR was demonstrated to be equal to or more effective than sham, 
conventional, and no treatment for various musculoskeletal and painful conditions.  The recent 
RCTs were methodologically superior with higher quality compared to the former ones. 
Nine studies concluded that MFR may be better than no treatment or sham treatment 
for various musculoskeletal and painful conditions. Seven studies demonstrated that MFR with 
a conventional therapy was more effective than a control group receiving no treatment (three 
 
139 
studies), sham treatment (one study) or with a conventional therapy. Two other studies 
highlighted MFR to be equally effective to conventional or “alternative” treatments (e.g., joint 
manipulation, back school or hot packs). These data suggest that the MFR can be a useful 
adjunct to the conventional therapies for various conditions. 
The authors quoted that “MFR may be useful as either a unique therapy or as an adjunct 
therapy to other established therapies for a variety of conditions like subacute low back pain, 
fibromyalgia, lateral epicondylitis, plantar fasciitis, headache, fatigue in breast cancer, pelvic 
rotation, hamstring tightness etc.” The reviewers concluded that MFR is emerging as a 
treatment strategy with a solid evidence base and that the studies in this review may help as a 
respectable base for future trials. In assessing the validity of this systematic review, it had clear 
inclusion and exclusion criteria and a sensitive search strategy. Included trials were assessed 
for quality using recognized critical appraisal tools. Overall, this systematic review is 
recommendable as a starting point for assessing the quality and variety of available evidence 
on the efficacy of MFR. 
Analysis of the systematic review with AMSTAR-2 tool revealed a moderate 
methodological quality. The review had positive findings regarding the inclusion criteria, 
method of selection of eligible studies and the consensus between the reviewers. The major 
flaw with this review was the noncompliance with the risk of bias analysis. The comprehensive 
research strategy met with a ‘partial yes’ as the study didn’t attempt to find out the grey 
literature and articles in press. No details of excluded studies were given in the review. 
7.3.1. Evaluation of the Validity of the Review 
Even though the systematic review clearly focused on MFR, the included studies were 
very heterogeneous in terms of population included, type of MFR administered, control groups, 
outcome measures, timing of follow-up and presentation of data. This might have affected the 
validity of the result and its generalization. Since MFR can be useful on a variety of condition 
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and relies on therapist patient interaction, the inclusion criteria might not be sufficient enough 
to streamline the result of the review. Although attempts were made to find all published RCTs, 
some relevant trials might have been overlooked including the language constraints. The 
identified studies have been evaluated for methodological quality by the PEDro Scale and the 
CEBM Scale and a risk of bias analysis was not done for the review. This might have an impact 
on the results interpreted, considering the varying quality and standard of the RCTs reviewed. 
An analysis of the possible biases or flaws might be an ideal component for the limitation part. 
The methodological quality evaluation was carried out by two independent reviewers and no 
details were given regarding the degree of agreement between them. This systematic review 
might be affected with reporting bias as four out of 19 RCTs included were from the principle 
author, but this was managed by selecting two independent evaluators not having any direct 
knowledge or expertise in MFR, once the author blinded the identified studies. The name of 
the authors, the journals, the country of origin and the results were concealed from the 
independent reviewers, as this information could theoretically influence the evaluation. 
As the systematic review of RCTs on MFR satisfies many of the factors necessary for 
internal validity, it can be assumed that the results emerging from the review will reflect the 
true effect of the intervention and it is less likely that they could have been influenced by other 
factors in a level which can influence the result. Restricting searches to databases of peer 
reviewed literature was another potential limitation including the so-called ‘grey literature’ 
would reduce potential publication bias, but would have likely increased data heterogeneity. 
Nonetheless, despite their heterogeneity and potential statistical conclusion validity issues, 
from the overall results, it can be inferred that it is worth running large scale trials to explore 
the effect of MFR in managing various conditions 
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7.3.2. Interpretation of the Results of the Review 
It is not uncommon that individual studies from a systematic review show different and 
even contradictory results. It is also relatively common to find that although the results of 
individual studies agree on the efficacy of a therapy, they do not agree on the magnitude of its 
effect. The reviewer tried to mention such issues like the heterogeneity of the population, 
treatments applied, outcome measure usage and assessment and the quality of studies included. 
The populations included in the studies could differ with regard to certain characteristics which 
influence the outcome such as the severity of the disease and population characteristics 
including but not limited to age, sex, health status etc. The reviewers commented on the 
heterogeneity in the treatments administered, and they were justifying it as a common problem 
faced by every manual therapy intervention. It is a much-recognized limitation of manual 
therapy as there is huge variation in the practice including, but not limited to, the pressure, 
technique, treatment times and engagement. It is appreciable that the authors were reporting 
these issues in their discussion part. They concluded this session with the comment that “until 
evidence is available on the possible mechanism of action of MFR, or until different 
interventions have been compared directly, there is no logical basis for choosing the optimal 
intervention” which is true in any type of manual therapy including MFR. The systematic 
review also revealed the reporting of the experience of the therapist in MFR as that, few studies 
only mentioned it, thus pointing towards a procedural bias. The session concludes by lauding 
on the reporting of adverse events as “different studies might have used different definitions of 
adverse reaction, research designs or styles of MFR in their studies”. 
Since the diversity of the cases included in the review was huge, the outcomes measured 
in the RCTs were also different with regard to the technique, the frequency or the criteria used 
which could jeopardize the comparability of results between studies.  There is no doubt that 
the scientific methodological quality in which a study is conducted could modify its results and 
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the differences between studies could be attributed to the differing qualities of the methods. 
The review did not carry out any homogeneity test. It was possible to evaluate the probability 
that the differences between the results were exclusively due to chance and not to the factors 
mentioned above. Nevertheless, a clinical view of the differences may be more informative 
than the result of a hypothesis test as the differences may have no statistical significance but 
actually be of clinical importance and vice versa. It was to be mentioned at this point the 
heterogeneity of the studies included was mainly due to the vast range of applicability of MFR 
and the methodological quality rated by the scale did not plot any unusual findings of the 
included RCTs. This might be the reason for the review team not incorporating any 
homogeneity or sensitivity tests to detect such issues and moreover the review in any steps did 
not attempt a meta-analysis.  
The two scales used for methodological quality of the included RCT were known for 
their ability to measure methodological quality and clinical hierarchy. A possible risk of bias 
analysis, if present, was an added advantage. The authors of the systematic review explain 
clearly that there was an issue with the protocol used in the studies reviewed as some studies 
used a fixed protocol while a few of them used a flexible one. It is acceptable that in manual 
therapy both methods are acceptable and have to be considered as valid until the research has 
advanced towards dose-response levels. The team reported varying levels of effectiveness and 
concluded that MFR effectiveness appears to be ‘encouraging’ and has ‘tremendous potential’, 
especially within ‘recently published studies’. 
Most of the studies reviewed did not have clear details about the blinding and most of 
the RCTs reported the blinding of the therapist and the patient as limitations. This can be 
justifiable considering the special characters that the manual therapy generally and MFR 
specifically exhibit in the interaction and application part. According to Franke et al. (2014) 
therapist or patient blinding within manual therapy trials are impossible. There were also larger 
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issues surrounding generalizability of strictly-controlled RCT-derived results into general 
manual therapy practice as required by an evidence-based model (Milanese, 2011). There is 
evidence that MFR alone or added to other conventional therapies relieves pain and improves 
function not less than conventional therapies studied. According to these results, MFR may be 
useful as either a unique therapy or as an adjunct therapy to other established therapies for a 
variety of conditions as mentioned in the review. The review also highlights the fact that ‘the 
magnitude of the effects were mostly retained’ in studies with follow ups even though such 
studies were less in number.  
Though the result of the review was pointing towards advocating its usefulness, there 
were a number of threats that challenge the statistical inferences underpinning these findings. 
Due to the high levels of data heterogeneity and underpowered sample size within trials, 
generalization of results was almost impossible. Results could not be concluded into a 
definitive statement on the effectiveness of MFR. The authors of the review in the beginning 
part of the discussion initiates this point with the statement, “it seems reasonable that in the 
authors’ qualitative synthesis, the best evidence would be provided by the higher quality studies 
which are less likely to have biased results”. This review supports the norm that it is unlikely 
that usage of any other rating system would have given a different result. 
The authors were pointing towards the higher possibility of the type I error this review 
can produce due to the underpowered samples tested and recommending caution on the result 
interpretation. All reviewed RCTs set a priori significance levels of p≤0.05, a level known to 
generate false positive findings in at least 30% of adequately powered studies and much higher 
percentages of false positive findings in underpowered studies (Colquhoun, 2014). The authors 
were indirectly mentioning the chance of super-realisation bias in the studies as most of the 
studies were with a relatively smaller sample size which in turn will produce more tightly 
controlled delivery of interventions and the collection of outcome data in ways that are not 
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logistically possible in larger ones (Crocker et al., 2013). This is not to say that the small trial 
results are therefore intrinsically biased, but pooling data from a number of these relatively 
well-controlled small trials may create a positive bias; pooling data from a series of small trials 
is not a substitute for a large scale trial (Slavin & Smith, 2009). 
7.3.3. Applicability of the Results of the Review for Clinical Practice 
It is impossible to actively promote implementation of the results of all systematic 
reviews because of the limited capacity of health systems to absorb the new evidence and 
implement the necessary measures to do away with the obstacles that hamper translation of the 
results of theory into practice. With underpowered sample size and the heterogeneity of the 
studies, we cannot argue that MFR need to be there in the management of the conditions studied 
in this review. This review can only suggest to clinicians that there is evidence that MFR alone 
or added to other conventional therapies, relieves pain and improves function not less than 
conventional therapies. To have more powerful recommendations, we need studies with 
properly calculated sample sizes, adequate power, more reliable and validated outcome 
measures, follow-up time points and appropriate levels of significance.  
If a therapist is looking at the results of a study he/she must consider the feasibility of 
selecting and applying a particular MFR technique based on the environment, the options 
available, the usage of best practices, the expertise of the staff in MFR, type and stage of the 
condition as well as factors such as the training of staff. If required, changes in established 
practice in the service and the acceptance by patients or their relatives that this new intervention 
should be applied to them. The patient and the therapist should both feel at ease around one 
another. The experience and training of the myofascial therapists who gave the treatments were 
mentioned in a few studies mentioned in the review. In other way one can say that MFR can 
be a non-invasive, non-pharmacological and low cost alternative for various conditions with 
very minimal adverse events. 
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Recommendations for future randomised, effectiveness trials on MFRs include: a-priori 
calculated sample sizes, adequate power, reliable and validated outcome measures,  limiting 
the sources of bias, follow-up time points beyond 24 hours and appropriate levels of 
significance, assessing the threats to statistical validity and appropriate registration. Most 
importantly, RCTs should present between group differences (complete with confidence 
intervals and effect sizes) and desist from reporting within group differences as evidence of 
effectiveness (Matthews and Altman, 1996; Schulz et al., 2010).  
Sample size calculation is one of the first and most essential parts of designing a good 
quality trial. To make a definitive conclusion about the findings of an RCT, it is essential to 
ensure at least 80% power throughout the trial. For ethical and methodological purposes, we 
strongly recommend involving an epidemiologist or a biostatistician at the planning stage of a 
study, because these calculations are prone to bias and because there are ethical and financial 
costs related to conducting an RCT. A well-planned and methodologically sound protocol will 
have a strong chance of success. 
These recommendations would support inferences of clinically meaningful results and 
facilitate future meta-analyses. We echo current calls for transparency within all clinical trials 
and endorse journal adoption of reporting guidelines (Hoffmann et al,2014; Chan et al., 2014).  
Finally, it is admirable to the conclusion of the authors, “to attain the highest-quality 
evidence, RCT designs should be good quality, participants should be randomised, adherence 
to the double blinding and the clinician performing the MFR should use it regularly in clinical 
practice”. They have added that the subjective component of MFR must be addressed in future 
study designs as it is having a major relevance in this type of studies. It is very clear that the 
effectiveness of MFR can vary with the comfort level of the patient controlling of which is 
difficult but not impossible. 
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In conclusion, this systematic review demonstrated moderate methodological quality as 
per the AMSTAR tool. Omission of a risk of bias analysis was the major limitation of this 
review. Lack of heterogeneity testing, missing components in ‘comprehensive research 
strategy’ and study setting details were the other limitations found. The authors concluded that 
the literature regarding the effectiveness of MFR was mixed in both quality and results. 
Although the quality of the RCT studies varied greatly, the result of the studies were 
encouraging, particularly with the recently published studies. The review ends by coining that 
MFR is emerging as a strategy with a solid evidence base and tremendous potential and the 
studies in this review may serve as a good foundation for the future trials 
It was appraisable that the systematic review ends with suggestions of refinement to be 
incorporated in the future trials like studying of clearly defined medical conditions, controlling 
the intrinsic and extrinsic factors to the maximum possible level, studying the effectiveness of 
MFR as single therapy and comparing it with a control (no-treatment) group and with other 
established treatments. The authors were hopeful that by adhering to such guidelines in the 
future will surely result in much higher quality studies producing more accurate results. This 
analysis supports many of the norms put forward by the systematic review team and believes 
that such attempts will make the research in physical therapy field more valid and reliable.  
Critical appraisal is an important element of evidence-based medicine to carefully and 
systematically examine research to judge its trustworthiness, its value and relevance in a 
particular context. This analysis concludes with a statement that ‘the three RCTs and systematic 
review analysed in this thesis have the potential to move the Myofascial release research into 
the next level, though methodological flaws and interpretation biases were evident’. These 
attempts should be highly appreciated as this will create reputable backgrounds on which the 
future trials can be built on. 
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8.1. Conclusion 
Fascia is a ubiquitous tissue permeating the entire body. It surrounds, supports, 
suspends, protects, connects and divides muscular, skeletal and visceral components of the 
organism. The fascial system is considered as a ‘tensegrity’ or tensional integrity structure to 
manage the balance between tension and compression around the organs, joints and muscles. 
Studying fascia objectively at the basic science and clinical level will provide important 
information that may change clinical practice. Once the structure and functions of fascia in the 
musculoskeletal system are further elucidated, the pathophysiology of many disorders and their 
consequences may be better explained. 
Myofascial release (MFR) is a form of manual therapy which involves the application 
of a low load and long duration stretch to the myofascial complex which is intended to restore 
optimal length, decrease pain and improve function. The rationale for these techniques can be 
traced to various studies that investigated plastic, viscoelastic, and piezoelectric properties of 
connective tissue. MFR is being used to treat patients with a wide variety of conditions, but 
there is scarcity of evidence to support its efficacy. The effects of manual fascial interventions 
can be local, segmental and global in extent and may occur at different intervals—ranging from 
minutes to weeks—after a given input with many interacting mechanisms influencing tissue 
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properties and behaviours including placebo.  Some of these factors are strongly supported by 
the available evidence whereas others need further investigation. 
This work attempted to critically analyse three published randomised controlled trials 
(RCTs) and one systematic review of myofascial release with an aim of facilitating the creation 
of a more homogenous and reputable base for the future trials in the field.  
Three randomised controlled studies on MFR were analysed in this review. The RCTs 
analysed in this study were of moderate to high methodological quality (PEDro Scale), with 
higher level of evidence (CEBM Scale) and fewer bias (RoB). The effectiveness of MFR on 
tension type headache was the first among the studies with a moderate methodological quality 
(6/10 in PEDro) and with 2b level of evidence in CEBM Scale. The study proved that direct 
technique or indirect technique MFR was more effective than the control intervention for 
tension headache. The second RCT studied MFR as a treatment for lateral epicondylitis. The 
study was of a moderately high quality on the PEDro Scale (7/10) with 1b- level in CBEM. 
This study verified that MFR was more effective than a control intervention for LE in computer 
professionals. The RCT on chronic low back pain also scored 7/10 in the PEDro Scale and 1b 
in the CEBM Scale. This study confirmed that MFR can be a useful adjunct to specific back 
exercises than a control intervention for CLBP.  
Even though the RCTs analysed were methodologically superior with higher quality 
compared to many studies in this field, all the three RCTs stated the usage of self-report 
measures and underpowered sample size as the major limitations along with a performance 
bias reported in the TTH trial. Limitations including improper blinding of the therapists and 
the patients, recall and reporting bias, long term follow up issues and lack of effect size 
calculation were a few among them. The missing of outcome data was mentioned in all the 
RCTs. The three trials included have reported that the outcome objective and patient 
improvement were assessed in a manner to limit bias even though the details were not present. 
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All of the RCTs have given some details about the expertise/experience of the practitioners and 
with a well-structured protocol. As the need and significance of this analysis mentioned, the 
main idea of the conducted researches were to create respectable base for future trial in this 
field. Since MFR practices vary from clinician to clinician or studies to studies, the authors 
were recommending more uniformity in the practice. 
The analysed systematic review on MFR was published in 2015 and was designed to 
assess the quality, results and limitations of 19 RCTs found in a multi-database literature search 
of peer-reviewed articles in the English language based on clear inclusion criteria. AMSTAR 
2 was used to measure the quality of the systematic review and demonstrated moderate 
methodological quality as a whole. Omission of a risk of bias analysis was the major limitation 
found. Considering the varying quality and standard of the RCTs reviewed, an analysis of the 
possible biases or flaws might have been an advantage. Lack of heterogeneity testing, missing 
components in ‘comprehensive research strategy’ and study setting details were the other 
limitations found but they were justified under limitations of the study.  The selected RCTs 
assessed a total of 1228 patients with the sample sizes varying from 10 to 200 with a mean 
(SD) of 65 (44) patients. The methodological qualities of the included RCTs were moderate to 
high. Rating with CEBM Scale revealed that 14 RCTs were in the category of 2b while the 
remaining were in category 1b. In many of these trials, the MFR treatment was adjunctive to 
other treatments and the potential specific MFR effect could not be determined. The authors 
quoted, “MFR may be useful as either a unique therapy or as an adjunct therapy to other 
established therapies for a variety of conditions”. 
  In assessing the validity of this systematic review, it had clear inclusion and exclusion 
criteria and a sensitive search strategy. Included trials were assessed for quality using 
recognized critical appraisal tools. Overall, this systematic review can be recommended as a 
starting point for assessing the quality and variety of available evidence on the efficacy of 
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MFR. Even though the systematic review clearly focuses on Myofascial release, the included 
studies were very heterogeneous. The reviewer tried to mention such issues like the 
heterogeneity of the population, treatments applied, outcome measure usage and assessment 
and the quality of studies included. Though the result of the review was pointing towards 
advocating its usefulness, there were a number of threats that challenge the statistical inferences 
underpinning these findings. The main issue was with the generalization of the result. They 
were even advocating caution on the result interpretation due to the possible type I error 
resulted from the underpowered samples. This review can only suggest a clinician that there is 
evidence that MFR alone or added to other conventional therapies, relieves pain and improves 
function not lesser than conventional therapies studied. Recommendations for future 
randomised, effectiveness trials on MFRs include: a-priori calculated sample sizes, adequate 
power, reliable and validated outcome measures, limiting the sources of bias, follow-up time 
points beyond 24 hours and appropriate levels of significance, assessing threats to statistical 
validity and appropriate registration. Most importantly, RCTs should present between group 
differences and desist from reporting within group differences as evidence of effectiveness. 
These recommendations would support inferences of clinically meaningful results and 
facilitate future meta-analyses. This review also supports for the call for transparency within 
all clinical trials and endorsing of journal adoption of reporting guidelines. The subjective 
component of MFR must be addressed in future study designs as it is having a major relevance 
in these types.  
This systematic review concludes by stating various measures to be incorporated in the 
future trials. The authors were optimistic that by adhering to such guidelines in the future will 
surely result in much higher quality studies there by more accurate results. This analysis 
supports many of the norms put forward by the systematic review authors and believes that 
such attempts will make the research in physical therapy field more valid and reliable.  
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Critical appraisal is an important element of evidence-based medicine to carefully and 
systematically examine research to judge its trustworthiness, value and relevance in a particular 
context. An in-depth analysis of the selected RCTs and systematic review was attempted here 
to find out the strength and weakness with suggestions for future works in this field. This 
analysis concludes that the three RCTs and the systematic review analysed in this review had 
the potential to move the Myofascial release research into the next level, though 
methodological flaws and interpretation biases are evident. These types of attempts should be 
appreciated and facilitated as this will create reputable backgrounds on which high quality 
future trials can be built on. 
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